Advertisement

Lexikon der Syndrome und Fehlbildungen

  • Regine Witkowski
  • Otto Prokop
  • Eva Ullrich
Chapter
  • 285 Downloads

Zusammenfassung

Genetisch bedingter Fehlbildungskomplex auf der Grundlage einer Genmutation.

Literatur

  1. Porteous, M.E.M., A. Curtis, S. Lindsay, O. Williams, D. Goudie, S. Kamaraki and S.S. Bhattacharya, The gene for AARSKOG syndrome is located between DXS255 and DXS566 (Xpl1.2-XqI3). Genomics 14 (1992) 298–301PubMedGoogle Scholar
  2. Teebi, A.S., J.K. Rucquoi and M.S. Meyn, AARSKOG syndrome: Report of a family and discussion of nosology. Am.J.Med.Genet. 46(1993) 501–509PubMedGoogle Scholar
  3. Zheng, Y., D.J. Fischer, M.F. Santos, G. Tigyi, N.G. Pasteris et al., The faciogenital dysplasia gene product FGDI functions as a Cdc42Hs-specific guanine- nucleotide exchange factor. J.Bio1.Chem. 52 (1996) 33169–33172Google Scholar
  4. D’ Avanzo, M., V. Pistoia, R. Santinelli, C. Tolone, R. Toraldo, A. Corcione, G. Canino and F. Iafusco, Heterogeneity of the erythropoietic defect in two cases of AASE-SMITH syndrome. Pediat.HematoLOnco1. 11 (1994) 189–195Google Scholar
  5. Hurst, J.A., M. Baraitser and B. Wonke, Autosomal dominant transmission of congenital erythroid hypoplastic anemia with radial abnormalities. Am.J.Med.Genet. 40 (1991) 482–484PubMedGoogle Scholar
  6. Muis, N., F.A. Beemer, P. van Dijken and J.M. Klepde Pater, The AASE syndrome. Eur.J.Pediat. 145 (1986) 153–157Google Scholar
  7. Pfeiffer, R.A. und E. Ambs, Das AAsE-Syndrom: autosomal rezessiv vererbte, konnatal insuffiziente Erythropoese und Triphalangie des Daumens. Mschr.Kinderheilk. 131 (1983) 235–237Google Scholar
  8. Gahl, W.A., G.F. Reed, J.G. Thoene et al., Cysteamine therapy for children with nephropathic cystinosis. New EngI.J.Med. 316 (1987) 971–977Google Scholar
  9. Gahl, W.A. and F. Tietze, Lysosomal cystine transport in cystinosis variants and their parents. Pediat. Res. 21 (1987) 193–196PubMedGoogle Scholar
  10. McDowell, G., T. lsogai, A. Tanigami et al., Fine mapping of the cystinosis gene using an integrated genetic and physical map of a region within human chromosome band 17p13. Biochem. Mol.Med. 58 (1996) 135–141PubMedGoogle Scholar
  11. Peters, U., G. Senger, M. Rahlmann, I.Du Chesne, I. Stec et al., Nephropathic cystinosis (CTNSLSB): Construction of a YAC contig comprising the refined critical region on chromosome 17p13. Eur.J.Hum.Genet. 5 (1997) 9–14PubMedGoogle Scholar
  12. Smith, M.L., O.L. Pellett, M.M.J. Cass et al., Prenatal diagnosis of cystinosis utilizing chorionic villous sampling. Prenatal Diagn. 7 (1987) 23–26Google Scholar
  13. Town, M., G. Jean, S. Cherqui, M. Attard, L. Forestier et al., A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nature Genet. 18 (1998) 319–324PubMedGoogle Scholar
  14. Cunningham, M.J., R.D. Eavey, and D.C. Channon, Familial vocal cord dysfunction. Pediatrics 76 (1985) 750–753PubMedGoogle Scholar
  15. Gacek, R.R., Hereditary abductor vocal cord paralysis. Ann.Otoi. 85 (1987) 90–93Google Scholar
  16. Manaligod, J.M. and R.J.H. Smith, Familial laryngeal paralysis. Am.J.Med.Genet. 77 (1998) 277 -280PubMedGoogle Scholar
  17. Schinzel, A., E.Hof, P. Dangel and W. Robinson, Familial congenital laryngeal abductor paralysis: different expression in a family with one male and three females affected. J.Med.Genet. 27 (1990) 715–716PubMedGoogle Scholar
  18. Cunningham, M.J., R.D. Eavey, and D.C. Channon, Familial vocal cord dysfunction. Pediatrics 76 (1985) 750–753PubMedGoogle Scholar
  19. Gacek, R.R., Hereditary abductor vocal cord paralysis. Ann.Otoi. 85 (1987) 90–93Google Scholar
  20. Facio, S., A. Sidoli, A. Vivenzio et al., A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene. J.lntern. Med. 229 (1991) 41–47Google Scholar
  21. Gay, G., M. Pessah, M.E. Bouma et al., L’hypobétalipoproteinemie familiale. Étude familiale de 4 cas. Rév.Med.lnterne 11 (1990) 273–279Google Scholar
  22. Heath, K.E., I.-A. Luong, I.V. Leonad et al., The use of a high informative CA repeat polymorphism within the abetalipoproteinaemia locus (4q22- 23). Prenatal Diagn. 17 (1997) 1181–1186Google Scholar
  23. Lodi, R., R. Rinaldi, A. Gaddi et al., Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinemia. J.NeuroI.Neurosurg.Psychiatry 62 (1997) 574–580Google Scholar
  24. Young, S.G., B. Bihain, L.M. Flynn, D.A. Sanan, M. Ayrault-Jarrier and B. Jacotot, Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2. Hum.Molec.Genet. 3 (1994) 741–744PubMedGoogle Scholar
  25. David, A., A. Gordeeff, J. Baduoal and J. Delaire, Macrostomia, ectropion, atrophic skin, hypertrichosis: another observation. Am.J.Med.Genet. 39 (1991) 112–115PubMedGoogle Scholar
  26. McCarthy, G.T. and C.M. West, Ablepharon macrostomia syndrome. Dev.Med.Child Neurol. 19 (1977) 659–672PubMedGoogle Scholar
  27. Pelegrino, J.E., R.E. Schnur, L. Boghosian-Sell et al., Ablepharon macrostomia syndrome with associated cutis laxa: possible localization to 18q. Hum.Genet. 97 (1996) 532.536Google Scholar
  28. Boue, J., A. Boue and P. Lazar. Retrospective and prospective epidemiological studies of 1500 karyotyped human abortions. Teratology 12 (1975) 11–26PubMedGoogle Scholar
  29. Marteai, T., H. Drake, M. Reid, M. Feijoo, M. Soares, I. Nippert, P. Nippert and M. Bobrow, Counselling following diagnosis of fetal abnormality: A comparison between German, Portuguese and UK geneticists. Eur.J.Hum.Genet. 2 (1994) 96–102Google Scholar
  30. Opitz, J., Blastogenesis and the ’Primary fields’ in human development. Birth Defects: OAS 29 (1993) 3–37Google Scholar
  31. Tharapel, A.T., S.A. Tharapel and R.M. Bannerman, Recurrent pregnancy losses and parental chromosome abnormalities: A review. Br.J.Obstet. Gynecol. 92 (1985) 899–914Google Scholar
  32. Fisher, G.H., F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middelton, A.Y. Lin et aL, Dominant interfe- ring Fasgene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81 (1995) 935–946PubMedGoogle Scholar
  33. Glastre, C. et D. Rigal, Le syndrome d’ OMENN. Pediatrie 45 (1990) 301–305PubMedGoogle Scholar
  34. Ohadi, M., M.R.A. Lalloz, P. Sham et al, Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. Am. J. Hum. Genet. 64 (1999) 165–177PubMedGoogle Scholar
  35. Straus, S.E., M. Lenardo and J.M. Puck, The CANALESMITH syndrome. New Engl.J.Med. 336 (1997) 1457PubMedGoogle Scholar
  36. Moller, D.E., O. Cohen, Y.Y amaguchi et al., Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 43 (1994) 247–255PubMedGoogle Scholar
  37. Tasjian, D. and M. Jarrat, Familial acanthosis nigricans. Arch.Derm. 120(1984) 1351–1354PubMedGoogle Scholar
  38. Boor, R., J. Herwig, J. Schrezenmeir et al., Familial insulin resistant diabetes associated with acanthosis nigricans, polycystic ovaries, hypogonadism, pigmentary retinopathy, labyrinthine deafness, and mental retardation. Am.J. Med.Genet. 45 (1993) 649–653PubMedGoogle Scholar
  39. Okamoto, N., S. Wada, T. Oga, Y. Kawabata, Y. Baba, D. Habu, Z.T akeda and Y. Wada, Hereditary ceruloplasmin deficiency with hemosiderosis. Hum.Genet. 97 (1996) 755–758PubMedGoogle Scholar
  40. Yoshida, K.K. Furihata, S. Taketa et al., A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genet. 5 (1995) 267- 272Google Scholar
  41. Yazaki, M., K. Yoshida, A. Nakamura et al., A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficieny with hemosiderosis. J.NeuroI.Sci. 156 (1998) 30- 34Google Scholar
  42. Kasirga, E., F. Özkinay, S. Tütümcüoglu, S. Aydogdu et al., Four siblings with achalia, alacrimia and neurological abnormalities in a consanguineous family. Clin.Genet. 49 (1996) 296–299PubMedGoogle Scholar
  43. O’Brien, c.J. and H.L. Smart, Familial coexistence of achalasia and non-achalasic oesophageal dysmotility: Evidence for a common pathogenesis. Gut 33 (1992) 1421–1423PubMedGoogle Scholar
  44. Weber, A., T.F. Wienker, M. Jung, D. Easton, H.J. Dean, C. Heinrichs, A. Reis and H.J.L. Clark, Linkage of the gene for the triple A syndrome to chromosome 12q13 near the type II keratin gene cluster. Hum.Molec.Genet. 5 (1996) 2061- 2066PubMedGoogle Scholar
  45. Duncan, P.A., The ACHARD syndrome. Birth Def., Orig.Art.Ser. 11 (1975) 69–73Google Scholar
  46. Lacombe, D. and J. Battin, MARFANoid features and craniosynostosis: report of one case and review. Clin. Dysmorphol. 2 (1993) 220–224PubMedGoogle Scholar
  47. Saal, H., D.I. Bulas, J. Fonda Allen, G. Vezina and D. Walton, Patient with craniosynostosis and MARFANOid phenotype (SHPRINTZEN-GOLDBERG syndrome) and cloverleaf skull. Am.J. Med.Genet. 57 (1995) 573–578PubMedGoogle Scholar
  48. Freire-Maia, A., N. Freire-Maia, N.E. Morton, E.S. Azevedo, and A. Quelce-Salgado, Genetics of acheiropodia (the handless and footless families of Brazil. Vr.). Formal genetic analysis. Am.J. Hum.Genet. 27 (1975) 521–527PubMedGoogle Scholar
  49. Morey, M.A. and R.R. Higgins, Ectro-amelia associated with an interstitial deletion of 7q. Am.J. Med.Genet. 99 (1990) 35–95Google Scholar
  50. Bogaert, R., G.E. Tiller, M.A. Weis et al., An amino acid substitution (Gly953_Glu) in the collagen alpha1(II) chain produces hypochondrogenesis. J.BioI.Chem. 267 (1992) 22422–22526Google Scholar
  51. Borochowitz, Z., A. Ornoy, R. Lachman and D.L. Rimoin, Achondrogenesis II -hypochondrogenesis: Variability versus heterogeneity. Am.J.Med.Genet. 24 (1986) 273–288PubMedGoogle Scholar
  52. Cai, G., M. Nakayama, Y. Hiraki and K. Ozono, Mutational analysis of the DTDSTgene in a fetus with achondrogenesis type lB. Am.J.Med.Genet. 78 (1998) 58–60PubMedGoogle Scholar
  53. Costa, T., G. Ramsby, F. Cassia, K.-R. Peters et al., GREBE syndrome: Clinical and radiographic findings in affected individuals and heterozygous carriers. Am.J.Med.Genet. 75 (1998) 523–529PubMedGoogle Scholar
  54. Curtis, D., Heterozygote expression in GREBE Chondrodysplasia. Clin.Genet. 29 (1986) 455- 456PubMedGoogle Scholar
  55. Eyre, D.R., M.P. Upton, F.D. Shapiro et al., Nonexpression of cartilage type II collagen in a case of LANGER-SALDINO achondrogenesis. Am.J. Hum.Genet. 39 (1986) 52–67PubMedGoogle Scholar
  56. Hunter, A.G.W. and M.W. Thompson, Acromesomelic dwarfism: description of a patient and comparison with previously reported cases. Hum.Genet. 34 (1976) 107–113PubMedGoogle Scholar
  57. Kulkarni, M.L., B. Kumar and A Nasser, GREBE syndrome: a very severely affected case. J.Med.Genet. 32 (1995) 326–327PubMedGoogle Scholar
  58. Langer, L.O., J. Cervenka, and M. Camargo, A severe autosomal recessive acromesomelic dysplasia, the HUNTER-THOMPSON type, and comparison with the GREBE type. Hum.Genet 81 (1989) 323–328PubMedGoogle Scholar
  59. Superti-Furga, A., A defect in the metabolic activation of sulfate in a patient with achondrogenesis type lB. Am.J.Hum.Genet. 55 (1994) 1137- 1145PubMedGoogle Scholar
  60. Superti-Furga, A., Achondrogenesis type lB. J.Med.Genet. 33 (1996) 957–961PubMedGoogle Scholar
  61. Thomas, J.T., M.W. Kilpatrick, K. Lin, L. Erlacher, P. Lembessis, T. Costa, P. Tsipouras and F. Luyten, Disruption of human limb morphogenesis by a dominant negative mutation in CDMP-1.Nature Genet. 7 (1997) 58–64Google Scholar
  62. Thomas, J.T., K. Lin, M. Nandedkar, M. Camargo, J. Cervenka and F.P. Luyten, A human chondrodysplasia due to a mutation in a TGF-Bsuperfamily. Nature Genet. 12 (1996) 315–317PubMedGoogle Scholar
  63. Küster, W., O. Rödder-Wehrmann und G. Plewig, Acne inversa. Pathogenese und Genetik. Hautarzt 42 (1991) 2–4Google Scholar
  64. Melnik, B. und G. Plewig, Neue lipidchemische Aspekte der follikularen VerhornungsstOrung bei Acne vulgaris. Z. Hautkr. 63 (1988) 591–396PubMedGoogle Scholar
  65. Rödder-Wehrmann, 0., W. Küster und W. Plewig, Acne inversa. Diagnose und Therapie. Hautarzt 42 (1991) 5–8PubMedGoogle Scholar
  66. Bennett, M.J., P.M. Coates, D.E. Hale et al., Analysis of abnormal urinary metabolites in the newborn period in medium-chain acyl-CoA dehydrogenase. J.Inherit.Metab.Dis. 13 (1990) 707–715PubMedGoogle Scholar
  67. Gregersen, M., B.S. Andresen, P. Bross, V. Winter, N. Rüdiger, S. Engst, E. Christensen, D. Kelly, A.W. Strauss, S. Kolvraa, L. Bolund and S. Ghisla, Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: identification of a lys329 to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein in E.coli. Hum.Genet. 86 (1991) 545–551PubMedGoogle Scholar
  68. Iolascon, A.T. Parrella, S. Perrotta, O. Guardamagna, P.M. Coates, M. Sartore, S. Surrey and P. Fortina, Rapid detection of medium chain acyl-CoA dehydrogenase gene mutations by non-radioactive, single strand conformation polymorphism minigels. J.Med.Genet. 31 (1994) 551–554PubMedGoogle Scholar
  69. Kemp, M.P., B.B. Little, R.O. Bost and D.B. Dawson, Whole blood levels of dodecanoic acid, a routinely detectable forensic marker for genetic disease often misdiagnosed as sudden infant death syndrome (SIDS): MCAD deficiency. Am.J.Forensic Med.Pathol. 17 (1996) 79–82PubMedGoogle Scholar
  70. Naito, E., Y. lndo and K. Tanaka, Identification of two variant short chain acyl-coenzyme A dehydrogenase alleles, each containing a different point mutation in a patient with short chain acyl-coenzyme A dehydrogenase deficiency. J.Clin.Invest. 85 (1990) 1575–1582PubMedGoogle Scholar
  71. Nowaczyk, M.J.M., S.I. Blaser and J.T.R. Clarke, Central nervous system malformations in ethylmalonic encephalopathy. Am.J.Med.Genet. 75(1998) 292–296PubMedGoogle Scholar
  72. Treem, W.R., C.A. Stanley. D.E. Hale, H.B. Leopold and J.S. Hyams, Hypoglycemia, hypotonia, and cardiomyopathy: the evolving clinical picture oflong-chain acyl-CoA dehydrogenase deficiency. Pediatrics 87 (1991) 328–333PubMedGoogle Scholar
  73. Vianey-Saban, C., P. Divry, M. Brivet et al., Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin.Chim.Acta 269 (1998) 43–62PubMedGoogle Scholar
  74. Hakoda, M., H. Yamanaka, N. Kamatani and N. Kamatani, Diagnosis of heterozygous states for adenine phosphoribosyltransferase based on detection of in vivo somatic mutants in blood T cells: Application to screening of heterozygotes. Am.J.Hum.Genet. 48 (1991) 536–545Google Scholar
  75. Menardi, C., R. Schneider, F. Neuschmid-Kaspar, H. Klocker, M. Hirsch-Kaufmann, B. Auer and M. Schweiger, Human APRT deficiency: Indication for multiple origins of the most common caucasian mutation and detection of a novel type of mutation involving intrastrand-templated repair. Hum.Mutation 10(1997) 251–255Google Scholar
  76. Taniguchi, A., M. Hakoda, H. Yamanaka, C. Terai, K. Hikiji et al., A germline mutation abolishing the original stop codon of the human adenine phosphoribosyltransferase (APRT) gene leads to complete loss ofthe enzyme protein. Hum.Genet. 102(1998) 197–202PubMedGoogle Scholar
  77. Zöllner, N. and V. Gresser, Nephrolithiasis in twins with APRT -deficiency. Stones as a marker of an inborn error of metabolism. Bildgebung Imaging 57 (1990) 64–66PubMedGoogle Scholar
  78. Tschang, T.P., E. Poulos, C.K. Ho and T.T. Kuo, Multiple sebaceous adenomas and intestinal malignant disease: A case report with chromosomal analysis. Hum.Path. 7 (1976) 589–594PubMedGoogle Scholar
  79. Agarwal, S.K., M.B. Kestner, L.V. Debelenko, C. Heppner, M.R. Emmert-Buck et al., Germline mutations of the MEN1gene in familial multiple endocrine neoplasia type 1 and related states. Hum.Molec.Genet. 6 (1997) 1169–1175PubMedGoogle Scholar
  80. Bassett, J.H.D., S.A. Forbes, A.A.J. Pannett, S.E. Lloyd et al., Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am.J. Hum.Genet. 62 (1998) 232–244PubMedGoogle Scholar
  81. European Consortium on MEN1, Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1). Hum.Genet. 100(1997) 657–665Google Scholar
  82. Jung, R.T., A.M. Grant, M. Davie, D. Jenkins, T.M. Chalmers et al., Multiple endocrine adenomatosis (type I) and familial hyperparathyroidism. Postgrad.Med.J. 54 (1978) 92–94PubMedGoogle Scholar
  83. Lamers, C.B., J.T. Buis, and J. van Tongeren, Secretion stimulated serum gastrin levels in hyperparathyroid patients from families with multiple endocrine adenomatosis type I. Ann.lntern. Med. 86 (1977) 719–724Google Scholar
  84. Manickam, P., S.c. Guru, L.V. Debelenko, S.K. Agarwal, S.-E. Olufemi et al., Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1)region. Hum.Genet. 101 (1997) 102–108PubMedGoogle Scholar
  85. Stuhrmann, M., Der direkte Gentest beim familiären medullären Schilddrüsenkarzinom und bei MEN-Syndromen. Nachweis von Mutationen in RET-Proto-Onkogenen erspart ScreeningUntersuchungen. Fortschr.Med. 113 (1995) 25- 28Google Scholar
  86. Boccia, L.-M., J.S. Green, c. Joys, C. Eng, S.A.M. Taylor and L.M. Muligan, Mutation of RETcodon 768 is associated with the FMTC phenotype. Clin.Genet. 51 (1997) 81–85PubMedGoogle Scholar
  87. Donis-Keller, H., S. Dou, D. Chi, K.M. Carlson, K. Toshima, T.C. Lairmore, R. Howe, J.F. Moley, P. Goodfellow and S.A. Wells, MEN 2A and FMTC. Hum.MoI.Genet. 2 (1993) 851–856Google Scholar
  88. Howe, J.R., T.C. Lairmore, S.K. Mishra et al., Improved predictive test for MEN2 using flanking dinucleotide repeats and RFLPs. Am.J.Hum.Genet. 51 (1992) 1430–1442PubMedGoogle Scholar
  89. Morrison, P.J. and N.C. Nevfin, Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, WAGENMANN-FROBOESE syndrome. J.Med.Genet. 33 (1996) 779–782PubMedGoogle Scholar
  90. Pausova, Z., E. Soliman, N. Amizuka et al., Role of the RETproto-oncogene in sporadic hyperparathyroidism and in hypoparathyroidism of multiple endocrine neoplasia type 2. J.Clin.Endocrinol. Metab. 81 (1996) 2711–2718Google Scholar
  91. Williamson, c., A.A.J. Pannnet, J.T. Pang, C. Wooding et al., Localisation of a gene causing endocrine neoplasia to a 4 eM region on chromosome Ip35-p36. J.Med.Genet. 34 (1997) 617–619PubMedGoogle Scholar
  92. Xue, F., H. Yu, L.H. Mauer, V.A. Memoli, N. NutileMcMenemy, M.K. Schuster, D.W. Bowden, J. Mao and W.W. Noll, Germline RETmutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. Hum.Molec.Genet. 3 (1994) 635–638PubMedGoogle Scholar
  93. Aitken, D.A., D.H. Gilmore, C.A. Frew et al., Early prenatal investigation of a pregnancy at risk of adenosine deaminase deficiency using chorionic villi. J.Med.Genet. 23 (1986) 52–54PubMedGoogle Scholar
  94. Hirschhorn, R., Adenosine deaminase deficiency. Immunodefic. Rev. 2/3 (1990) 175–198PubMedGoogle Scholar
  95. Hogerbrugge, P.M., J.J.H. Blessing, J.M. Vossen and D. Valerio, Treatment of adenosine deaminase deficiency. Biodrugs 9 (1998) 87–93Google Scholar
  96. Hanel, H.K. and J. Cohn, Adenosin-triphosphatase deficiency in a family with non-spherocytic hemolytic anaemia. Scand.J. Haemat. 9 (1972) 28–35PubMedGoogle Scholar
  97. Harvald, B., K.H. Hanel, R. Squires, and J. Trap-Jensen, Adenosine-triphosphatase deficiency in patients with non-spherocytic hemolytic anemia. Lancet 1964/II 18–19Google Scholar
  98. Harriman, D.G.F. and H. Garland, The pathology of ADIE’S syndrome. Brain. 91 (1968) 401–418PubMedGoogle Scholar
  99. Vogir, R., A propos de syndrome d’ ADIE. Rev.Neurol. 132 (1976) 869–872PubMedGoogle Scholar
  100. Geller, D.H., R.J. Auchus, B.B. Mendonca and W.L. Miller, The genetic and functional basis of isolated 17,20-lyase deficiency. Nature Genet. 17 (1997) 201–205PubMedGoogle Scholar
  101. Gordon, M.T., D.l. Conway, D.C. Anderson and R. Harris, Genetics and biochemical variability of variants of 21-hydroxylase deficiency. J.Med.Genet. 22 (1985) 354–360PubMedGoogle Scholar
  102. Haglund-Stengler, B., E.M. Ritzen, J. Gustafsson and H. Luthman, Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency. Proc.Nat.Acad.Sci.USA 88 (1991) 8352–8356PubMedGoogle Scholar
  103. Joehrer, K., St. Geley, E.M.C. Strasser-Wozak, R. Azziz, H.A. Wolimann, K. Schmitt, R. Kofler and P.C. White, CYPllB1mutations causing nonclassical adrenal hyperplasia due to ll/i-hydroxylase deficiency. Hum.Molec.Genet. 6 (1997) 1829–1834PubMedGoogle Scholar
  104. Lifton, R.P., R.G. Dluhy, M. Powers, G.M. Rich, S. Cook, S. Ulick and L.-M. Lalouel, A chimaeric 11-ß-hydroxylase/aidosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355 (1992) 262–265PubMedGoogle Scholar
  105. Nishi, Y. and T. Tezuka, Mild adrenal3-ß-hydroxysteroid dehydrogenase deficiency in children with accelerated growth, premature pubarche and/or hirsutism. Europ.J.Pediat. 151 (1992) 19–23PubMedGoogle Scholar
  106. Rosier, A., N. Weshler, E. Leiberman, Z. Hochberg, J. Weidenfeld, J. Sack and J. Chemke, 11-fJ-hydroxylase deficiency congenital adrenal hyperplasia: update of prenatal diagnosis. J.Clin Endocr.Metab. 66 (1988) 830–838Google Scholar
  107. Scaroni, C., A. Biason, G. Carpene, G. Opocher and F. Mantero, 17 -a-hydroxylase deficiency in three siblings: short- and long-term studies. J.Endocr. Invest. 14 (1991) 99–108PubMedGoogle Scholar
  108. Yanase, T., E.R. Simpson and M.R. Waterman, 17-ahydroxylaseI17,20- lyase deficiency: from clinical investigation to molecular definition. Endocr. Rev. 12 (1991) 91–108PubMedGoogle Scholar
  109. Gartner, J., A. Braun, A. Holzinger et al., Clinical and genetic aspects of X-linked adrenoleukodystrophy. Neuropediatrics 29 (1998) 3–13PubMedGoogle Scholar
  110. Marynen, P., M. Fransen, P. Raeymaekers, G.P. Mannaerts and P.P. van Veldhoven, The gene for the peroxisomal targeting signal import receptor (PXRl) is located on human chromosome 12p13, flanked by TPIland D12S1089. Genomics 30 (1995) 366–368PubMedGoogle Scholar
  111. Mosser, J., Y. Lutz, M.E. Stoeckel et al., The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum.MoI.Genet. 3 (1994) 263–271Google Scholar
  112. Uichiyama, M., Y. Hata and S. Tada, MR imaging of adrenoleukodystrophy. Neuroradiology 33 (1991) 25–29Google Scholar
  113. Adams, l.J., P.B. Mitchell, S.l. Fielder, A. Rosso, J.A. Donald and P.R. Schofield, A susceptibility locus for bipolar disorders on chromosome 4q35. Am.J.Hum.Genet. 62 (1998) 1084–109lPubMedGoogle Scholar
  114. Baron, A., M.P. Piccardi and M. Del Zompo, Is bipolar disorder linked to Xq28 ? Nature Genet. 6 (1994) 224Google Scholar
  115. Breschel, T.S., M.G. McInnis, R.l. Margolis, F. Sirugo, B. Corneliussen et al., A novel, heritable, expanding CTG repeat in an intron of the SEF2–1gene on chromosome 18q2l.l. Hum.Molec.Genet. 6 (1997) 1855–1863PubMedGoogle Scholar
  116. Hebebrand, J. and K. Henninghausen, A critical analysis of data presented in eight studies favouring X-linkage of bipolar illness with special emphasis on formal genetic aspects. Hum.Genet. 90(1992) 289–293PubMedGoogle Scholar
  117. MacKinnon, D.F., K.R. Jamison and J.R. DePaulo, Genetics of manic depressive illness. Annu.Rev. Neurosci. 20(1997) 355–373Google Scholar
  118. Nöthen,M.M., M. Rietschel und P. Propping, Genetik der bopolaren affektiven Erkrankungen. Med.Genet. 10(1998) 394–397Google Scholar
  119. Risch, N. and D. Botstein, A manic depressive history. Nature Genet. 12 (1996) 351–353PubMedGoogle Scholar
  120. Sadovnick, A.D., R.A. Remick, R. Lam, A.P. Zis, LM.L. Yee, M.J. Huggins and P.A. Baird, Mood disorder service genetic database: Morbidity risks for mood disorders in 3,942 first -degree relatives of 671 index cases with single depression, recurrent depression, bipolar I, or bipolar II. Am.J.Med.Genet. 54 (1994) 132–140PubMedGoogle Scholar
  121. Serretti, A., F. Macciardi, M. Verga, C. Cusin, S. Pedrini and E. Smeraldi, Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am.J.Med.Genet. 81 (1998) 127–130PubMedGoogle Scholar
  122. Tsuang, M.T., S.V. Faraone, J.A. Fleming, Familial transmission of affective disorders. Is there evidence supporting the distinction between unipolar disorders ? Br.J.Psychiat. 146 (1985) 268–271Google Scholar
  123. Zerbin-Riidin, E., Genetik. In: Kisker,K.P., H. Lauter, J.E. Meyer, C. Miiller und E. Stromgren: Psychiatrie der Gegenwart. Bd.5, 3.Aufl., S.137- 164. Springer-VerI. Berlin, Heidelberg, New York, London, Paris, Tokyo 1987Google Scholar
  124. Hadnagy, Cs. and A. Jaklovszky, Vier Fälle von kongenitaler Afibrinogenämie. Klin.pädiat. 187 (1975) 471–476Google Scholar
  125. Buckley, R.H., R.I. Schiff, S.E. Schiff et al., Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J.Pediatr. 130(1997) 378–387PubMedGoogle Scholar
  126. Durandy, A., N. Cerf-Bensussan, J. Dumez and C. Griscelli, Prenatal diagnosis of severe combined immunodeficiency with defective synthesis of HLA molecules. Prenatal Diagn. 7 (1987) 27–34Google Scholar
  127. Friedrich, W., S.F. Goldmann, W. Ebel, R. BluttersSawatzki et al., Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors. Eur.J.Pediat. 144 (1985) 125–130Google Scholar
  128. Leonard, W.J., M. Noguchi, S.M. Russel and O.W. McBride, The molecular basis of X-linked severe combined immunodeficiency: The role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma (c). Immunol. Rev. 138 (1994) 61–89PubMedGoogle Scholar
  129. Macchi, P., A. Villa, S. Giliani et al., Mutations ofJak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377 (1995) 65–68PubMedGoogle Scholar
  130. Pepper, A.E., R.H. Buckley, T.N. Small and J.M. Puck, Two mutational hotspots in the interleukin-2 receptor)’ chain gene causing human X-linked severe combined immunodeficiency. Am.J.Hum. Genet. 57 (1995) 564–571PubMedGoogle Scholar
  131. Puck, J.M., Molecular and genetic basis of X-linked immunodeficiency disorder. J.Clin.lmmunol. 14 (1994) 81–89Google Scholar
  132. Puck, J.M., S.M. Deschenes, J.c. Porter et al., The inter- leukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDXl. Hum.Mol. Genet. 2 (1993) 1099–1104Google Scholar
  133. Allen, R.C., R.G. Nachtman, H.M. Rosenblatt and J.W. Belmont, Application of carrier testing to genetic counseling for X-linked agammaglobulinemia. Am.J.Hum.Genet. 54 (1994) 25–35PubMedGoogle Scholar
  134. Conley, M.E., D. Mathias, J. Treadaway, Y. Minegishi and J. Rohrer, Mutations in Btk in patients with presumed X-linked Agammaglobulinemia. Am.J.Hum.Genet. 62 (1998) 1034–1043PubMedGoogle Scholar
  135. Gaspar, H.B., T. Lester, R.J. Levinsky and C. Kinnon, BRUTON’S tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA. Clin.Exp.lmmunol. 111 (1998) 334–338Google Scholar
  136. Joumet. O., A. Durandy, M. Doussau, F. Le Deist, J. Couvreur et al., Carrier detection and prenatal diagnosis of X-linked agammaglobulinemia. Am.J.Med.Genet. 43 (1992) 885–887Google Scholar
  137. Morena, M.de la, R.N. Haire, Y. Ohta, R.P. Nelson, R.T. Litman, N.K. Day, R.A. Good and G.W. Litman, Predominance of sterile immunoglobulin transcripts in a female phenotypically resembling BRUTON’S agammaglobulinemia. Europ. J.lmmun. 25 (1995) 809–815Google Scholar
  138. Vetrie, D., l. Vorechovsky, P. Sideras et al., The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosin kinase. Nature 361 (1993) 226–233PubMedGoogle Scholar
  139. Schmitt, K., R. Fries, L. Hohenauer, Z. Rosic und R. Stalder, Das Oro-Akrale Syndrom. Mschr.Kinderheilk. 129 (1981) 245–247Google Scholar
  140. Tuncbilek, E., C. Yalcin and M. Atasun, Aglossiaadactylia syndrome (special emphasm on the inheritance pattern). Clin. Genet. 11 (1977) 421- 423PubMedGoogle Scholar
  141. Daghistani, D., J. Jimenez, S.R. Toledano et al., Congenital neutropenia: A case study. Am.J.Pediatr. Hematol.Oncol. 12 (1990) 210–214Google Scholar
  142. Iselius. l. and K.H. Gustavson, Spatial distribution of the gene for infantile genetic agranulocytosis. Hum.Hered. 34 (1984) 358 363Google Scholar
  143. Herring, W.J., S. Litwer, J.L. Weber and D.J. Danner, Molecular genetic basis of maple syrup urine disease in a family with two defective alleles for branched chain acyltransferase and localization of the gene to human Chromosome 1. Am.J. Hum.Genet. 48 (1991) 342–325PubMedGoogle Scholar
  144. Nobokuni. Y, H. Mitsubuchi, F. Endo et al., Maple sirup urine disease. Complete primary structure of the E1ßsubunit of human branched chain a-keto acid dehydrogenase complex deduced from the nucleotide sequence and a gene analysis of patients with this disease. J.Clin.Invest. 86 (1990) 242–247PubMedGoogle Scholar
  145. Peinemann, F. and D.J. Danner, Maple syrup urine disease 1954 to 1993. J.Inherit.Metab.Dis. 17 (1994) 3–15PubMedGoogle Scholar
  146. Gedik, Y., E. Erduran, Y. Aslan, H. Soyluf, H. Mocan and A. Demirci, AI CARD! syndrome: A variant example with new clinical findings. Genet. Counsel. 4 (1993) 281–283PubMedGoogle Scholar
  147. Hoyt, C.S., F. Billson, R. Ouvrier and G. Wiese, Ocular features of AICARD!’S syndrome. Arch.Ophthal. 96 (1978) 291–295PubMedGoogle Scholar
  148. Nielsen, K.B., M. Anvret, O. Flodmark et al., AI CARD! syndrome: Early neuroradiological manifestations and results of DNA studies in one patient. Am.J.Med.Genet. 38 (1991) 65–68PubMedGoogle Scholar
  149. Alvares, V., C. López-Larrea and E. Coto, Mutational analysis of the CCR5and CCR4genes (HlV-l coreceptors) in resistance to HIV-l infection and AIDS development among intravenous drug users. Hum.Genet. 102(1998) 483–486Google Scholar
  150. Cameron, P.U., S.A. Mallal, M.A.H. French and R.L. Dawkins, Major histocompatibility complex genes influence the outcome of HIV infection: Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum.Immunol. 29 (1990) 282–295PubMedGoogle Scholar
  151. Kaplan, C., J.Y. Muller, C. Doinel et al., HLA-associated susceptibility to acquired immune deficiency syndrome in HIV-l seropositive subjects. Hum.Hered. 40(1990) 290–298PubMedGoogle Scholar
  152. Louie, L.G., Are human genes risk factors for AIDS? Nature Genet. 7 (1994) 456–457PubMedGoogle Scholar
  153. Quillent, C., E. Oberlin, J. Braun et al., HIV-l-resistance phenotype conferred by combination of two seperate inherited mutations of CCR5gene. Lancet 351 (1998) 14–18PubMedGoogle Scholar
  154. Smith, M.W., M. Dean, M. Carrington, C. Winkler et al., Contrasting genetic influence of CCR2 and CCR5 variants on HIV infection and disease progression. Science 277 (1997) 959–965PubMedGoogle Scholar
  155. Stephens, J.e., D.E. Reich, D.B. Goldstein, H.D. Shin, M.W. Smith, M. Carrington et al., Dating the origin of the CCR5.J32AIDS-resistence allele by the colascence of haplotypes. Am.J.Hum.Genet. 62 (1998) 1507–1515PubMedGoogle Scholar
  156. Winkler, c., W. Modi, M. W. Smith, G.W. Nclson, X. Wu, M. Carrington et al., Genetic restriction of AIDS pathogenesis by an SDF-l chemokine gene variant. Science 279 (1998) 389–393PubMedGoogle Scholar
  157. Horwith, M.T. and LTunick, Ainhum, report of six cases in New York. Arch.Derm.Syph. 36 (1937) 1058–63Google Scholar
  158. Spinzig, E. W., Ainhum. Its occurrence in the United States. Am.J.Roentgenol. 42 (1939) 246Google Scholar
  159. Kay, M.M.B., Band 3 in aging and neurological disease. Ann.NY. Acad.Sci 621 (1991) 179–204PubMedGoogle Scholar
  160. Rubio, J.P., A. Danek, C. Stone, R. ChaImers, N. Wood et al., Choreo-acanthosis: genetic linkage to chromosome 9q21. Am.J.Hum.Genet. 61 (1997) 899–908PubMedGoogle Scholar
  161. Sakai, T., H. lwashita and M. Kakugawa, Neuroacanthocytosis syndrome and choreoacanthocytosis (LEVINE-CRITCHLEY syndrome). Neurology 35 (1985) 1679PubMedGoogle Scholar
  162. Serra, S., A. Xerra and A. Arena, Amyotrophic choreo- acanthocytosis: A new observation in Southern Europe. Acta Neurol. Scand. 73 (1986) 481–486PubMedGoogle Scholar
  163. Spitz, M.C., J. Jankovic and J.M. Killian, Familial tic disorder, PARKINsoNism, motor neuron disease, and acanthocytosis: a new syndrome. Neurology 35 (1985) 366–370PubMedGoogle Scholar
  164. David, H. und P.Reinke, Peroxisomale Erkrankungen - eine neue Gruppe von Organellenerkrankungen auf der Basis der Erkenntnisse der modemen Zellularpathologie. Zschr.Klin.Med. 43 (1988) 459–468Google Scholar
  165. Kittur, S., J.W. M. Hoppener, S.E. Antonarakis, J.D.J. Daniels et al., Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin and insulinlike growth factor II. Proc.Nat.Acad.Sci.VSA 82 (1985) 5064–5067Google Scholar
  166. Ogata, M., Acatalasia. Hum.Genet. 86 (1991) 331- 334Google Scholar
  167. Pereira, S.C.S., C.M.G. Rocha, M.L. Guion-Almeida and A. Richieri-Costa, Postaxial acrofacial dysostosis: Report on two patients. Am.J.Med.Genet. 44 (1992) 274–279PubMedGoogle Scholar
  168. Pfeiffer, R.A., G. Legat and V. Trautmann, Acrocallosal syndrome in a child with de novo inverted tandem duplication 12p 11.2-p 13.3. Ann.Genet. 35 (1992) 41–46PubMedGoogle Scholar
  169. Turolla, L., M. Clementi and R. Tenconi, How wide is the clinical spectrum of the acrocallosal syndrome ? J.Med.Genet. 27 (1990) 516–518PubMedGoogle Scholar
  170. Grinder, A. and M.F. Monat, The acrodermatitis enteropathica mutation affects protein expression in human fibroblasts: Analysis by two-dimensional gel electrophoresis. J. Nutr. 128 (1998) 1311- 1314Google Scholar
  171. Ohlsson, A., Acrodermatitis enteropathica: reversibility of cerebral atrophy with zinc therapy. Acta Pediat.Scand. 70(1981) 269–273Google Scholar
  172. Hernandez, M., A. Miranda and S. Kofman-Alfaro, Acrodysostosis in two generations: an autosomal dominant syndrome. Clin.Genet. 39 (1991) 376–382PubMedGoogle Scholar
  173. Viljoen, D. and P. Beighton, Epiphyseal stippling in acrodysostosis. Am.J.Med.Genet. 38 (1991) 43- 45PubMedGoogle Scholar
  174. Boullie, M.-C., P.Y. Vénencie, E. Thomine et al., Syndrome d’ EHLERs-DANLOS type IV à type d’acrogeria. Ann.Derm.Vénérol. 113 (1986) 1077–1085Google Scholar
  175. Greally, J.M., L.Y. Boone, S.G. Lenkey, S.L. Wenger and M.W. Steele, Acromegageria: a spectrum of ’premature aging’ syndrome. Am.J.Med.Genet. 44 (1992) 334–339PubMedGoogle Scholar
  176. Konohana, A., S. Miyakawa, S. Tajima and T. Nishikawa, Decreased collagen and hyaluronic acid content in lesional skin of acrogeria. Dermatologica 172 (1986) 241–244PubMedGoogle Scholar
  177. Greiner, J., J. Krüger, L. Palden, E.G. Jung and F. Vogel, A linkage study of acrokeratoelastoidosis: possible mapping to chromosome 2. Hum.Genet. 63 (1983) 222–227PubMedGoogle Scholar
  178. Herndon, J.H.jr. and J.D. Wilson, Acrokeratosis verruciformis (HoPF) and DARIER’S disease. Genetic evidence for a unitary origin. Arch.Derm. 93 (1966) 305–310Google Scholar
  179. Van den Bosch, J., A new syndrome in three generations of a Dutch family. Ophthalmologica 137 (1959) 422–423Google Scholar
  180. Mignot, E., Behavioral genetics ’97. Genetics of narcopepsy and other sleep disorders. Am.J.Hum. Genet. 60 (1997) 1289–1302PubMedGoogle Scholar
  181. Trenkwalder, C., Restless Legs Syndrom, Klinik, Differentialdiagnose, Neurophysiologie, Therapie. Springer-Verlag Heidelberg 1998Google Scholar
  182. Trenkwalder, C., V. Colladoso-Seidel, T. Gasser and W.H. Oertel, Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov. Disord. 11 (1997) 389–394Google Scholar
  183. Walters, A.S., D. Picchietti, W. Hening and A. Lazzarini, Variable expressivity in familial restless legs syndrome. Arch.Neurol. 47 (1990) 1219 1220PubMedGoogle Scholar
  184. Kaler, S.G., R.L. Geggel and A. Sadeghi-Nejad, HAJDU- CHENEY syndrome associated with severe cardiac valvular and conduction disease. Dysmorphology 4 (1990) 43–47Google Scholar
  185. Karrer, S. and M. Landthaler, Initial aero-osteolysis ulcero-mutilans in two brothers with hereditary type I motor sensory neuropathy. Eur.J.Derm. 6 (1996) 11–13Google Scholar
  186. Kozlowski, K.A. Barylak, F. Eftekhari, K. Pasyk and E. Wislocka, Acroosteolysis. Problems of diagnosis - Report of four cases. Pediat.Radiol. 8 (1979) 79–86PubMedGoogle Scholar
  187. Crifasi, P.A., M.C. Patterson, D. Bonde and V.V. Michelis, Severe HAJDU-CHENEY syndrome with upper airway obstruction. Am.J.Med.Genet. 70 (1997) 261–266PubMedGoogle Scholar
  188. Bertola, D.R., L.M. Wolf, H.V. Toriello and M.L. Netzloff, Acro-Oto-Ocular syndrome: further evidence for a new autosomal recessive disorder. Am.J.Med.Genet. 73 (1997) 442–446PubMedGoogle Scholar
  189. Verloes, A., M. LeMerrer, J.-P. Farriaux and P. Maroteaux, Metaphyseal acroscyphodysplasia. Clin.Genet. 39 (1991) 362–369PubMedGoogle Scholar
  190. Vichi G.F., M. Pacini, R. Jenuso et al., Una nuova displasis spondilo-metafisaria ? Descrizione di un caso. Riv. Ital.Pediatr. 12 (1986) 772–775Google Scholar
  191. Ades, L.C., J.C. Mulley, I.P. Senga, L.L. Morris, D.J. David and E.A. Haan, JACKSON-WEISS syndrome: clinical and radiological findings in a large kindred and exclusion of the gene from 7p21 and 5qter. Am.J.Med.Genet. 51 (1994) 121–130PubMedGoogle Scholar
  192. Bellus, G.A., K. Gaudenz, E.H. Zackai, L.A. Clarke, J. Szabo, C.A. Francomano and M. Muenke, Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genet. 14 (1996) 174–176PubMedGoogle Scholar
  193. Brueton, L.A., L. van Herwerden, K.A. Chotai and R.M. Winter, The mapping of a gene for craniosynostosis: evidence for linkage ofthe SAETHRECHOTZEN syndrome to distal chromosome 7p. J.Med.Genet. 29 (1992) 681–685PubMedGoogle Scholar
  194. Cohen, M.M.Jr., PFEIFFER syndrome update, clinical subtypes, and guidelines for differential diagnosis. Am.J.Med.Genet. 45 (1993) 300–307PubMedGoogle Scholar
  195. Jabs, E.W., Toward unterstanding the pathogenesis of craniosynostosis through clinical and molecular correlates. Clin.Genet. 53 (1998) 79–86PubMedGoogle Scholar
  196. Lefort, G., P. Sarda, C. Humeau and D. Rieu, APERT syndrome with partial preaxial polydactyly. Genet. Couns.3 (1992) 107–109PubMedGoogle Scholar
  197. Howard, T.D., W.A. Paznekas, E.D. Green, L.C. Chiang et al., Mutations in TWISTa basic helix-loop-helix transcription factor, in SAETHRE- CHOTZEN syndrome. Nature Genet. 15 (1997) 36–41PubMedGoogle Scholar
  198. Moloney, D.M., S.F. Slaney, M. Oldridge, S.A. Wall, P. Sahlin et al., Exclusive paternal origin of new mutations in APERT syndrome. Nature Genet. 13 (1996) 48–53PubMedGoogle Scholar
  199. Muenke, M., U. Schell, A. Hehr et al., A common mutation in the fibroblast growth factor receptor 1 gene in PFEIFFER syndrome. Nature Genet. 8 (1994) 269–274PubMedGoogle Scholar
  200. Niemann-Seyde, S.c., S.W. Eber and B. Zoll, SAETHRE- CHOTZEN syndrome (ACS III) in four generations. Clin.Genet. 40 (1991) 271–276PubMedGoogle Scholar
  201. Paznekas, W.A., M.L. Cunningham, T.D. Howard, B.R. Korf et al., Genetic heterogeneity of SAETHRE- CHOTZEN syndrome, due to TWISTand FGFRmutations. Am.J.Hum.Genet. 62 (1998) 1370–1380PubMedGoogle Scholar
  202. Prevel, C.D., B.L. Epple and McCarthy, M., Acrocephalosyndactyly syndromes: A review. J.Craniofac. Surg. 8 (1997) 279–285Google Scholar
  203. Pierquin, G., R.Seligmann and N.Van Regemorter, Familial occurrence of SUMMITT syndrome or a variant example of CARPENTER syndrome? Genet. Couns. 3 (1992) 101–105Google Scholar
  204. Sarimski, K., Children with APERT syndrome: Behavioural problems and familial stress. Dev.Med.Child Neurol. 40 (1998) 44–49PubMedGoogle Scholar
  205. Wilkie, A.O.M., Craniosynostosis: genes and mechanisms. Hum.Molec.Genet. 95 (1997) 1647- 1656Google Scholar
  206. Hegab, S.M. and S.A. AI-Mutawa, Congenital hereditary autosomal recessive alacrimia. Ophtha!.Genet. 17 (1996) 35–38Google Scholar
  207. Milunsky, J.M., V.W. Lee, B. SSiegel and A. Milunsky, Agenesis or hypoplasia of major salivary and lacrimal glands. Am.J.Med.Genet. 37 (1990) 371–374PubMedGoogle Scholar
  208. Mondino, B.J. and S.J. Brown, Hereditary congenital alacrimia. Arch.Ophthal. 94 (1976) 1478–1480PubMedGoogle Scholar
  209. Camera, G., G. Ferraiolo, D. Leo, A.Spauiale and S.Pozzolo, Limb/pelvis-hypoplasia/aplasia syndrome (AL-AwADI/ RAAS-RoTHSCHILD syndrome): report of two Italian sibs and further confirmation of autosomal recessive inheritance. J.Med.Genet. 30(1993) 65–69PubMedGoogle Scholar
  210. Farag, T.I., S.A. AI-Awadi, M.J. Marafie, L. Bastaki, S.A. Al-Othman, F.M. Mohammed, I.S. Al-Suliman and D.S. Krishna Murthy, The newly recognized limb/pelvis-hypoplasia/aplasia syndrome: report of a Bedouin patient and review. J.Med. Genet. 30(1993) 62–64Google Scholar
  211. Genuardi, M., P. Gasparini, G. Neri and L. Zelante, Limb-pelvis hypoplasia/aplasia: a discrete entity in the fibuloulnar developmental field complex. Am.J.Med.Genet. 68 (1997) 190–194PubMedGoogle Scholar
  212. Kumar, D., M.B. Duggan, R.F. Mueller and G. Karbani, Familial aplasia/hypoplasia of pelvis, femur, fibula, and ulna with abnormal digits in an inbred Pakistani muslim family: A possible new autosomal recessive disorder with overlapping manifestations of the syndromes of FUHRMANN, AL-AwADI and RAAS-RoTHSCHILD. Am.I.Med. Genet. 70(1997) 107–113Google Scholar
  213. Al-Rasheed, S.A., O. AI-Mohrij, N. AI-Jurayyan et al., Osteopetrosis in children. Int.J.Clin.Pract. 52 (1998) 15–18PubMedGoogle Scholar
  214. Andersen, P.E.jr. and J. Bollerslev, Heterogeneity of autosomal dominant osteopetrosis. Radiology 164 (1987) 223–225PubMedGoogle Scholar
  215. Bollerslev, J., Osteopetrosis. A genetic and epidemiological study. Clin.Genet. 31 (1987) 86–90PubMedGoogle Scholar
  216. Gandelman Horovitz, D.D., J.G.B. Neto, R. Boy, F.R. Vargas, J.C. Llerena Jr. and J.C. Cabral de Almeida, Autosomal dominant osteosclerosis type STANESCU: The third family. Am.J.Med.Genet. 57 (1995) 605–609Google Scholar
  217. Gerritson, E.J.A., J.M. Vossen, A. Fasth et al., Bone marrow transplantation for autosomal recessive osteopetrosis. J.Pediatr. 125 (1994) 896–902Google Scholar
  218. Heaney, C., H. Shalev, K. Elbedour, R. Carmi et al., Human autosomal recessive osteopetrosis maps to llq13, a position predicted by comparative mapping ofthe murine osteosclerosis (oc) mutation. Hum.Molec.Genet. 7 (1998) 1407- 1410PubMedGoogle Scholar
  219. Van Hul, W., J. Bollerslev, J. Gram, E. Van Hul, W. Wuyts, O. Benichou, F. Vanhoenacker and P.J. Willems, Localization of a gene for autosomal dominant osteopetrosis (ALBERS-SCHONBERG disease) to chromosome 1 p21. Am.J.H urn. Genet. 61 (1997) 363–369Google Scholar
  220. Yoshida, H., S. -LHayashi, T. Kunisada et al., The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 (1990) 442–444PubMedGoogle Scholar
  221. Aqauron, R., Oculocutaneous albinism in Cameroon. A 15 year follow-up study. Ophthalmic Paediatr.Genet. 11 (1990) 255–263Google Scholar
  222. Van Dorp, D.B., Albinism, or the NOACH syndrome. Clin. Genet. 31 (1987) 228–242PubMedGoogle Scholar
  223. Alitalo, T., T.A. Kruse, H. Forsius et al., Localization of the Aland Island eye disease locus to the pericentric region of the X chromosome by linkage analysis. Am.J.Hum.Genet. 48 (1991) 31–34PubMedGoogle Scholar
  224. Bassi, M.T., A.A.B. Bergen, M.C. Wapenaar, M.V. Schiaffino et al., A submicroscopic deletion in a patient with isolated X-linked ocular albinism (OA1). Hum.Molec.Genet. 3 (1994) 647- 648PubMedGoogle Scholar
  225. Bergen, A.A.B., E.J. Schuurman, L.I. Van den Born, C. Samanns et al., Carrier detection in X-linked ocular albinism of the NETTLESHIP-FALLS type by DNA analysis. Clin.Genet. 41 (1992) 135–138PubMedGoogle Scholar
  226. Pillers, D.-A.M., W.K. Seltzer, B.R. Powel et al, Negative- configuration electroretinogram in Oregon eye disease: Consistent phenotype in Xp21 deletion syndrome. Arch.Ophtalmol. 11 (1993) 1558–1563Google Scholar
  227. Schiaffino, M.V., C. Baschirotto, G. Pellegrini et al., The ocular albinism type I gene product is a membrane glycoprotein localized to melanosoms. Proc.NatI.Acad.Sci.USA 93 (1996) 9055- 9060Google Scholar
  228. Schnur, R.E., M. Gao, P.E. Wick, M. Keller, P.J. Benke et al., OA1mutations and deletions in X-linked ocular albinism. Am.J.Hum.Genet. 62 (1998) 800–809PubMedGoogle Scholar
  229. Fleischmann, R.A., Human piebald trait resulting from a dominant negative mutant of the c-kit membrane receptor gene. J.Clin.Invest. 89 (1992) 1713–1717Google Scholar
  230. Winship, I., K. Young, R. Martell, R. Ramesar, D. Curtis and P. Beighton, Piebaldism: an autonomous autosomal dominant entity. Clin.Genet. 39 (1991) 330–337PubMedGoogle Scholar
  231. Oetting, W.S. and R.A. King, Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: Mutations and polymorphisms of the human tyrosinase gene. Hum.Mutat. 2 (1993) 1 - 6PubMedGoogle Scholar
  232. Kedda, M.A., G. Stevens, P. Manga, C. Viljoen, T. Jenkins and M. Ramsay, The tyrosinase-positive oculocutaneous albinism gene shows locus homogeneity on chromosome 15q11-q13 and evidence of multiple mutations in southern African negroids. Am.J.Hum.Genet. 54 (1994) 1078- 1084PubMedGoogle Scholar
  233. Manga, P., J.G.R. Kronberg, N.F. Box, R.A. Sturm, T. Jenkins and M. Ramsay, Rufous oculocutaneous albinism in South African blacks is caused by mutations in the TYRIgene. Am.J.Hum.Genet. 61 (1997) 1095–110lPubMedGoogle Scholar
  234. Ramsay, M., M.-A. Colman, G. Stevens, E. Zwane, J. Kromberg, M. Farrali and T. Jenkins, The tyrosinase- positive oculocutaneous albinism locus maps to chromosome 15q1l.2-q12. Am.J. Hum. Genet. 51 (1992) 879–884PubMedGoogle Scholar
  235. Amiel, J., P.M. Watkin, M. Tassabehji, A.P. Read and R.M. Winter, Mutation of the MITFgene in albinism- deafness syndrome (TIETz syndrome). Clin.Dysmorphol. 7 (1998) 17–20PubMedGoogle Scholar
  236. Winship, I.M., M. Babaya and R.S. Ramescar, X-linked ocular albinismus and sensorineural deafness: Linkage to Xp22.3. Genomics 18 (1993) 444–445PubMedGoogle Scholar
  237. Happle, R., The Mc CUNE-ALBRIGHT syndrome: a lethal gene surviving by mosaicism. Clin.Genet. 29 (1986) 321–324PubMedGoogle Scholar
  238. Lee, P.A., C. van Dop and C.J. Migeon, Mc CUNE-ALBRIGHT syndrome. Long-term follow-up. J.Am. Med.Ass. 256 (1986) 2980–2984Google Scholar
  239. Pfeffer, S., E. Molina, P. Feuilian and T.R. Simon, Mc CUNE-ALBRIGHT syndrome: The pattern of scintigraphic abnormalities. J.NucI.Med. 31 (1990) 1474–1478Google Scholar
  240. Schwindinger, W.F., C.A. Francomano and M.A. Levine, Identification of a mutation in the gene encoding the a subunit of the stimulatory G protein of adenylyl cyclase in Mc CUNE-ALBRIGHT syndrome. Proc.NatI.Acad.Sci USA 89 (1992) 5152- 5156Google Scholar
  241. Araki, Y., S. Mori, M. Kanoh et al., Congenital hemicerebral arterial ectasia complicating unilateral megalencephaly. Br.J.Radiol. 60(1987) 395–400PubMedGoogle Scholar
  242. Barbier, F., A. FilIa, F.A. de Falco and G.A. Buscamo, ALEXANDER’S disease. A clinical study with computerized tomographic scans of the first two Italian cases. Acta Neuropath. 35 (1980) 1–9Google Scholar
  243. Booth, l.W., G. Stange, H. Murer, T.R. Fenton and P.J. MilIa, Defective jejunal brush-border Na+/ H + exchange: a cause of congenital secretory diarrhoea. Lancet 1985/1 1066–1069PubMedGoogle Scholar
  244. Höglund, P., Molecular genetics of congenital chloride diarrhea. Academic dissertation, Helsinki 1997,64 SGoogle Scholar
  245. Höglund, P., P. Sistonen, R. Norio, ChLHomberg, A. Demberg, K.-H. Gustavson, A. De la Chapelle and J. Kere, Fine mapping of the congenital diarrhea gene by linkage disequilibrium. Am.J. Hum.Genet. 57 (1995) 95–102PubMedGoogle Scholar
  246. Höglund, P., S. Haila, J. Socha, L. Tomaszewski, U. Saarialho-Kere et al., Mutations of the down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea. Nature Genet. 14 (1996) 316–319PubMedGoogle Scholar
  247. Höglund, P., S. Haila, K.-H. Gustavson, M. Taipale, K. Hannula, K. Popinska et al., Clustering of private mutations in the congenital chloride diarrhea/ down-regulated in adenoma gene. Hum. Mutat. 11 (1998) 321–327PubMedGoogle Scholar
  248. Holmberg, C., J. Perheentupa, K. Launiala, and N. Halleman, Congenital chloride diarrhoea. Clinical analysis of 21 Finnish patients. Arch.Dis. Childh. 52 (1977) 255–267Google Scholar
  249. Albers, S.E., S.J. Bozena, L.F. Glass and N.A. Denske, Alkaptonuria and ochronosis: Case report and review. J.Am. Acad.Dermatol. 27(1992) 609–614PubMedGoogle Scholar
  250. Beltrán-Valero de Bernabé, D., B. Granadino, I. Chiarelli, B. Porfirio et al., Mutation and polymorphism analysis of the human homogentisate 1,2 dioxygenase gene in alkaptonuria patients. Am.J.Hum.Genet. 62 (1998) 776–784Google Scholar
  251. La Du, B.N.Jr., Are we ready to try to cure alkaptonuria ? Am.J.Hum.Genet. 62 (1998) 765–767Google Scholar
  252. Ball, D.M. and R.M. Murray, Genetics of alcohol misuse. Br.Med.Bull. 50(1994) 18–35PubMedGoogle Scholar
  253. Chao, Y.-C., S.-R. Liou, Y.-Y. Chung et al., Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology 19 (1994) 360–366PubMedGoogle Scholar
  254. Goate, M.A. and H.J. Edenberg, The genetics of alcoholism. Curr.Opin.GeneI.Develop. 8 (1998) 282–286Google Scholar
  255. Guze, S.B., The genetics of alcoholism: 1997. Clin. Genet. 52 (1997) 398–403PubMedGoogle Scholar
  256. Guze, S.B., The genetics of alcoholism: 1997. Clin. Genet. 52 (1997) 398–403PubMedGoogle Scholar
  257. Miyakawa, T., T. Yagi, H. Kitazawa,M. Yasuda, N. Kawai, K. Tsuboi and H. Niki, Fin-kinase as a determinant of ethanol sensitivity: Relation to NMDA-receptor function. Science 278 (1997) 698–701PubMedGoogle Scholar
  258. Muramatsu, T., W. Zu-Chen, F. Yi-Ru, H. Kou-Bao et al., Alcohol and aldehyde dehydrogenase genotypes and drinking behavior of Chinese living in Shanhai. Hum.Genet. 96 (1995) 151–154PubMedGoogle Scholar
  259. National Institute of Alcohol Abuse and Alcoholism, Edit., The genetics of alcoholism. Alcohol Health and Research World 19 (1995) 161–256Google Scholar
  260. Sander, T., H. Harms, H. Rommelspacher et al., Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcoholwithdrawal delirium. Psychiatr.Genet. 8 (1998) 13–17PubMedGoogle Scholar
  261. Stone, W.S. and l.l.Gottesman, A perspective on the search for the causes of alcoholism: Slow down the rush to genetical judgment. Neurol.Psychiatry Brain Res. 1 (1993) 123–132Google Scholar
  262. Tu, G.-c. and Y. lsrael, Alcohol consumption by Orientals in North America is predicted largely by a single gene. Behav.Genet. 25 (1995) 59–66PubMedGoogle Scholar
  263. Blum, A. und H. Loser, Diagnose der Alkoholembryopathie. Dtsch.Med.Wschr. 120 (1995) 184–189Google Scholar
  264. Church, M. W. and J.A. Kaltenbach, Hearing, speech, language, and vestibular disorders in the fetal alcohol syndrome: A literature review. Alcohol.Clin. Res. 21 (1997) 495–512Google Scholar
  265. Grummer, M.A. and R.D. Zachman, Prenatal ethanol consumption alters the expression of cellular retinol binding protein and retinoic acid receptor mRNA in fetal rat embryo and brain. AlcohoI. Clin.Exp.Res. 19 (1995) 1376–1381Google Scholar
  266. Happle, R., Alopecia areata. In: Braun-Falco, O. u. Mitarb., Fortschritte der praktischen Dermatologie und Venerologie XI. Springer-V erl. Berlin, Heidelberg, New York 1986Google Scholar
  267. Küster, W. and R. Happle, The inheritance of common baldness: two be or not two. J.Am.Acad. Derm. 11 (1984) 921–926PubMedGoogle Scholar
  268. McMichael, A.J., The genetic epidemiology and autoimmune pathogenesis of alopecia areata. J.Europ. Acad.Dermato!. Venera!. 9 (1997) 36–43Google Scholar
  269. Van der Steen, H. Traupe, H. Happle, J. Boezeman, R. Strater and H. Hamm, The genetic risk for alopecia areata in first degree relatives of severely affected patients: an estimate. Acta Derm.Venera!. 72 (1992) 373–375Google Scholar
  270. Ahmad, W., M. Faiyaz ul Haque, V. Brancolini, H.C. Tsou, S. Ulhaque et al., Alopecia universalis associated with a mutation in the human hairlessgene. Science 279 (1998) 720–724PubMedGoogle Scholar
  271. Devriendt, K., H.Van den Berghe and J.P. Fryns, Alopecia-mental retardation syndrome associated with convulsions and hypogonadotropic hypogonadism. Clin.Genet. 49 (1996) 6–9PubMedGoogle Scholar
  272. Hanning V.L. and G.E. Tiller, Alopecia/mental retardation syndrome. Am.J.Med.Genet. 58 (1995) 123–124Google Scholar
  273. Idmore, C., M. Baraitser, E.M. Brett, Alopecia, mental retardation, epilepsy and microcephaly in two cousins. Clin.Dysmorph. 1 (1992) 79–84Google Scholar
  274. Kauschansky, A., M. Shohat, M. Frydman, A. Rösler, E. Greenbaum and L. Sirota, Syndrome of alopecia totalis and 17 -hydroxysteroid dehydrogenase deficiency. Am.J.Med.Genet. 76 (1998) 28–31PubMedGoogle Scholar
  275. Nöthen, M.M., S. Cichon, I.R. Vogt, S. Hemmer, R. Kruse et al., A gene for universal congenital alopecia maps to chromosome 8p21–22. Am.J. Hum.Genet. 62 (1998) 386–390PubMedGoogle Scholar
  276. Pignata, C., M. Fiore, V. Guzzetta, A. Castaldo, G. Sebastio, F. Porta and A. Guarino, Congenital alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. Am.J.Med.Genet. 65 (1996) 167–170PubMedGoogle Scholar
  277. Timar, L., A.E. Czeisel and P. Koszo, Association of SHOKEIR syndrome (congenital universal alopecia, epilepsy mental subnormality and pyorrhea) and giant pigmented nevus. Clin.Genet. 44 (1993) 76–78PubMedGoogle Scholar
  278. Van Gelderen, H.H., Syndrome of total alopecia, multiple skeletal anomalies, shortness of stature, and mental deficiency. Am.J.Med.Genet. 13 (1982) 383–387PubMedGoogle Scholar
  279. Baer, R.L., Erfahrungen mit Mimoxidil. In: BraunFalco und W.B.Schill, Fortschritte der prakti schen Dermatologie und Venerologie. XI, Springer- VerI. Berlin, Heidelberg, New York 1987Google Scholar
  280. Bergfeld, W.F., Androgenic alopecia: An autosomal dominant disorder. Am.J.Med. 98 (199s)/Suppl. 5A-95Google Scholar
  281. Rook, A. and K. Dawber, Diseases of hear and scalp. Blackwell, Oxford, 2. Aufl. 1991, S.l36Google Scholar
  282. Frydman, M., E. Jager-Roman, L. de Vries, G. Stoltenburg- Didinger, M. Nussinovich and L. Sirota, ALPERS progressive infantile neonatal form with findings of the fetal akinesia syndrome. Am.J. Med.Genet. 47 (1993) 31–36PubMedGoogle Scholar
  283. Hart, Z.H., C.-H. Chang, E.V.D. Perrin, J.S. Neerunjun and R. Ayyar, Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Arch.Neurol. 34 (1977) 180–185PubMedGoogle Scholar
  284. Moller, P., H.J. Christen, E. Wilichowski and F. Hanefeld, Progressive neural degeneration of childhood with liver diseases (Morbus ALPERS). Mschr.Kinderhk. 142 (1994) 863–867Google Scholar
  285. Braun, J., S. Welle, J. Van Wees et al., Dauersubstitution bei homozygotem al-Antitrypsin-Mangel. EinfluB auf das Proteinasen-AntiproteinasenGleichgewicht in Plasma und Sputum. Dtsch.Med.Wschr. 115 (1990) 889–894PubMedGoogle Scholar
  286. Carrell, R.W., D.A. Lomas, S. Sidhar and R. Foreman, a-antitrypsin deficiency: a confonnational disease. Chest 110/6(1997) 243–247Google Scholar
  287. Poller, W., J.-P. Faber and K. Olek, Highly variable clinical course in a1-antitrypsin deficiency - use of polymerase chain reaction for the detection of rare deficiency alleles. Klin.Wschr. 68 (1990) 857–863PubMedGoogle Scholar
  288. Sakkas, L.I., D.G.Macfarlane, H.Bird, et al., Association of osteoarthritis with homozygosity for a 5.8 kb Taq 1 fragment of the α1-antichymotrypsin gene. Brit.J.Rheumatol. 29(1990) 245–248Google Scholar
  289. McVey, J.H., K.Michaelides, L.P.Hansen, et al., AGA substitution in an HNF I binding site in the human α-fetoprotein gene is associated with the hereditary persistence of α-fetoprotein (HPAFP). Hum.Mol.Genet. 2(1993) 379–384PubMedGoogle Scholar
  290. Kato, A., S.Hirosawa, S.Toyota, et al., Localization of the human α-plasmin inhibitor gene (PLI) to 17p13. Cytogenet.Cell Genet. 62(1993) 190–191PubMedGoogle Scholar
  291. Kluft, c., H.K. Nieuwenhuis, D.C. Rijken, E. Groenveld, G. Wijngaards, et al., α-2-antiplasmin Enschede: dysfunctional α-2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. J.Clin.Invest. 80(1997) 1391–1400Google Scholar
  292. Antiganc, c., J. Zhou, M. Sanak, et al., ALPORT syndrome and diffuse leiomyomatosis: Deletions in the 5’end of the COL4A5 collagen gene. Kidney Int. 42(1992) 1178–1183Google Scholar
  293. Brody, H.A., R.A. Chole, G.C. Griffin and J.G. White, Macrothrombocytopenia and progressive deafness: a new genetic syndrome. Am.J.Otol. 13(1992) 507–511Google Scholar
  294. Hudson, B.G., R. Kalluri, S. Gunwar, et al., The pathogenesis of ALPORT syndrome involves type IV collagen molecules containing the α3 (IV) chain: Evidence from anti-GBM nephritis after renal transplantation. Kidney Int. 42(1992) 179–187PubMedGoogle Scholar
  295. Jonsson, J.J., ALPORT syndrome, mental retardation, midface hypoplasia, and eliptocytosis: a new X-linked contiguous gene deletion syndrome? J.Med.Genet. 35(1998) 273–278PubMedGoogle Scholar
  296. Kashtan, C.E., R.J. Butkowski, M.M. Kleppel, et al., Posttransplant anti-glomerular basement membrane nephritis in related males with ALPORT syndrome. J.Lab.Clin.Med. 116(1990) 508–515PubMedGoogle Scholar
  297. Lemmink, H.H., C.H. Schröder, L.A.H. Monnens and H.J.M. Smeets, The clinical spectrum of type IV collagen. Hum.Mutat. 9(1997) 477–499PubMedGoogle Scholar
  298. Boor, R., J. Herwig, J. Schrezenmeir, et al., Familial insulin resistant diabetes associated with acanthosis nigricans, polycystic ovaries, hypogonadism, pigmentary retinopathy, labyrinthine deafness, and mental retardation. Am.J. Med.Genet. 45(1994) 649–653Google Scholar
  299. Collin, G.B., J.D. Marshall, L.R. Cardon and P.M. Nishina, Homozygosity mapping of ALSTRÖM syndrome to chromosome 2p. Hum.Molec.Genet. 6(1997) 213–219PubMedGoogle Scholar
  300. Marshall, J.D., M.D. Ludman, S.E. Shea, S.R. Salisbury, S.M. Willi, R.G. LaRoche and P.M. Nishina, Genealogy, natural history, and phenotype of ALSTRÖM syndrome in a large Acadian kindred and three additional families. Am.J.Med.Genet. 73(1997) 150–161PubMedGoogle Scholar
  301. Blacker, D., M.A. Wilcox, N.M. Laird, L. Rodes, F.M. Horvath, et al., Alpha-2 macroglobulin is genetically associated with ALZHEIMER disease. Nature Genet. 19(1998) 357–361PubMedGoogle Scholar
  302. Breitner, J.C.S., Clinical genetics and genetic counseling in ALZHEIMER’S disease. J.Geriatr.Psychiatry 25(1992) 229–246Google Scholar
  303. Chartier-Harlin, M.-C., F. Crawford, H. Houldem, et al., Early ALZHEIMER’S disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353(1991) 844–846PubMedGoogle Scholar
  304. Chartier-Harlin, M.C., M. Parfitt, S. Legrain, J. Pérez-Tur, et al., Apolipoprotein E, eta4 allele as a major risk factor for sporadic early and late-onset forms of ALZHEIMER’S disease: analysis of the 19q13.2 chromosomal region. Hum.Molecul.Genet. 3(1994) 569–574Google Scholar
  305. Crook, R., A. Verkkoniemi, J. Perez-Tur, et al., A variant of ALZHEIMER’S disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presinilin 1. Nature Med. 4(1998) 452–455PubMedGoogle Scholar
  306. Cruts, M., C.M. van Duijn, H. Backhoven, M. Van den Broeck, A. Wehnert, et al., Estimation of the genetic contribution of presenilin-l and -2 mutations in a population-based study of presenile ALZHEIMER disease. Hum.Molec.Genet. 7(1998) 43–51PubMedGoogle Scholar
  307. Felsenstein, K.M., L.W. Hunihan and S.B. Roberts, Altered cleavage and secretion of a recombinant ß-APP bearing the Swedish familial ALZHEIMER’S disease mutation. Nature Genetics 6(1994) 251–255PubMedGoogle Scholar
  308. Haass, C., C.A. Lemere, A. Capeli, et al., The Swedish mutation causes early-onset ALZHEIMER’S disease by β-secretase cleavage within the secretory pathway. Nature Med. 1(1996) 1291–1296Google Scholar
  309. Hutchin, T. and G. Cortopassi, A mitochondrial DNA clone is associated with increased risk for ALZHEIMER disease. Proc.Natl.Acad.Sci.VSA 92(1995) 6892–6895Google Scholar
  310. Hutton, M. and J. Hardy, The presenilins and ALZHEIMER’S disease. Hum.Molec.Genet. 6(1997) 1619–1646Google Scholar
  311. Jakes, R., M.G. Spillantini and M. Goedert, Identification of two distinct synucleins from human brain. FEBS Lett. 345(1994) 27–32PubMedGoogle Scholar
  312. Kamboh, M.I., D.K. Snaghera, R.E. Ferrell and S.T. DeKosky, APOE*4-associated ALZHEIMER’S disease is modified by α1-antichymotrypsin polymorphism. Nature Genet. 10(1995) 486–488PubMedGoogle Scholar
  313. Lendon, C.I., F. Ashali and A.M. Goate, Exploring the etiology of ALZHEIMER disease using molecular genetics. JAMA 277(1997) 825–831PubMedGoogle Scholar
  314. Levy-Lahad, E., P. Poorkaj, K. Wang, Y. Hui Fu, J. Oshima, J. Mulligan and G.D. Schelienberg, Genomic structure expression of STM2, the chromosome 1 familial ALZHEIMER disease gene. Genomics 34(1996) 198–204PubMedGoogle Scholar
  315. Monoya, S.E., C.E. Aston, S.T. DeKosky, A.I. Kamboh, J.S. Law and R.E. Ferrell, Bleomycin-hydrolase is associated with risk of sporadic ALZHEIMER’S disease. Nature Genet. 18(1998) 211–212Google Scholar
  316. Relkin, N.R., R. Tanzi, J. Breitner, et al., Apolipoprotein E genotyping in ALZHEIMER’S disease. Lancet 347(1996) 1091–1095Google Scholar
  317. Sandbrik, R und V. Müller, Molekulargenetik der ALZHEIMER-Krankheit. Med.Genet. 10(1998) 378–382Google Scholar
  318. Schellenberg, G.D., T.D. Bird, E.M. Wijsman, et al., Genetic linkage evidence for a familial ALZHEIMER’S disease on locus 14. Science 258(1992) 668–671PubMedGoogle Scholar
  319. Edwards, M.J., D. McDonald, P. Moore and J. Rae, Scalp-ear-nipple syndrome: additional manifestations. Am.J.Med.Genet. 50(1994) 247–250PubMedGoogle Scholar
  320. Mathews, J., Bilateral absence of breasts. N.Y.St.J. Med. 74(1974) 87–89Google Scholar
  321. Rich, M.A., A. Heimler, L. Waber and W.A. Brock, Autosomal dominant transmission of ureteral triplication and bilateral amastia. J.Urol. 137(1987) 102–105PubMedGoogle Scholar
  322. Tsakalos, N., F.H. Jordaan, J.J.F. Taljaard and S.F. Hough, A previously undescribed ectodermal dysplasia of the tricho-odonto-onychial subgroup in a family. Arch.Derm. 122(1986) 1047–1053Google Scholar
  323. Camuzat, A., H. Dollfus, J.-M. Rozet, S. Gerber, D. Bonneau, et al., A gene for LEBER’S congenital amaurosis maps to chromosome 17p. Hum.Molec.Genet. 4(1995) 1447–1452PubMedGoogle Scholar
  324. Lambert, S.R., S. Sherman, D. Taylor, et al., Concordance and recessive inheritance of LEBER congenital amaurosis. Am.J.Med.Genet. 46(1993) 275–277PubMedGoogle Scholar
  325. Marlhens, F., X. Bareil, J.-M. Griffoin, E. Zrenner, P. Amalric, et al., Mutations in RPE65cause LEBER’S congenital amaurosis. Nature Genet. 17(1997) 139–140PubMedGoogle Scholar
  326. Perrault, I., J.M. Rozet, P. Calvas, S. Gerber, A. Camuzat, et al., Retinal-specific guanylate cyclase gene mutations in LEBER’S congenital amaurosis. Nature Genet. 14(1996) 461–464PubMedGoogle Scholar
  327. Fraser, F.e., R.A. Anderson, J.I. Mulvihili and M. Preus, An aminopterine-like syndrome without aminopterin (ASSA). Clin.Genet. 32(1987) 28–34PubMedGoogle Scholar
  328. Warkany, J., Aminopterin and methotrexate: folic acid deficiency. Teratology 18(1978) 353–357Google Scholar
  329. Krajewska-Walasek, M. Aminopterin syndrome sine aminopterin (ASSA) syndrome in two siblings: further delineation of the syndrome and review of the literature. Genet. Counsel. 5(1994) 345–355PubMedGoogle Scholar
  330. Abrahamson, M., S. Jonsdottir, I. Olafsson, O. Jensson and A. Grubb, Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum.Genet. 89(1992) 377–380PubMedGoogle Scholar
  331. Almeida, M.R., I. Longo Alves, Y. Sasaki, et al., Prenatal diagnosis of familial amyloidotic polyneuropathy: Evidence for an early expression of the associated transthyretin methionine 30. Hum.Genet. 85(1990) 623–626PubMedGoogle Scholar
  332. Davis, J. and W.E. van Nostrand, Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc.Natl.Acad.Sci.U.S. 93(1996) 2996–3000Google Scholar
  333. Li, S., J.L. Sobeli and S.S. Sommer, From molecular variant to disease: Initial steps in evaluating the association of thransthyretin M with disease. Am.J.Hum.Genet. 50(1992) 29–41Google Scholar
  334. Maury, C.P.J., J. Kere, R. Tolvanen and A. De la Chapelle, Homozygosity for the Asn187 Gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 13(1992) 902–903PubMedGoogle Scholar
  335. Skare, J., H. Yazici, E. Erken, et al., Homozygosity for met30 transthyretin gene in a Turkish kindred with familial amyloidotoxic polyneuropathy. Hum.Genet. 86(1990) 89–90PubMedGoogle Scholar
  336. Uemichi, T., J.J. Liepnieks, F. Alexander and M.D. Benson, The molecular basis of renal amyloidosis in Irish-American and Polish-Canadian kindreds. Q.Mon.J.Assoc.Phys. 89(1996) 745–750Google Scholar
  337. Gedeon, A.K., J.C. Mulley, H. Kozman, A. Donnelly and M.W. Partington, Localisation of the gene for X-linked reticulate pigmentary disorder with systemic manifestations (PDR), previously known as X-linked cutaneous amyloidosis. Am.J.Med.Genet. 52(1994) 75–78PubMedGoogle Scholar
  338. Minchiotti, L., S. Watkins, J. Madison, et al., Structural characterization of four genetic variants of human serum albumin associated with alloalbuminemia in Italy. Eur.J.Biochem. 247(1997) 476–482PubMedGoogle Scholar
  339. Murray, J.C., C.M. Demopulos, R.M. Lawn and A.G. Motulsky, Molecular genetics of human serum albumin: restriction enzyme length polymorphisms and analbuminemia. Proc.Nat. Acad.Sci.USA 80(1983) 5951–5955PubMedGoogle Scholar
  340. Indo, Y., M. Tsuruta, Yayashida, M.A. Karim, K. Ohta, et al., Mutations in the TRKA/NGFreceptor gene in patients with congenital insensitivity to pain with anhidrosis. Nature Genet. 13(1996) 485–488PubMedGoogle Scholar
  341. Landrieu, P., G. Said and C. Allaire, Dominantly transmitted congenital indifference to pain. Ann.Neurol. 27(1990) 574–578PubMedGoogle Scholar
  342. Trush, D.C., Congenital insensitivity to pain. A clinical, genetic, and neurological study of four children from the same family. Brain 96(1973) 369–386Google Scholar
  343. Toolis, F.A.C. Parker, A. White and S. Vrbaniak, Familial autoimmune haemolytic anaemia. Brit. Med.J. 1977/I 13–92Google Scholar
  344. Fukuda, M.N., K.A. Masri, A. Dell, et al., Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding α-mannosidase II. Proc.Nat. Acad.Sci.USA 87(1990) 7443–7447Google Scholar
  345. Gasparini, P., E.M. Del Giuduce, J. Delaunay, et al., Localization of the congenital dyserythropoietic anamia II locus to chromosome 20q 11.2 by genomewide search. Am.J.Hum.Genet. 61(1997) 1112–1116PubMedGoogle Scholar
  346. Iolascon, A., E.M. Del Giudice, S. Perrotta, et al., Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II). Blood 90(1997) 4197–4200PubMedGoogle Scholar
  347. Ohisalo, J.J., J. Vitala, R. Lintula and T. Ruutu, A new congenital dyserythropoietic anaemia. Brit.J. Haemat. 68(1988) 111–114PubMedGoogle Scholar
  348. Wickramasinkhe, S.N., V A. Wahlin, D. Anstee, S.F. Parsons, G. Stopps, et al., Observations on two members of the Swedish family with congenital dyserythropoietic anaemia, type III. Europ. J.Haematol. 50(1993) 213–221Google Scholar
  349. Quattrin, N., Dyserythropoetische Anämien. Schweiz.Med.Wschr. 105 (1975) 65–69PubMedGoogle Scholar
  350. Casademont, J., A. Barrientos, F. Cardellach, et al., Multiple deletions of mtDNA in two brothers with sideroblastic anemia and mitochondrial myopathy and in their mother. Hum.Molec.Genet. 3(1994) 1945–1949PubMedGoogle Scholar
  351. Jardine, P.E., P.D. Cotter, S.A. Johnson, E.J. Fitzsimons, L. Tyfield and P.W. Lunt, Pyridoxinerefractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exelusion exelusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis. J.Med.Genet. 31(1994) 213–218PubMedGoogle Scholar
  352. Larsson, N.-G., H.G. Eiken, H. Boman, E. Holme, A. Oldfors and M.H. Tulinius, Lack of transmission of deleted mtDNA from a woman with KEARNS-SAYRE syndrome to her child. Am.J. Hum. Genet. 50(1992) 360–363PubMedGoogle Scholar
  353. Raskind, W.H., E. Wijsman, R.A. Pagom, et al., X-linked sideroblastic anemia and ataxia: Linkage to phosphoglycerate kinase at Xq13. Am.J.Hum. Genet. 48(1991) 335–341Google Scholar
  354. Rötig, A., T. Bourgeron, D. Chretien, P. Rustin and A. Munnich, Spectrum of mitochondria DNA rearrangements in the PEARSON marrow-pancreas syndrome. Hum.Molec.Genet. 4(1995) 1327–1330PubMedGoogle Scholar
  355. Neufeld, E.J., H. Mandel, T. Raz, R. Szargel, C.N. Yandava, A. Stagg, S. Fauré, T. Barrett, N. Buist and N. Cohen, Localization of the gene for thiamine- responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. Am.J.Hum.Genet. 61(1997) 1335–1341PubMedGoogle Scholar
  356. Rindi, G., C. Patrini, U. Laforenza, H. Mandel, M. Berant, M.B. Viana, V. Poggi, et al., Further studies on erythrozcyte thiamine transport and phosphorylation in seven patients with thiamine-responsive megaloblastic anemia. J.lnherit.Metab.Dis. 17(1994) 667–677Google Scholar
  357. Bromberg, J.E.C., R.J.E. Rinkel, A. Algra, et al., Familial subarachnoid hemorrhage: Distinctive features and patterns of inheritance: Ann.Neurol. 38(1996) 929–934Google Scholar
  358. Kuivaniemi, H., D.J. Prockop, Y. Wu, et al., Exclusion of mutations in the gene for type III collagen (COL3Al) as a common cause of intracranial aneurysm or cervical artery dissections: Results from sequence analysis of the coding sequences of type III collagen from 55 unrelated patients. Neurology 43(1993) 2652–2658PubMedGoogle Scholar
  359. Leblanc, R., Familial cerebral aneurysm. Can.J.Neurol.Sci. 24(1997) 191–199PubMedGoogle Scholar
  360. Mathieu, J., G. Hebert, L. Perusse, et al., Familial intracranial aneurysms: Recurrence risk and accidental aggregation study. Can.J.Neurol.Sci. 24(1997) 326–33lPubMedGoogle Scholar
  361. Ohaegbulam, S.c., M. Dujovny, J.I. Ausman, et al., Ethnic distribution of intracranial aneurysms. Acta Neurochir. 106(1990) 132–135Google Scholar
  362. Rokainen, A., J. Hernesniemi, M. Puranen, et al., Familial intracranial aneurysms. Lancet 349(1996) 380–384Google Scholar
  363. Souhami, L., A. Olivier, E.B. Podgorsak, et al., Radiosurgery of cerebral arteriovenous malformations with the dynamic stereotactic irradiation. Int. J.Radiat.Oncol.Biol.Phys. 19(1990) 775–782PubMedGoogle Scholar
  364. Pletcher, B.A., J.E. Fox, R.A. Boxer, S. Singh, D. Blumenthal, T. Cohen, S. Brunson, P. Tafreshi and E. Kahn, Four sibs with arterial tortuosity: Description and review of the literature. Am.J.Med.Genet. 66(1966) 121–128Google Scholar
  365. Rasooly, R., J.M. Gomori and D. BenEzra, Arterial tortuosity and dilatation in LARSEN syndrome. Neuroradiology 30(1988) 258–260PubMedGoogle Scholar
  366. Bürger, J., K. Buiting, B. Dittrich, S. Groß, Ch. Lichy, K. Sperling, B. Horsthemke and A. Reis, Different mechanisms and recurrent risk of imprinting in ANGELMAN syndrome. Am.J.Hum.Genet. 61(1997) 88–93PubMedGoogle Scholar
  367. Clayton-Smith, J. and M.E. Pembrey, ANGELMAN syndrome. J.Med.Genet. 29(1992) 412–415PubMedGoogle Scholar
  368. Dittrich, B., K. Buiting, B. Korn, S. Rickard, J. Buxton, S. Saitoh, et al., Imprint switching on human chromosome 15 may involve alternativ transcripts of the SNRPNgene. Nature Genet. 14(1996) 163–170PubMedGoogle Scholar
  369. Fung, D.C.Y., B. Yu, K.F. Cheong, A. Smith and R.J. Trent, UBE3A„mutations“in two unrelated and phenotypically different ANGELMAN syndrome patients. Hum.Genet. 102(1988) 487–492Google Scholar
  370. Kishino, T., M. Lalande and J. Wagstaff, UBE3AIE6- APmutations cause ANGELMAN syndrome. Nature Genet. 15(1997) 70–73PubMedGoogle Scholar
  371. Malcolm, S., J. Clayton-Smith, M. Nichols, et al., Uniparental disomy in ANGELMAN’S syndrome. Lancet 1991/I 694–697Google Scholar
  372. Malzac, P., H. Webber, A. Moncla, J.M. Graham Jr., et al., Mutation analysis of UBE3Ain ANGELMAN syndrome patients. Am.J.Hum.Genet. 62(1998) 1353–1360PubMedGoogle Scholar
  373. Matsuura, T., J.S. Sutcliffe, P. Fang, R.-J. Galjaard, Y. Hu Jiang, et al., De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A)in ANGELMAN syndrome. Nature Genet. 15(1997) 74–77PubMedGoogle Scholar
  374. Webb, T., S. Malcolm, M.E. Pembrey and J. ClaytonSmith, Inheritance of parental chromosomes 15 in ANGELMAN syndrome - implications for the family. Genet.Couns. 4(1993) 1 - 6PubMedGoogle Scholar
  375. Baraitser, P. and C. Shieff, Cutaneomeningo-spinal angiomatosis: the syndrome of COBB. A case report. Neuropediatrics 21(1990) 160–16lPubMedGoogle Scholar
  376. Blei, F., J. Walter, S.J. Orlow and D.A. Marchuk, Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch.Derm. 134(1998) 718–722PubMedGoogle Scholar
  377. Craig, H.D., M. Günel, O. Capeda, E.W. Johnson, L. Ptacek, et al., Multilocus linkage identifies two new loci for a MENDELian form of stroke, cerebral cavernous malformation, at 7p15–13 and 3q25.2–27. Hum.Molec.Genet. 7 (1998) 1851–1858PubMedGoogle Scholar
  378. Marchuk, D.A., C.J. Gallione, L.A. Morrison, C.L. Clericuzio, et al., A locus for cerebral cavernous malformations maps to chromosome 7q in two families. Genomics 28(1995) 311–314PubMedGoogle Scholar
  379. Polymeropoulos, M.H., O. Hurko, F. Hsu, et al., Linkage of the locus for cerebral caverous hemangiomas to human chromosome 7q in four families of Mexican-American descent. Neurology 48(1997) 752–757PubMedGoogle Scholar
  380. Walter, J.W., F.M. Blei and D.A. Marchuk, Description of a novel hereditary form of capillary hemangioma and genetic mapping of predisposing chromosomal loci. Am.J.Hum.Genet. 61/Suppl. (1997) A299Google Scholar
  381. Axton, R., I. Hanson, S. Danes, G. Sellar, V. van Heyningen and J. Posser, The incidence of PAX6mutation in patients with simple aniridia: an evaluation of mutation detection in 12 cases. J.Med Genet.nm 34(1997) 279–286Google Scholar
  382. Courteney-Harris, R.G. and P.P. Mills, Aniridia and deafness: An inherited disorder. J.Laryngol.Otol. 104(1990) 419–420PubMedGoogle Scholar
  383. Glaser, T., L. lepeal, I.G. Edwards, S.R. Young, J. Favor and R.L. Maas, PAX6gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nature Genet. 8(1994) 463–471Google Scholar
  384. Héon, E., B.P. Sheth, I.W. Kalenak, S.L.F. Sunden, L.M. Streb, et al., Linkage of autosomal dominant iris hypoplasia to the region of the RIEGER syndrome locus (4q25). Hum.Molec.Genet. 4(1995) 1435–1439PubMedGoogle Scholar
  385. Martha, A.D., R.E. Ferrell and G.F. Saunders, Nonsense mutation in the homeobox region of the aniridia gene. Hum.Mutat. 3(1994) 297–300PubMedGoogle Scholar
  386. Martha, A.D., R.E. Ferrell, H. Minth-Hittner, L.A. Lyons and G.F. Saunders, Paired box mutations in familial and sporadic aniridia predicts truncated aniridia proteins. Am.J.Hum.Genet. 54(1994) 801–811PubMedGoogle Scholar
  387. Mirzayans, F., W.G. Pearce, I.M. McDonald and M.A. Walter, Mutation of the PAX6gene in patients with autosomal dominant keratitis. Am.J.Hum.Genet. 57(1995) 539–548PubMedGoogle Scholar
  388. Nelson, J., M. Flaherty and P. Grattan-Smith, GILLESPIE syndrome. A report of two further cases. Am.J.Med.Genet. 71(1997) 134–138PubMedGoogle Scholar
  389. Prosser, J. and V. van Heyningen, PAX6mutations reviewed. Hum.Mutat. 11(1998) 93–108PubMedGoogle Scholar
  390. Ohishi, M., S. Kai. S. Ozeki and H. Tashiro, Alveolar synechia, ankyloblepharon, and ectodermal disorders: An autosomal rezessive disorder? Am.J.Med.Genet. 38(1991) 13–15PubMedGoogle Scholar
  391. Seres-Santamaria, A., J.L. Arimany and F. Muniz, Two sibs with cleft palate, ankyloblepharon, alveolar synechiae, and ectodermal defects: a new syndrome? 30(1993) 793–795Google Scholar
  392. Bos, C.J.M., P.F. Ippel and F.A. Beemer, DOOR syndrome: additional case and literature. Clin.Dysmorph. 3(1994) 15–20PubMedGoogle Scholar
  393. Devriendt, K., D. Stoffelen, R. Pfeiffer, A. Leys and J.-P. Fryns, Oto-onycho-peroneal syndrome: confirmation of a syndrome. J.Med.Genet. 35(1998) 508–509PubMedGoogle Scholar
  394. Kumar, D. and R.K. Levick, Autosomal dominant onychodystrophy and anonychia with type B brachydactyly and ectrodactyly. Clin.Genet. 30(1986) 219–225PubMedGoogle Scholar
  395. Malhoudji, M. and M. Amidi, Simple anonychia. Further evidence for autosomal recessive inheritance. J.Med.Genet. 8(1971) 478–480Google Scholar
  396. Nevin, N.C., P.S. Thomas, D.J. Eedy and C. Sheperd, Anonychia and absence/hypoplasia of distal phalanges (COOKS syndrome): report of a second family. J.Med.Genet. 32(1995) 638–641PubMedGoogle Scholar
  397. Teebi, A.S., and P. Kaurah, Total anonychia congenital and microcephaly with normal intelligence: a new autosomal-recessive syndrome? Am.J.Med.Genet. 66(1996) 257–260PubMedGoogle Scholar
  398. Arroyo, I., M.J. Garcia, C.E. Cimadevilla, et al., Bilateral anophthalmia, esophageal atresia, and right cryptorchidism: A new entity? Am.J.Med.Genet. 43(1992) 686–687PubMedGoogle Scholar
  399. Ercal, D. and B. Say, Cerebro-oculo-nasal syndrome: another case and review of the literature. Clin. Dysmorphol. 7(1998) 139–141PubMedGoogle Scholar
  400. Podlech, Bilateral agenesis/aplasia of the lungs: Report of a second case in the offspring of one woman. Pediatr.Pathol.Lab.Med. 15(1995) 781–790PubMedGoogle Scholar
  401. Prosser, J. and V. van Heyningen, PAX6mutation reviewed. Hum.Mutat. 11(1998) 93–108PubMedGoogle Scholar
  402. Selier, M.J., T.B. Davis, C.N. Fear, F.A. Flinter, I. Ellis and A.G. Gibson, Two sibs with anophthalmia and pulmonary hypoplasia (the MATTHEW-WOOD syndrome). Am.J.Med.Genet. 62(1996) 227–229Google Scholar
  403. Sensi, A., C. Incorvaia, A. Sebastiani and E. Calzolari, Clinical anophthalmos in a family. Clin.Genet. 32(1987) 156–159PubMedGoogle Scholar
  404. Warburg, M., H. Jensen, J.U. Prause, S. Bolund, F. Skovby and M.J. Miranda, Anophthalmia-microphthalmia- oblique clefting syndrome: Confirmation of the FRYNS anophthalmia syndrome. Am.J.Med.Genet. 73(1997) 36–40PubMedGoogle Scholar
  405. Ansley Green, A., M. Zachmann, R. Illig, et al., Congenital anorchia in childhood: a clinical, endocrine, and therapeutic evaluation of twenty one cases. Clin.Endocrinol. 5(1976) 381–391Google Scholar
  406. Hall, J.G., A. Morgan, and R.M. Blizzard, Familial congenital anorchia. Birth Def., Orig.Art.Ser. 11(1975) 115–119Google Scholar
  407. Elbadawy, M.H.F., M.J. Cliffe and P.T. James., A monocygotic twin pair discordant for anorexia nervosa. Can.J.Psychiatr. 30(1985) 544–545Google Scholar
  408. Gorwood, P., M. Bouvard, M.C. Mouren-Simeoni, et al., Genetics and anorexia nervosa: A review of candidate genes. Psychiatr.Genet. 8(1998) 1–12PubMedGoogle Scholar
  409. Halmi, K., J.L. Katz, G. Gorczinski and H. Werner, Anorexia nervosa and gonadal dysgenesis; further evidence of a relationship. Arch.Gen.Psychiat. 34(1977) 332–335Google Scholar
  410. Hebebrand, J. and H. Remschmidt, Anorexia nervosa viewed as an extreme weight condition: Genetic implication. Hum.Genet. 95(1995) 1–11PubMedGoogle Scholar
  411. Hebebrand, J., A. Hinney and H. Remschmidt, Genetik der Anorexia nervosa. Med.Genet. 10(1998) 412–414Google Scholar
  412. Pumariega, A.J., J. Pursell, A. Spock, and J.D. Jones, Eating disorders in adolescence with cystic fibrosis. Am.J. Child. Psychiatr. 25(1986) 269–275Google Scholar
  413. Suematsu, H., T. Kuboki and E. Ogata, Anorexia nervosa in monozygotic twins. Psychother. Psychosom. 45(1986) 46–50PubMedGoogle Scholar
  414. Walsh, B.T. and M.J. Devlin, Eating disorders: Progress and problems. Science 280(1998) 1387–1390PubMedGoogle Scholar
  415. Francke, U., Microdeletions and Mendelian phenotype. In: Vogel, F. and K. Sperling, Human Genetics. Proc. 7th Intern. Congr. Berlin 1986, Springer- Verl. Berlin, Heidelberg, New Yark, London, Paris, Tokyo 1987. S.201–210Google Scholar
  416. Lygonis, C.S., Familiar absence of olfaction. Hereditas 61(1969) 413–416PubMedGoogle Scholar
  417. Wissell Enechy, D. and E.J. Amoore, Odour blindness to musk: Simple recessive inheritance. Nature 242(1973) 271–273Google Scholar
  418. Reisman, L.E., Anti-mongolism. Studies in an infant with a partial monosomy of the 21 chromosome. Lancet 1966/II 394–397Google Scholar
  419. Richmond, H.G., P. Cacarthur and F. Hunter, A’G’ deletion syndrome. Antimongolism. Acta Paediat.Scand. 62(1973) 216–220PubMedGoogle Scholar
  420. Blajchman, M.A., An overview of the mechanism of action of antithrombin and its inherited deficiency states. Blood Coagul.Fibrinolysis 5 Suppl. 1(1994) S5-S11Google Scholar
  421. Blajchman, M.A., R.C. Austin, F. Fernandez-Rachubinski and W.P. Sheffield, Molecular basis of inherited human antithrombin deficiency. Blood 80(1992) 2159–2171PubMedGoogle Scholar
  422. Dürr, c., A. Hinney, C. Luckenbach, J. Kömpf and H. Ritter, Genetic studies of antithrombin III with IEF and ASO hybridization. Hum.Genet. 90(1990) 457–459Google Scholar
  423. Rosendaal, F.R., H. Hejboer, E. Briet, et al., Mortality in hereditary antithrombin-III- deficiency 1830- 1989. Lancet 337(1991) 260–262PubMedGoogle Scholar
  424. Antley, R.A. and D. Bixler, Development in the trapezoidocephaly - multiple synostosis syndrome. Am.J.Med.Genet. 14(1983) 149–150PubMedGoogle Scholar
  425. Bottoro, L., G. Cinalli, P. Laburne, et al., Le syndrome d’ ANTLEY-BIXLER. Déscription de deux nouveaux cas et révue de la literature. Elements prognostiques et thérapeutiques. Ann.Chir.Lat.Estet. 42(1997) 48–55Google Scholar
  426. Chun, K, J. Siegel-Bartelt, D. Chitayat, J. Phillips and P.N. Ray, FGFR2 mutation associated with clinical manifestations consistent with ANTLEY-BIXLER syndrome. Am.J.Med.Genet. 77(1998) 219–224PubMedGoogle Scholar
  427. Hassell, S. and M.G. Butler, ANTLEY-BIXLER syndrome: report of a patient and review of the literature. Clin.Genet. 46(1994) 372–376PubMedGoogle Scholar
  428. Kito, H., H. Nogami, T. Oki, et al., ANTLEY-BIXLER syndrome: A disorder characterized by congenital synostosis of the elbow joint and the cranial suture. J.Pediatr.Orthop. 16(1996) 243–246Google Scholar
  429. Poddevin, F., B. Delobel, P. Courreges and M. Bayart, ANTLEy-BIXLER syndrome: Case report and review of the literature. Genetic Couns. 6(1995) 241–246Google Scholar
  430. Bartsch, O., U. Kuhnle, L.L. Wu, E. Schwinger and G.K. Hinkel, Evidence for a critical region for penoscrotal inversion, hypospadias, and imperforate anus within chromosomal region 13q32.2q34. Am.J.Med.Genet. 65(1996) 218–221PubMedGoogle Scholar
  431. Kohlhase, J., A. Wischermann, H. Reichenbach U. Froster and W. Engel, Mutations in the SALL1putative transcription factor gene cause TOWNES-BROCKS syndrome. Nature Genet. 18(1998) 81–83PubMedGoogle Scholar
  432. Serville, F., D. Lacombe, R. Saura, C. Billeaud and M.P. Sergent, TOWENS-BROCKS syndrome in an infant with translocation t(5;16). Genet.Couns. 4 (1993) 109–112PubMedGoogle Scholar
  433. Tunell, W.P., J.C. Austin, P.D. Barnes, and A. Reynolds, Neurological evaluation of sacral abnormalities in imperforate anus complex. J.Pediat.Surg. 22(1987) 58–061PubMedGoogle Scholar
  434. de Vries-van der Weerd, M.-A.C.S., P.J. Willems, H.M. Mandema and L.P. Penkate, A new family with TOWNES-BROOKS syndrome. Clin.Genet. 34(1988) 195–200PubMedGoogle Scholar
  435. Francke, U., M.A. Berg, K. Tynan, T. Brenn, W. Liu, T. Aoyama, C. Gasner, D.G. Miller and H. Furthmayr, A Gly1127Ser mutation in an EGF-like do- main of the fibrillin-1 gene is a risk factor for ascending aortic aneurysma and dissection. Am.J. Hum.Genet. 56(1995) 1287–1296PubMedGoogle Scholar
  436. Limet, R., Le risque familial de I’anevrisme de l’aorte abdominale et ses consequences pour l’organisation d’un depistage selectif. J.Mal.Vasc. 20(1995) 285–287PubMedGoogle Scholar
  437. Loosemore, T.M., A.H. Child and J.A. Dormandy, Familial abdominal aortic aneurysms. J.Roy.Soc.Med. 81(1988) 472–473PubMedGoogle Scholar
  438. Majumbder, P.P., P.L. St. Jean, R.E. Ferrell, et al., On the inheritance of abdominal aortic aneurysm. Am.J.Hum.Genet. 48(1991) 164–170Google Scholar
  439. Verloes, A., N. Sakalihasan, L. Koulischer and R. Limet, Aneurysms of the abdominal aorta: Familial and genetic aspects in three hundred thirteen pedigrees. J.Vasc.Surg. 21(1995) 646–655PubMedGoogle Scholar
  440. Numano, F., I. Ischisa, U. Kishi, M. Arita and Maezewa, TAKAYASU’S disease in twin sisters. Possible genetic factors. Circulation 58(1978) 173–177PubMedGoogle Scholar
  441. Kimura, A., H. Kitamura, Y. Data and F. Numano, Comprehensive analysis of HLA genes in TAKAYASU arteriitis in Japan. Int.J.Cardiol. 54(1996) /Suppl. 65–73Google Scholar
  442. Deluca, S.A., Coarctation of the aorta. Am.Pam.Phys. 42(1990) 1285–1288Google Scholar
  443. Germoni, S., G. Sabatino, R. Mingarelli and B. Dallapiccola, Coarctation of the aorta, interrupted aortic arch, and hypoplastic left heart syndrome in three generations. J.Med.Genet. 30(1993) 328–329Google Scholar
  444. Tikkanen, J. and O.P. Heinonen, Risk factors for coarctation of the aorta. Teratology 47(1993) 565–572PubMedGoogle Scholar
  445. Ashkenas, J., WILLIAMS syndrome start making sense. Am.J.Hum.Genet. 59(1996) 756–761PubMedGoogle Scholar
  446. Curran, M.E., D.L. Atkinson, A.K. Ewart, The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 73(1993) 159–168PubMedGoogle Scholar
  447. Mari, A., F. Amati, R. Mingarelli, A. Giannotti, G. Sebastio, V. Colloridi, G. Novelli and B. Dellapiccola, Analysis of the elastin gene in 60 patients with clinical diagnosis of WILLIAMS syndrome. Hum.Genet. 96(1995) 444–448PubMedGoogle Scholar
  448. Lenhoff, H.M., P.P. Wang, F. Freenberg and V. Bellugi, WILLIAMS syndrome and the brain. Scient.Amer. (1997) 42–47Google Scholar
  449. Monaco, A.P., Human genetics: Dissecting WILLIAMS syndrome. Curr.Biol. 6 (1996) 196–197Google Scholar
  450. Morris, C.A. and J.C. Carey, Three diagnostic signs in WILLIAMS syndrome. Am.J.Med.Genet. 6/Suppl. (1990) 100–101Google Scholar
  451. Olson, T.M., V.V. Michels, N.M. Lindor, G.M. Pastores, J.L. Weber, D.J. Schaid, D.J. Driscoll, R.H. Feldt and S.N. Thibodeau, Autosomal dominant supravalvular aortic stenosis: localization to chromosome 7. Hum. Molec.Genet. 2(1993) 869–873PubMedGoogle Scholar
  452. Tassabehji, M., K. Metcalfe, D. Donnai, J. Hurst, W. Reardon, M. Burch and A.P. Read, Elastin. Genomic structure and point mutations in patients with supravalvular aortic stenosis. Hum.Molec.Genet. 6(1997) 1029–1036PubMedGoogle Scholar
  453. Wedemeyer, N., R. Peoples, H. Himmelbauer, H. Lehrach, V. Francke and E.E. Wanker, Localization of the human HIP1gene close to the elastin (ELN)locus on 7q11.23. Genomics 46(1997) 313–315PubMedGoogle Scholar
  454. Bamforth, J.S., P. Kaurah, J. Byrne and P. Ferreira, ADAMS-OLIVER syndrome: A family with extreme variability in clinical expression. Am.J. Med.Genet. 49(1994) 393–396PubMedGoogle Scholar
  455. Elliott, A.M. and A.S. Teebi, Further examples of autosomal dominant transmission of nonsyndromic aplasia cutis congenita. Am.J.Med.Genet. 73(1997) 495–496PubMedGoogle Scholar
  456. Fullana, F., M. Gonzáles, M. Nó and V. Gonzáles-Mestre, Aplasia cutis congenita of the scalp in five successive generations of one family. Plast. Reconstr.Surg. 95(1995) 214–315PubMedGoogle Scholar
  457. Park, M.-S., S.-H. Hahn, Ch.-H. Hong, J.-S. Kim and H.-S. Kim, Extensive form of aplasia cutis congenita: a new syndrome ? J.Med.Genet. 35(1998) 609–911PubMedGoogle Scholar
  458. Sybert, V.P., Aplasia cutis congenita: A report of 12 new families and review of the literature. Pediat. Derm. 3(1985) 1–14PubMedGoogle Scholar
  459. Toriello, H. V., Y. Lacassie, P. Droste and J.V. Higgins, Provisionally unique syndrome of ocular and ectodermal defects in two unrelated boys. Am.J. Med.Genet. 45(1993) 764–766PubMedGoogle Scholar
  460. Günel, M. and R.P. Lifton, Counting strokes. Nature Genet. 13(1996) 384–385PubMedGoogle Scholar
  461. Pullicino, P., S. Greenberg and M. Trevisan, Genetic stroke risk factors. Curr.Opin.Neurol. 10(1997) 58–63PubMedGoogle Scholar
  462. Hannan, M.A., D. Sigut, M. Waghray and G.G. Gascon, Ataxia-ocular motor apraxia syndrome: an investigation of cellular radiosensitivity of patients and their families. J.Clin.Genet. 31(1994) 953–956Google Scholar
  463. Kloos, D.-U., S. Jakubiczka, T. wienker, G. Wolff and P. Wieacker, Localization of the gene for WIEAKKER- WOLFF syndrome in the pericentromeric region of the X chromosome. Hum.Genet. 100(1997) 426–430PubMedGoogle Scholar
  464. Zee, S., R.D. Yee, and H.S. Singer, Congenital ocular motor apraxia. Brain 100(1977) 581–599PubMedGoogle Scholar
  465. Pijpers, L., W.J. Kleijer, A. Reuss, M.G.J. Jahoda, F.J. Los, et al., Transabdominal chorionic villus sampling in a multiple pregnancy at risk of arginino succinic aciduria: a case report. Am.J.Med.Genet. 36(1990) 449–450PubMedGoogle Scholar
  466. Simard, L., W.E. O’Brien and R.R. McInnes, Arginino succinate lyase deficiency: Evidence for heterogeneous structural gene mutations by immunoblotting. Am.J.Hum.Genet. 39 (1986) 38–51PubMedGoogle Scholar
  467. Stuart, G., C. Wren and H. Bain, Idiopathic infantile arterial calcification in two siblings: failure of treatment with diphosphonate. Brit.Heart J. 64(1989) 156–159Google Scholar
  468. Van Dyck, M., W. Proesmans, E. Van Hollebeke, G. Marchal and Ph. Moerman, Idiopathic infantile arterial calcification with cardiac, renal and central nervous system involvement. Eur.J. Pediatr. 148(1989) 374–377PubMedGoogle Scholar
  469. Bermann, M., M. Ebke, Y. Yuan, et al., Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): A morphological study of a German family. Acta Neuropathol. 92(1996) 341–350Google Scholar
  470. Clair, D.St., J. Bolt, St. Morris and D. Doyle, Hereditarymulti- infarct dementia unlinked to chromosome 19q 12 in a large Scottish pedigree: evidence of probable locus heterogeneity. J.Med.Genet. 32(1995) 57–60Google Scholar
  471. Ducros, A., T. Nagy, S. Alamowitch, A. Nibbio, et al., Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM interval. Am.J.Hum.Genet. 58(1996) 171–181PubMedGoogle Scholar
  472. Hutchinson, M., J. O’Riordan, M. Javed, et al., Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL). Ann.Neurol. 38(1995) 817–824PubMedGoogle Scholar
  473. Joutel, A., C. Corpechot, A. Ducros, et al., Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383(1996) 707–710PubMedGoogle Scholar
  474. Ruchoux, M.-M. and C.-A. Maurage, CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J.Neuropathol.Exp.Neurol. 56(1997) 947- 964PubMedGoogle Scholar
  475. Tournier Lasserve, E., A. Joutel, J. Melki, et al., Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy maps to chromosome 19q12. Nature Genet. 3(1993) 256–295PubMedGoogle Scholar
  476. Bamshad, M., W.S. Watkins, R.K. Zenger, J.F. Bonsack and J.C. Carey, A gene for distal arthrogryposis type I maps to the pericentromeric region of chromosome 9. Am.J.Hum.Genet. 55(1994) 1153–1158PubMedGoogle Scholar
  477. Bamshad, M., L.B. Jorde and J.C. Carey, A revisted and extended classification of the distal arthrogryposes.b Am.J.Med.Genet. 65(1996) 277–281PubMedGoogle Scholar
  478. Burglen, L., J. Amiel, L. Viollet, et al., Survival motor neuron gene deletion in the arthrogryposis multiplex congenita-spinal muscular atrophy association. J.Clin.lnvest. 98(1996) 1130–1132Google Scholar
  479. Hall, J.G., Arthrogryposis associated with unsuccessful attemps at termination of pregnancy. Am.J.Med.Genet. 63(1996) 293–300PubMedGoogle Scholar
  480. Hall, J.G., S.D. Reed and G. Greene, The distal arthrogryposis: Delineation of new entities. Review and nosologic discussion. Am.J.Med.Genet. 11(1982) 185–239PubMedGoogle Scholar
  481. Hall, J.G., S.D. Reed, C.I. Scott, J.G. Rogers, K.L. Jones and A. Camarano, Three distinct types of X-linked arthrogryposis seen in 6 families. Clin.Genet. 21(1982) 81–97PubMedGoogle Scholar
  482. Krakowiak, P.A., J.F. Bohnsack, J.C. Carey and M. Bamshad, Clinical analysis of a variant of FREEMAN-SHELDON syndrome (DA2B). Am.J. Hum.Genet. 76(1998) 93–98Google Scholar
  483. Kobayashi, H., L. Baumbach, T.C. Matise, A. Schiavi, F. Greenberg and E.P. Hoffman, A gene for a severe lethal form of X-linked arthrogryposis (Xlinked infantile spinal muscular atrophy) maps to human chromosome Xpl1.3-ql1.2. Hum.Molec.Genet. 4(1995) 1213–1216PubMedGoogle Scholar
  484. McPherson, E. and M. Clemens, BRUCK syndrome (Osteogenesis imperfecta with congenital joint contractures): Review and report on the first North American case. Am.J.Med.Genet. 70(1997) 28–31PubMedGoogle Scholar
  485. Shohat, M., R. Lotan, N. Magal, T. Shohat, et al., A gene for arthrogryposis multiplex congenita neuropathic type is linked to D5S394 on chromosome 5qter. Am.J.Hum.Genet. 61(1997) 1139–1143PubMedGoogle Scholar
  486. Schrander-Stumpel, C.T.R.M., J.P. Fryns, J.J.P. Schrande and J. Vles, Distal arthrogryposis, specific facial dysmorphism and psychomotor retardation: A recognizable entity in surviving patients with the fetal akinesia deformation sequence. Genet. Couns. 2(1991) 659–675Google Scholar
  487. Stratton, R.F., R.J. Jörgenson and I.C. Krause, Possible second case of tricho-oculo-dermo-vertebral (ALVES) syndrome. Am.J.Med.Genet. 46(1993) 313–315PubMedGoogle Scholar
  488. Stoll, C., Y. Alembik et B. Dott, Arthrogryposis distal familiale de type r. Ann.Génét. 39(1996) 75–80PubMedGoogle Scholar
  489. Verloes, A., P. Dodinval, M.Ch. Retz, J.-P. Schaaps and L. Koulischer, A hydropic fetus with translucent ribs, arthrogryposis multiplex congenital and congenital myopathy: etiological heterogeneity of A.M.C., TORIELLO-BAUSERMAN type? Genet.Couns. 2(1991) 63–66PubMedGoogle Scholar
  490. Verloes, A., N. Mulliez, M. Gonzales, et al., Restrictive dermopathy, a lethal form of arthogryposis multiplex with skin and bone dysplasias: Three new cases and review of the literature. Am.J.Med.Genet. 43(1992) 539–547PubMedGoogle Scholar
  491. Vuopala, K. and R. Herva, Lethal congenital contracture syndrome: further delineation and genetic aspects. J.Med.Genet. 31(1994) 521–527PubMedGoogle Scholar
  492. Barnett, M.L., L.L. Bosshardt and A.F. Morgan, Double lip and double lip with blepharochalasis (ASCHER’S syndrome). Oral Surg. 34(1972) 727–733PubMedGoogle Scholar
  493. Ikonen, E., M. Baumann, K. Gron, et al., Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO 10(1991) 51–58Google Scholar
  494. Park, H., M.B. Vettese, A.H. Fensom, et al., Characterization of three alleles causing aspartylglycosaminuria: Two from a British family and one from an American patient. Biochem.J. 290(1993) 735–741PubMedGoogle Scholar
  495. Annérén, G., N. Dahl, U. Uddenfeldt and L.-O. Janols, ASPERGER syndrome in a boy with balanced de novo translocation: t(17;19)(p13.3;p11). Am.J. Med.Genet. 56(1995) 330–331PubMedGoogle Scholar
  496. Seltipane, G.A. and R.K. Puddupakkam, Aspirin intolerance. III. Subtypes, familial occurrence, and cross reactivity with tartrazine. J.Allergy Clin. Immunol. 56(1975) 215–221Google Scholar
  497. Arts, W.F.M., M.C.B. Sengers and J.L. Slooff, X-linked ataxia, weakness, deafness, and loss of vision in early childhood with fatal course. Ann.Neurol. 33(1993) 535–539PubMedGoogle Scholar
  498. Bouchard, J.P., A. Barbeau, R. Bouchard and R.W. Bouchard, Autosomal recessive spastic ataxia of Charlevoix -Saguenay. Canad.J.Neurol.Sci. 5 (1978) 61–69PubMedGoogle Scholar
  499. Koenig, M., G. Sirugo et F. Duclos, Génétique moleculaire et ataxies héréditaires. Rev.Neurol. 149(1993) 698–702PubMedGoogle Scholar
  500. Neuhauser, G. and J.M. Opitz, Autosomal recessive syndrome of cerebellar ataxia and hypogonadotropic hypogonadism. Clin. Genet. 7(1975) 426–434PubMedGoogle Scholar
  501. Nicolaides, P., Appleton, R.E. and A. Freyer, Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome. J.Med.Genet. 33(1996) 419–421PubMedGoogle Scholar
  502. Nystuen, A., P.J. Benke, J. Merren, E.M. Stone and V.C. Sheffield, A cerebellar ataxia locus identified by DNA pooling to search for linkage disequili disequilibrium in an isolated population from the Cayman Islands. Hum.Molec.Genet. 5(1996) 525- 531PubMedGoogle Scholar
  503. Rasmussen, F., K.-H. Gustavson, V.R. Sara and Y. Floderus, The dysequilibrium syndrome: a study of the etiology and pathogenesis. Clin.Genet. 27(1985) 191–195PubMedGoogle Scholar
  504. Schwartz, C.E., J. Ulmer, A. Brown, et al., ALLAN-HERNDON syndrome. II. Linkage to DNA markers in Xq21. Am.J.Hum.Genet. 47(1990) 454–458PubMedGoogle Scholar
  505. Auburger, G., T. Ratzlaff, A. Lunkes, H.W. Nelles, B. Leube, et al., A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1 p, probably within 2cM between DlS443 and DlS197. Genomics 31(1996) 90–94PubMedGoogle Scholar
  506. Browne, D.L., S.T. Gancher, J.G. Nutt, E.R.P. Brunt, E.A. Smith, P. Kramer and M. Litt, Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nature Genet. 8(1994) 136–140PubMedGoogle Scholar
  507. Jodice, c., E. Mantuano, L. Venetiano, F. Trettel, G. Sabbadini, et al., Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A (CACNLlA4) gene on chromosme 19p. Hum.Molec.Genet. 6(1997) 1973–1978PubMedGoogle Scholar
  508. Kurlemann, G., I. Hörnig und D.G. Palm, Famiäre periodische Ataxie. Mschr.Kinderheilk. 136(1988) 462–463Google Scholar
  509. Ophof, R.A., G.T. Terwindt, M.N. Vergouwe, R. Van Eijk, et al., Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+channal gene CACNLlA4. Cell 87(1996) 543–552Google Scholar
  510. Scheffer, H., E.R.P. Brunt, G.J.J. Mol, P. van der Vlies, R.P. Stulp, et al., Three novel KNCA1mutations in episodic ataxia type I families. Hum.Genet. 102(1998) 464–466PubMedGoogle Scholar
  511. Dick, D.J., P.K. Newman and P.G. Cleland, Hereditary spastic ataxia with congenital miosis: four cases in one family. Br.J.Ophthal. 67(1983) 97- 101Google Scholar
  512. Hogan, G.R. and M.L. Banman, Familial spastic ataxia: occurrence in childhood. Neurology 27(1977) 520–526PubMedGoogle Scholar
  513. Cavalier, L., K. Ouahchi, H.J. Kayden, S. Di Donato, L. Reutenauer, J.-L. Mandel and M. Koenig, Ataxia with isolated vitamin E deficiency: Heterogeneity of mutations and phenotype variability in a large number of families. Am.J.Hum.Genet. 62(1998) 301–310PubMedGoogle Scholar
  514. DiDonato, St., Can we avoid AVED ? Nature Genet. 9(1995) 106–107Google Scholar
  515. Ouahchi, K., M. Arita, H. Kayden, F. Hentati, M.B. Hamida, R. Sokol, H. Arai, K. Inoue, J.L. Mandel and M. Koenig, Ataxia with isolated vitamin E deficiency is caused by mutations in the a-tocopherol transfer. Nature Genet. 9(1995) 141–145PubMedGoogle Scholar
  516. Bejjani, B.A., K.C. Oberg, I. Wilkins, A. Moise, C. Langston, A. Superti-Furga and J.R. Lupski, Prenatal ultrasonographic description and postnatal pathological findings in atelosteogenesis. Am.J.Med.Genet. 79(1998) 392–395PubMedGoogle Scholar
  517. Canki-Klain, N., V. Stanescu, R. Stanescu, et al., Lethal short limb dwarfism with dysmorphic face, omphalocele and severe ossification defect: PIEPKORN syndrome or severe’boomerang dysplasia’ ? Ann. Genet. 35(1992) 129–133PubMedGoogle Scholar
  518. Hunter, A.G.W. and B.F. Carpenter, Atelosteogenesis I and boomerang dysplasia: a question of nosology. Clin.Genet. 39(1991) 471–480PubMedGoogle Scholar
  519. Newbury-Ecob, R., Atelosteogenesis type 2. J.Med.Genet. 35(1998) 49–53PubMedGoogle Scholar
  520. Nishimura, G., T. Horiuchi, O.H. Kim and Y. Sasamoto, Atypical skeletal changes in otopalatodigital syndrome type II: Phenotypic overlap among otopalatodigital syndrome type II, Boomerang dysplasia, atelosteogenesis type I and type III, and lethal male phenotype of MELNICK- NEEDLES syndrome. Am.J.Med.Genet. 73(1997) 132–138PubMedGoogle Scholar
  521. Nores, J.A., S. Rotmensch, R. Romero, et al., Atelosteogenesis type II: Sonographic and radiological correlation. Prenatal Diagn. 12(1992) 741–753Google Scholar
  522. Schrander-Stumpel, C., M. Havenith, E.V.D. Linden, W. Maerzdorf, J. Offermans and J. Van der Harten, De la CHAPELLE dysplasia (atelosteogenesis type II): case report and review of the literature. Clin.Dysmorphol. 3(1994) 318–327PubMedGoogle Scholar
  523. Winship, I., B. Cremin and P. Beighton, Boomerang dysplasia. Am.J.Med.Genet. 36(1990) 440–443PubMedGoogle Scholar
  524. De Felice, M., C. Ovitt, E. Biffali, A. Rodriguez-Mallon, C. Arra, et al., A mouse model for hereditary thyroid dysgensis and cleft palate. Nature Genet. 19(1998) 395–397PubMedGoogle Scholar
  525. Greig, W.R., A.S. Henderson, J.A. Boyle, E.M. McGirr and J.H. Hutchinson, Thyroid dysgenesis in two pairs of monozygotic twins and in a mother and a child. J.Clin.Endocrin. 26(1966) 1309–1311Google Scholar
  526. Maenpaa, J., Congenital hypothyroidism. Aetiological and clinical aspects. Arch.Dis.Child. 46(1972) 914–917Google Scholar
  527. Barnes, K.C., J.D. Neely, D.L. Duffy, et al., Linkage of asthma and total serum IgE concentration to markers on chromosome 12q: Evidence from Afro-Caribbean and Caucasian populations. Genomics 37(1996) 41–50PubMedGoogle Scholar
  528. Collaborative Study on Genetics in Asthma, A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nature Genet. 15(1997) 389–392Google Scholar
  529. Cookson, W.O.C.M. and J.M. Hopkin, Dominant inheritance of atopic immunoglobulin-E responsiveness. Lancet 1988/1, 86–88PubMedGoogle Scholar
  530. Diepgen, T.L. and M. Fartasch, Recent epidemiological and genetic studies in atopic dermatitis. Acta Derm-Venereol.Suppl. 176(1992) 13–18Google Scholar
  531. Diepgen, T.L. and M. Blettner, Analysis of familial aggregation of atopic eczema and other diseases by odd ratio regression models. J.Invest.Dermat- ol. 106(1996) 977–981Google Scholar
  532. Doull, I.J.M., S. Lawrence, M. Watson, et al., Allelic association of gene markers on chromsome 5q and 11q with atopy and bronchial hyperresponsiveness. Am.J.Respir.Crit.Care Med. 153(1996) 1280–1284PubMedGoogle Scholar
  533. Föister-Hoist, R., H.W. Moises, L. Yang, W. Fritsch, J. Weissenbach and E. Christophers, Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families. Hum.Genet. 102(1998) 236–239Google Scholar
  534. Hall, I.P., Edit., Genetics of asthma and atopy. Karger 1996Google Scholar
  535. Laing, I.A., J. Goldblatt, E. Eber, C.M. Hayden, P.J. Rye, N.A. Gibson, et al., A polymorphism of the CC16 gene is associated with an increased risk of asthma. J.Med.Genet. 35(1998) 463–467PubMedGoogle Scholar
  536. Liggett, S.B., Polymorphism of the ß2-adrenergic receptor and asthma. Am.J.Respir.Crit.Care Med. 156/Suppl. 4 II (1997) 156–162Google Scholar
  537. Mao, X.-Q., T. Shirakawa, M. Kawai, T. Enomoto, et al., Association between asthma and an intragenic variant of CC16 on chromosome 11q13. Clin.Genet. 53(1998) 54–56PubMedGoogle Scholar
  538. Meyers, D.A., D.S. Postma, C.I.M. Panhuysen, et al., Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 23(1994) 464–470PubMedGoogle Scholar
  539. Nickel, R., U. Wahn, N. Hizawa, N. Maestri, D.L. Duffy, K.C. Barnes, K. Beyer, J. Forster, R. Bergmann, et al., Evidence for linkage of chromosome 12q15- q24.1 markers to high total serum IgE concentrations in children of the German multicenter allergy study. Genomics 46(1997) 159–162PubMedGoogle Scholar
  540. Noguchi, E., M. Shibasaki, T. Arinami, et al., Evidence for linkage between asthma/atopy in childhood and chromosome Sq31-q33 in a Japanese population. Am.J.Respir.Crit.Care Med. 156(1997) 1390–1393PubMedGoogle Scholar
  541. Noguchi, E., M. Shibasaki, T. Arinami, et al., Evidence for linkage between the development of asthma in childhood and the T-cell receptor ß chain in japanese. Genomics 47(1998) 121–124PubMedGoogle Scholar
  542. Ober, c., N.j. Cox, M. Abney, A. Dirienzo, E.B. Lander, et al., Genome-wide search for asthma susceptibility loci in a founder population. Hum.Molec.Genet. 7(1998) 1393–1398PubMedGoogle Scholar
  543. Rosenwasser, L.J. and L. Borish, Genetics of atopy and asthma: the rationale behind promotor-based candidate gene studies. Am.J.Respir.Crit.Care Med. 156/Suppl.4 II (1997) 152–155Google Scholar
  544. Schultz-Larsen, F., N.V. Holm and K. Hennigsen, Atopic dermatitis: A genetic-epidemiologic study in a population-based twin sample. J.Am. Acad.Derm. 15(1986) 487–494Google Scholar
  545. Thomas, N.S., J. Wilkinson and S.T. Holgate, The candidate region approach to the genetics of asthma and allergy. Am.J.Respir.Crit.Care.Med. 156/4 II Suppl. (1997) 144–151Google Scholar
  546. Uehara, M., Heterogeneity of serum IgE levels in atopic dermatitis. Acta Derm.-V enerol. 66(1986) 404–408Google Scholar
  547. Beckman, L.E., G.F. Van Landeghem, S. Sikström and L. Beckman, DNA polymorphism and haplotypes in the human transferrin gene. Hum.Genet. 102(1998) 141–144PubMedGoogle Scholar
  548. Hayashi, A., Y. Wada, T. Suzuki and A. Shimizu, Studies on familial hypotransferrinemia: Unique clinical course and molecular pathology. Am.J. Hum.Genet. 53(1993) 201–213PubMedGoogle Scholar
  549. Amati, F., A. Mari, R. Mingarelli, M. Gennarelli, M.C. Digilio, et al., Two pedigrees of autosomal dominant artioventricular canal defect (AVCD). Exclusion from the critical region on 8p. Am.J.Med.Genet. 57(1995) 483–488PubMedGoogle Scholar
  550. Digilio, M.e., B. Marino, M.P. Cicini, A. Giannotti, R. Formigari and B. Dallapiccola, Risk of congenital heart defects in relatives of patients with atrioventricular canal. Am.J.Dis.Child 147(1993) 1295–1297PubMedGoogle Scholar
  551. Douglas, A.A., I. Waheed and C.T. Wyse, Progressive bifocal chorio-retinal atrophy: a rare familial disease of the eye. Brit.J.Ophthal. 52(1968) 742–751PubMedGoogle Scholar
  552. Francois, J., F. Barbier et A. de Ruock, A propos des conducteurs du gène de l’atrophia gyrata chorioideae et retinae de Fuchs. Acta Genet.Med.Gemell. 15(1986) 34–35Google Scholar
  553. Kelsell, R.E., B.F. Godley, K. Evans, P.A.C. Tiffin, C.A. Gregory, et al., Localization of the gene for progressive bifocal chorioretinal atrophy (PBCRA) to chromosome 6q. Hum.Molec.Genet. 4(1995) 1653–1656PubMedGoogle Scholar
  554. Lestringant, G.G., Küster, W., Frossard, P.M. and Happle, R. Congenital ichthyosis, follicular atrophoderma, hypotrichosis, and hypohidrosis. Am.J.Med.Genet. 75 (1998) 186–189PubMedGoogle Scholar
  555. Plosila, M., Kiistala, R. and Niemi, K.M. The BASEX syndrome: follicular atrophoderma with multiple basal cell carcinomas, hypotrichosis, and hypohidrosis. Clin.Exp.Dermat. 6 (1981) 31–41Google Scholar
  556. Vabres, P., Lacomb, D., Rabinowitz, L.G. et al., The gene for BAZEX-DuPRÉ-CHRISTOL syndrome maps to chromosome Xq. J.Invest.Dermatol. 105(1995) 87–91PubMedGoogle Scholar
  557. Korn-Heydt, G.E., Erbliche Aplasien, Hyperplasien und Tumoren. In: Jadassohn,J., Handbuch der Haut- und Geschlechtskrankheiten, Bd. VII, Springer-Verl., Berlin, Heidelberg, New York 1966Google Scholar
  558. Eiberg, H. and Mohr, J. Assignment of genes coding for brown eye colour (BEY2) and brown hair colour (HCL3) on chromosome 15q. Eur.J.Hum. Genet. 4 (1997) 237–241Google Scholar
  559. Eiberg, Hand J.Mohr, Major genes of eye color and hair color linked to LU and SE. Clin.Genet. 31 (1987) 186–191PubMedGoogle Scholar
  560. Blumberg, B.S., Sutnick, A.I., London, W.T. and Millman, I. Australia antigen and hepatitis. New Engl.J.Med. 283 (1979) 349Google Scholar
  561. Couroucé-Pauty, A.-M., Plancon, A. and Souler, J.P. Distribution of HBsAg subtypes in the world. Vox. Sang. 4 (1983) 197–199Google Scholar
  562. Bailey, A., LeCouteur, A., Gottesman, I. et al., Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol.Med. 25 (1995) 63–77PubMedGoogle Scholar
  563. Cook, E.H., Jr., Lindgren, V., Lebenthal, B.L., Courchesne, R., Lincoln, A., Shulman, C., Lord, C. and Courchesne, E. Autism or atypical autism in maternally but not paternally derived proximal15q duplication. Am.J.Hum.Genet. 60(1997) 928- 934PubMedGoogle Scholar
  564. Courchesne, E., Yeung-Courchesne, R., Press, G.A. et al. Hypoplasia of cerebellar vermal lobules VI and VII in autism. New Engl.J.Med. 318 (1988) 1349–1354PubMedGoogle Scholar
  565. Fein, D., Pennington, B., Markowitz, P. et al., Toward a neuropsychological model of infantile autism: are the social deficits primary? J.Am.Acad.Child Psychiatry 25 (1986) 198–212PubMedGoogle Scholar
  566. Hallmayer, J., Spiker, D., Lotspeich, L. et al., Male-tomale transmission in extended pedigrees with multiple cases of autism. Am.J.Med.Genet. 67 (1996) 13–18PubMedGoogle Scholar
  567. Herault, J., Petit, E., Martineau, J. et al., Autism and genetics: Clinical approach and association study with two markers of HRAS gene. Am.J.Med. Genet.Neuropsychiatr.Genet. 60(1995) 276–281Google Scholar
  568. International Molecular Genetic Study of Autism Consortium, A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum.Molec.Genet. 7 (1998) 571–578Google Scholar
  569. KIauck, S.M., Poustka, A. und Poustka, F. Genetik des Autismus. Med.Genet. 10(1998) 409–411Google Scholar
  570. Schroer, R.J., Phelan, M.C., Michaelis, R.C., Crawford, E.C., Skinner, S.A. et al., Autism and maternally derived aberrations of chromosome 15q. Am.J. Med.Genet. 76 (1998) 327–336PubMedGoogle Scholar
  571. Smalley, S.L., Behavioural genetics ’97. Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit/hyperactivity disorder. Am.J.Hum.Genet. 60(1997) 1276–1282PubMedGoogle Scholar
  572. Spiker, D., Lotspeich, L., Kraemer, H.C., Halimayer, J., McMahon, W., Petersen, P.B., Nicholas, P., Pingree, C., Wiese-Slater, S. et al., Genetics of autism: Characterization of affected and unaffected children from 37 multiplex families. Am.J.Hum. Genet. 54 (1994) 27–35Google Scholar
  573. Swillen, A., Heliemans, H., Steyaert, J. and Fryns, J.-P. Autism and genetics: High incidence of specific genetic syndromes in 21 autistic adolescents and adults living in two residential homes in Belgium. Am.J.Med.Genet. 67 (1996) 315–316PubMedGoogle Scholar
  574. Hall, R., S.G.Owen and G.A.Smart, Paternal transmission of thyroid autoimmunity. Lancet 19641II 115Google Scholar
  575. Roitt, L.M., Leitfaden der Immunologie. Steinkopff Verlag Darmstadt 1984Google Scholar
  576. Chaabani, C.H., Hadj-Khlil, A., Ben-Dhia, N. and Braham, H. The primary hereditary form of distal renal tubular acidosis: clinical and genetic studies in a 6O-member kindred. Clin.Genet. 45 (1994) 194–199PubMedGoogle Scholar
  577. Dunger, D.B., Benton, D.P. and Cain, A.R. Renal tubular acidosis and nerve deafness. Arch.Dis. Child 55 (1980) 221–225Google Scholar
  578. Karet, F.E., Gainza, F.J., Gyory, A.Z. et al., Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not recessive distal renal tubular acidosis. Proc.Natl.Acad.Sci. USA 95 (1998) 6337–6342PubMedGoogle Scholar
  579. Pintos-Morell, G., Haas, R., Prondanos, C. et al., Cytochrome c oxidase deficiency in muscle with dicarboxylic aciduria and renal tubular acidosis. J.Child Neurol. 5 (1990) 147–152PubMedGoogle Scholar
  580. Stoll, c., Gentine, A. and Geisert, J. Siblings with congenital renal tubular acidosis and nerve deafness. Clin.Genet. 50(1996) 235–239PubMedGoogle Scholar
  581. Aramaki, S., Yoshida, I., Yoshida, M. et al., Carbonic anhydrase II deficiency in three unrelated J apanese patients. J.Inherit.Metab.Dis.16 (1993) 982- 990PubMedGoogle Scholar
  582. Beechey, C., Tweedie, S., Spurt, N. et al., Mapping of mouse carbonic anhydrase-3, Car-3: Another locus in the homologous region of mouse chromosome 3 and human chromosome 8. Genomics 6 (1990) 692–696PubMedGoogle Scholar
  583. Dotchev, D., Hungeriand, H., Liappis, N. and Oyanagi, K. Hyperaminoazidurie und Dysaminoazidurie bei der Endemischen (Balkan-) Nephropathie. Miinch.Med.Wschr. 116 (1974) 363–368Google Scholar
  584. Manolova, Y. Manolov, G., Parvanova, L. et al., Induction of characteristic chromosomal aberrations, particularly X-trisomy, in cultured human lymphocytes treated by ochratoxin A, a mycotoxin implicated in Balkan endemIC nephropathy. Mutat.Res. 231 (1990) 143–149PubMedGoogle Scholar
  585. Toncheva, D. and Dimitrov, T. Genetic predisposition to Balkan endemic nephropathy. Nephron 72 (1996) 564–569PubMedGoogle Scholar
  586. Carethers, J.M., Furnari, F.B., Zigman, A.F. et al., Absence of PTEN/MMACgerm-line mutations in sporadic BANNAYAN-RILEy-RUVALCABA syndrome. Cancer Res. 58 (1998) 2724–2726PubMedGoogle Scholar
  587. Godin, R.J., Cohen, M.M., Codon, L.M. and Burke, B.A. BANNAYAN-RILEY-RUVALCABA syndrome. Am.J.Med.Genet. 44 (1992) 307–314Google Scholar
  588. Marsh, D.J., Dahia, P.L.M., Zheng, Z., Liaw, D., Parson, R., Gorlin, R.J. and Eng, C. Germline mutations in PTENare present in BANNAYAN-ZONANA syndrome. Nature Genet. 16 (1997) 333–335PubMedGoogle Scholar
  589. Zigman, A.R., Lavine, J.E., Jones, M.C. et al., Localization of the BANNAYAN-RILEy-RUVALCABA syndrome gene to chromosome 10q23. Gastroenterology 113 (1997) 1433–1437PubMedGoogle Scholar
  590. Baraitser, M. and Winter, R.M. Iris coloboma, ptosis, hypertelorism, and mental retardation: a new syndrome. J.Med. Genet. 25 (1988) 41–43PubMedGoogle Scholar
  591. Vedois, A., Iris coloboma, ptosis, hypertelorismus, and mental retardation: BARAITSER-WINTER syndrome or NOONAN syndrome? J.Med.Genet. 30(1993) 425–426Google Scholar
  592. Mazzanti, I., Bergamaschi, R., Neri, I., Perri, A., Patrazi, A., Cacciari, E. and Forabosco, A. BARBER-SAY syndrome: Report of a new case. Am.J.Med.Genet. 78 (1998) 188–191PubMedGoogle Scholar
  593. Santana, S.M., F.P. Alvarez, J.L. Frias and M.-L. Martinez- Frias, Hypertrichosis, atrophic skin, ectropion, and macrostomia (BARBER-SAY syndrome): Report of a new case. Am. J.Med.Genet. 47 (1993) 20–23Google Scholar
  594. Sod, R., lzbizky, G. and Cohen-Salama, M. Macrostomia, hypertelorism, atrophic skin, severe hypotrichosis without ectropion: Milder form of BARBER- SAY syndrome. Am.J.Med.Genet. 73 (1997) 366–367PubMedGoogle Scholar
  595. Hennekam, R.C.M., Huber, J. and Varied, D.. BARTSACOS- PAPAS syndrome with internal anomalies: Evidence for a more generalized epithelial defect or a new syndrome? Am.J.Med.Genet. 53 (1994) 102–107PubMedGoogle Scholar
  596. Martinez-Frias, M.L., Frias, J.L., Vazquez, I. and Fernandez, J. BAR TSACOS-PAPAS syndrome: Three familial cases from Spain. Am.J.Med.Genet. 39 (1991) 34–37PubMedGoogle Scholar
  597. Brennan, T.M.H., Landau, D., Shalev, H., Lamb, F., Schutte, B.C. et al., Linkage of infantile BARTTER syndrome with sensorineural deafness to chromosome 1p. Am.J.Hum.Genet. 62 (1998) 355- 361PubMedGoogle Scholar
  598. Kurtz, C.L., Karolyi, L., Seyberth, H.W. et al., A common NKCC2 mutation in Costa Rican BARTTER’S syndrome patients: Evidence for a founder effect. J.Am.Soc.N ephrol. 8 (1997) 1706–1711Google Scholar
  599. Landau, D., Shalev, H., Ohaly, M. and Carmi, R. Infantile variant of BARTTER syndrome and sensorineural deafness. Am.J.Med.Genet. 59 (1995) 454- 459PubMedGoogle Scholar
  600. Lemmink, H.H., Van Dijk, L.P.W.J. et al., Linkage of GITELMAN syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families. Pediatr. Nephrol. 10(1996) 403–407PubMedGoogle Scholar
  601. Simon, D.B., Nelson-Williams, C., Bia, M.J., Ellison, D., Karet, F.E. et al., GITELMAN’S variant of BARTTER’S syndrome, inherited hypokaliaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-CI co transporter. Nature Genet. 12 (1996) 24–30PubMedGoogle Scholar
  602. Shalev, H., Ohaly, M., Meizner, I. and Carmi, R. Prenatal diagnosis of BARTTER syndrome. Prenatal. Diagn. 14 (1994) 996–998Google Scholar
  603. Simon, D.B., Karet, F.E., Hamdan, J.M., DiPietro, A., Sanjad, S.A. and Lifton, R.P. BARTTER’S syndrome, hypokaliaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2CI co transporter NKCC2. Nature Genet. 13 (1996) 183–188PubMedGoogle Scholar
  604. Simoin, D.B., Karet, F.E., Rodriguez-Soriano, J., Hamdan, J.H., DiPietro, A., Trachtman, H., Sanjad, S.A. and Lifton, R.P. Genetic heterogeneity of BARTTER’S syndrome revealed by mutations in the K+channel, ROMK. Nature Genet. 14 (1996) 152–156Google Scholar
  605. Simon, D.B., Bindra, R.S., Mansfield, T.A., NelsonWilliams, C., Mendonca, E. et al., Mutations in the chloride channel gene, CLCNKBcause BARTTER’S syndrome type III. Nature Genet. 17 (1997) 171–178PubMedGoogle Scholar
  606. Bonifas, J.M., Bare, J.W., Kerschmann, R.L., Master, S.P. and Epstein, E.H. Parental origin of chromosome 9q22.3-q31 lost in basal cell carcinomas from basal cell nevus syndrome patients. Hum. Mol.Genet. 3 (1994) 447–448PubMedGoogle Scholar
  607. Gailani, M.R., Bale, S.J., Leffel, D.J. et al., Developmental defects in GORLIN syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 69 (1992) 111–117PubMedGoogle Scholar
  608. Grubben, c., Fryns, J.P., E. Smeets and H. Van den Berghe, NOONAN phenotype in the basal cell nevus syndrome. Genet. Counsel. 2 (1991) 47–54PubMedGoogle Scholar
  609. Kimonis, V.E., A.M. Goldstein, B. Pastakia, M.L. Yang et al., Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am.J.Med.Genet. 69 (1997) 299–308PubMedGoogle Scholar
  610. Linss, G., E. Gebel, A. Reis et al., Localisation of the gene defect for the naevoid basal cell carcinoma syndrome (GORLIN-GOLTz syndrome) and other cytological investigations in one family. Eur.J.Dermatol. 6 (1996) 262–263Google Scholar
  611. Wieking, C., S. Gillies, I. Smyth, S. Shanley, L. Fowles et al., De novo mutations of the patched gene in nevoid basal cell carcinoma syndrome help to define the clinical phenotype. Am.J.Med.Genet. 73 (1997) 304–307Google Scholar
  612. Bahn, R.S., C.M. Dutton, A.E. Heufelder and G. Sarker, A genomic point mutation in the extracellul~ r do~ain of the,thyrotropin receptor in patients With GRAVES ophthalmopathy. J.Clin.Endocrin. Metab. 78 (1994) 256–260Google Scholar
  613. Brix, T.H., K.O. Kyrik and I. Hegedus, What is the evidence of genetic factors in the etiology of GRAVES’ disease? A brief review. Thyroid 8 (1998) 627–634PubMedGoogle Scholar
  614. Kopp, P:, J.I. Jameson and T.F. Roe, Congenital nonautOimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid 7 (1997) 765–770PubMedGoogle Scholar
  615. Krude, H., H. Biebermann, H.P. Krohn et al., Congenital hyperthyroidism. Exp.Clin.Endocrinol. Diabetes 105/Suppl. 4 (1997) 6–11Google Scholar
  616. Rossi, E., R. Zarrilli and O. Zuffardi, Regional assignment of the gene coding for a human GRAVES’ disease autoantigen to 10q21.3-q22.1. Hum.Genet. 90(1993) 653–654PubMedGoogle Scholar
  617. Tomer, Y., G. Barbesino, M. Keddache et al., Mapping of a major susceptibility locus for GRA YES’ disease (GD-I) to chromosome 14q3. J.Clin.Endocrinol. Metab. 82 (1997) 1645–1648PubMedGoogle Scholar
  618. Zhang, Z.-G., J.R. Wall and N.F. Bernard, Tissue distribution and quantification of a gene expressing a 64-kDa antigen associated with thyroid-associated ophthalmoplegy. Clin. Immun. Immunopath. 80(1996) 236 - 244PubMedGoogle Scholar
  619. Boyd, P.A., A. Bhattacharjee, S. Gould et al., Outcome of prenatally diagnosed anterior abdominal wall defects. Arch.Dis.Child.Fetal Neonat.Ed. 78 (1998) 209–213Google Scholar
  620. Merati, P., M. Protino, L. Ciralli and M. Busacca, The prune belly syndrome: A familial case. New Trends Gynaecol. Obstet. 2 (1986) 359–361Google Scholar
  621. Jacobson, Z., J. Glickstein, T. Hensle and R.W. Marion, Further delineation of the OPITZ G/BBBsyndrome: Report of an infant with complex congenital heart disease and bladder exstrophy, and review of the literature. Am.J.Med.Genet. 78 (1998) 294–299PubMedGoogle Scholar
  622. Robin, N., G.J. Feldman, A.L. Aronson, H.F. Mitchell, R. Weksberg et al., OPITZ syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2. Nature Genet. 11 (1995) 459–461PubMedGoogle Scholar
  623. Tar, A., A. Ion, J. Sólyom, B. Györvári, C. Stephenson, S. Barbaux, M. Nunes, M. Fellous and K. McEireavey, Hypertelorism and hypospadias associated with a de novo apparently balanced transloca tion between 8q22.3–23 and 20p13. Am.J.Med. Genet. 68 (1997) 231–235PubMedGoogle Scholar
  624. Zotto, L.D., N.A. Quaderi, R. Elliott, P.A. Lingerfelter et al., The mouse midI gene: implication for the pathogenesis of OPITZ syndrome and the evaluation of the mammalian pseudoautosomal region. Hum.Molec.Genet. 7 (1998) 489–499Google Scholar
  625. Babcock, D., C. Gasner and V. Francke, A single mutation that results in an Asp to His substitution and partial exon skipping in a family with congenital contractural arachnodactyly. Hum.Genet. 103(1998) 22–28PubMedGoogle Scholar
  626. McKusick, V.A., The defect in MARFAN syndrome. Nature 352 (1991) 279–28lPubMedGoogle Scholar
  627. Phadke, S.R., R. Gulati and S.S. Agarwal, Further delineation of a new (Van den ENDE-GUPTA) syndrome ofblepharophimose, contractural arachnodactyly, and characteristic face. Am.J.Med.Genet. 77 (1998) 16–18PubMedGoogle Scholar
  628. Safarazi, R., P. Tsipouras, F. Ramirez and D.W. Hollister, Linkage of MAR FAN syndrome and a phenotypically related disorder to two different flbrillin genes. Nature 352 (1991) 330–33lGoogle Scholar
  629. Viljoen, D., Congenital contractural arachnodactylyn BEALS syndrome) J.Med.Genet. 31 (1994) 640–643PubMedGoogle Scholar
  630. Wang, M., C.L. Cloericuzio and M. Godfrey, Familial occurrence of typical and severe lethal congeni- tal contractural arachnodactyly caused by missplicing of exon 34 of Fibrillin-2. Am.J.Hum.Genet. 59 (1996) 1027–1034PubMedGoogle Scholar
  631. Bird, S. and J.A. Stewart, Genetic analysis of families of patients with BEHyET’S syndrome: Data incompatible with autosomal recessive inheritance. Plast.Reconstr.Surg. 77 (1986) 650–653Google Scholar
  632. Goolamali, S.K., S.J. Comaish, F. Hassanyeh and A. Stephens, Familial BEHYET’S syndrome. Br.J.Derm. 95 (1986) 637–642Google Scholar
  633. Mizuki, N., H. Inoko, K. Sugimura et al., RFLP analysis in the TNF-ßgene and the susceptibility to alloreactive NK cells in BEHYET’S disease. Invest. Ophthalmo!’Visual.Sci. 33 (1992) 3084- 3090Google Scholar
  634. Mizuki, N., M. Ota, M. Kimura et al., Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GST repetitions with BEHYET disease. Proc.Natl. Acad.Sci.U.S.A. 94 (1997) 1298–1303PubMedGoogle Scholar
  635. Neetens, A. and J.J. Martin, The hereditary familial optic atrophies. Neuroophthalmology 6 (1986) 277–297Google Scholar
  636. DeMarco, I., M. Mazzucato, F. Fabris et al., Variant BERNARD-SOULIER syndrome type BOLZANO. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. J.Clin.Invest. 86 (1990) 25–31Google Scholar
  637. Finch, C.N., J.I. Miller, V.A. Lyle and R.I. Handin, Evidence that an abnormality in the glycoprotein Ib agene is not the cause of abnormal platelet function in a family with classic BERNARD-SOULIER disease. Blood 75 (1990) 2357–2362PubMedGoogle Scholar
  638. Li, C., S.E. Martin and G.J. Roth, The genetic defect in two well-studied cases of BERNARD-SOULIER syndrome: A point mutation in the fifth leucine- rich repeat of patelet glycoprotein Ib a.Blood 86 (1995) 3805–3814PubMedGoogle Scholar
  639. Suzuki, K., T. Hayashi, A. Yahagi et al., Novel point mutation in the leucine-rich motif of the platelet glycoprotein IX associated BERNARD-SOULIER syndrome. Brit.J.Haematol. 99 (1997) 794–800Google Scholar
  640. Broughton, B.C., H. Steingrimsdottir, C.A. Weber and A.R. Lehmann, Mutations in the xeroderma pimentos urn group D DNA repair/transcription gene in patients with trichothiodystrophy. Nature Genet. 7 (1994) 189–194PubMedGoogle Scholar
  641. Itin, P.H. and M.R. Pittelkow, Trichothiodystrophy: Review of sulfur-deficient brittle hair syndromes and association with the ectodermal dysplasias. J.Am.Acad.Dermatol. 22 (1990) 705–717PubMedGoogle Scholar
  642. Stary, A. and A. Sarin, The genetic basis of xeroderma pigmentosum and trichothiodystrophy syndromes. Cancer Surv. 26 (1996) 155–171PubMedGoogle Scholar
  643. Stefanini, M., P. Lagomarsini, S. Giliani et al., Genetic heterogeneity of the repair defect associated with trichothiodystrophy. Carcinogenesis 14 (1993) 1101–1105PubMedGoogle Scholar
  644. Tolmie, J.L., D.de Berker, R. Dawber, C. Galloway, D.W. Gregory, A.R. Lehmann et al., Syndromes associated with trichothiodystrophy. Clin.Dysmorphol. 3 (1994) 1–14PubMedGoogle Scholar
  645. Weeda, G., E. Eveno, L. Donker, W. Vermeulen et al., A mutation in the XPB/ERCC3DNA repair transcription gene, associated with trichothiodystrophy. Am.J.Hum.Genet. 60(1997) 320–329PubMedGoogle Scholar
  646. Hart, P.S., J. Hymes and B. Wolf, Biochemical and immunological characterization of serum biotinidase in profound biotinidase deficiency. Am.J.Hum.Genet. 50(1992) 126–136PubMedGoogle Scholar
  647. Pomponio, R.J., T.R. Reynolds, H. Cole, G.A. Buck and B. Wolf, Mutational hotspot in the human biotinidase gene causes profound biotinidase deficiency. Nature Genet. 11 (1995) 96–98PubMedGoogle Scholar
  648. Sander, J. und C. Niehaus, Ergebnisse einer Pilotstudie für ein Neugeborenen-Screening auf angeborenen Biotinidasemangel. Mschr.Kinderheilk. 134 (1986) 729–732Google Scholar
  649. Taitz, L.S., J.V. Leonard and K. Bartlett, Long-term auditory and visual complications of biotinidase deficiency. Early Hum.Dev. 11 (1985) 325–331PubMedGoogle Scholar
  650. Warner-Rogers, J., S.E. Waisbren and H.L. Levy, Cognitive function in early treated biotinidase deficiency; Follow-up of children detected by newborn screening. Screening 4 (1995) 125–130Google Scholar
  651. Wolf, B., K. Norrgard, R.J. Pomponio, D.M. Mock, J.R. Secor-McVoy et al., Profound biotinidase deficiency in two asymptomatic adults. Am.J.Med. Genet. 73 (1997) 5–9PubMedGoogle Scholar
  652. Galliano, M., L. Minchiotti, F. Porta, A. Rossi et al., Mutations in genetic variants of human serum albumin found in Italy. Proc.Nat.Acad.Sci.USA 87 (1990) 8721–8725PubMedGoogle Scholar
  653. Madison, J., K. Arai, Y. Sakamoto, R.D. Feld et al., Genetic variants of serum albumin in Americans and Japanese. Proc.Nat.Acad.Sci.USA 88 (1991) 9853–9857PubMedGoogle Scholar
  654. Changanti, R.S.K., P.R.K. Koduru, R. Chakraborty and W.B. Jones, Genetic origin of a trophoblastic choriocarcinoma. Cancer Res. 50(1990) 6330- 6333Google Scholar
  655. Mogiabey, Y.B., R. Kircheisen, M. Seoud et al., Genetic mapping of a maternal locus responsible for familial hydatiform moles. Hum.Molec.Genet. 8(1999) 667–67lGoogle Scholar
  656. Surti, U., A.E. Szulman, K. Wagner, M. Leppert and S.J.O. Brien, Tetraploid partial hydatiform moles: two cases with a triple paternal constitution and a 92,XXXY karyotype. Hum.Genet. 72 (1986) 15–2lPubMedGoogle Scholar
  657. Taillon-Miller, P., LBauer-Sardina, H.Zakeri, L. Hillier, D.G. Mutch and P.-Y. Kwok, The homozygous complete hydatiform mole: a unique resourse for genomic studies. Genomics 46 (1997) 307–3010PubMedGoogle Scholar
  658. Vejerslev, L.O., R.A. Fisher, U. Surti, and N. Wake, Hydatiforme mole: parental chromosome aberrations in partial and complete moles. J.Med.Genet. 24 (1987) 613–615PubMedGoogle Scholar
  659. Godin, R.J., H. Zellweger, M. Waziri Curtis, H.R. Wiedemann, M. Warburg et al., BlepharoCheilo- Dontic (BCD) syndrome. Am.J.Med.Genet. 65 (1996) 109–112Google Scholar
  660. Guion-Almeida, M.L., E.S.O. Rodini, N.M. KokitsuNakata and D. Bologna-Amantini, Blepharocheilo- dontic (BCD) syndrome: report on four new patients. Am.J.Med.Genet. 76 (1998) 133- 136PubMedGoogle Scholar
  661. Biesecker, L.G., The OHDO blepharophimosis syndrome: A third case. J.Med.Genet. 28 (1991) 131–134PubMedGoogle Scholar
  662. Bonthron, D.T., K.M. Barlow, A.M. Burt and D.G.D. Barr, Parental consanguinity in the blepharo phimosis, heart defect, hypothyroidism, mental retardation syndrome (YOUNG-SIMPSON syndrome). J.Med.Genet. 30(1993) 255–256PubMedGoogle Scholar
  663. Cai, T., D.A. Tagle, X. Xia, P. Yu, X.X. He, I.Y. Li and J.H. Xia, A novel case of unilateral blepharophimosis syndrome and mental retardation associated with de novo trisomy for chromosome 3q. J.Med.Genet. 34 (1997) 772–776PubMedGoogle Scholar
  664. Clayton-Smith, J., M. Krajewska-Walasek, A. Fryer and D. Donnai, OHDo-like blepharophimosis syndrome with distinctive facies, neonatal hypotonia, mental retardartion and hypoplastic teeth. Clin.Dysmorphol. 3 (1994) 115–120PubMedGoogle Scholar
  665. Costa, T., R. Pashby, M. Huggins and T.E. Teshima, Deletion 3q in two patients with blepharophimosis- ptosis-epicanthus inversus syndrome (BPES). J.Pediatr.Ophthalmol. Strabismus 35 (1998) 271–276Google Scholar
  666. Cunniff, c., M. Curtis, S.J. Hassed and H.E. Hoyme, Blepharophimosis. A causally heterogeneous malformation frequently associated with developmental disabilities. Am.J.Med.Genet. 75 (1998) 52–54PubMedGoogle Scholar
  667. Frydman, J.M., H.A. Cohen, G. Karmon and H. Savir, Autosomal recessive blepharophimosis, ptosis, V -esotropia, syndactyly and short stature. Clin. Genet. 41 (1992) 57–61PubMedGoogle Scholar
  668. Fujita, H., J. Meng, M. Kawamura et al., Boy with a chromosome del(3)(q12q23) and blepharophimosis syndrome. Am.J. Med.Genet. 44 (1992) 434–436PubMedGoogle Scholar
  669. Gorlin, R.J., H. Zellweger, M.W. Curtis, H.-R. Wiedemann, M. Warburg et al., Blepharo-Cheilo-Dontic (BCD) syndrome. Am.J.Med.Genet. 65 (1996) 109–112PubMedGoogle Scholar
  670. Maw, M., B. Kar, J. Biswas, P. Biswas, D. Nancarrow, M. Denton and R. Bridges, Linkage of blepharophimosis syndrome in a large Indian pedigree to chromosome 7p. Hum.Molec.Genet. 5 (1996) 2049–2054PubMedGoogle Scholar
  671. Mhanni, A.A., A.J. Dawson and A.E. Chudley, Vertical transmission of the OHDO blepharophimosis syndrome. Am.J.Med.Genet. 77 (1998) 144–148PubMedGoogle Scholar
  672. Rasmussen, M. and P. Stromme, Congenital ptosis and blepharophimosis in a mentally retarded girl: a new case of OHDO syndrome ? Clin.Dysmorphol. 7 (1998) 61–63PubMedGoogle Scholar
  673. Rausch, A., U. Trautmann und R.A. Pfeiffer, Deletion 3p25 als eine wenig bekannte Ursache der syndromalen Blepharoptose. Monatsschr.Kinderheilk. 143 (1995) 979–982Google Scholar
  674. Bitoun, P., C. Philippe, M. Chrif, M.T. Mulcahy and S. Gilgenkrantz, Incontinantia (type 1) and X;5 translocation. Ann.Genet. 35 (1992) 51–54PubMedGoogle Scholar
  675. Curtis, A.R.J., S. Lindsay, E. Boye, A.J. Clarke, S.J. Landy and S.S. Bhattacharya, A study of Xchromsome activity in two incontinentia pigmenti families with probable linkage to Xq28. Eur.J.Hum.Genet. 2 (1994) 51–58PubMedGoogle Scholar
  676. Hatchwell, E., Hypomelanosis of ITO and X;autosome translocations: a unifying hypothesis. J.Med.Genet. 33 (1996) 177–183PubMedGoogle Scholar
  677. Jewett, T., P.S. Hart, P.N. Rao and M.J. Pettenati, A case revisited: Recent presentation of incontinentia pigmenti in association with a previously reported X;autosome translocation. Am.J.Med. Genet. 69 (1997) 96–97PubMedGoogle Scholar
  678. Landau Roberts, J., B. Morrow, C. Vega-Rich, C.M. Salafia and H.M. Nitowsky, Incontinentia pigmenti in a newborn male infant with DNA confirmation. Am.J.Med.Genet. 75 (1998) 159- 163Google Scholar
  679. Landy, S.J. and D. Donnai, Incontinentia pigmenti (BLOCH-SULZBERGER syndrome). J.Med.Genet. 30 (1993) 53–59. Scheurle, A.E., Male cases of incontinentia pigmenti: Case report and review. Am.J.Med.Genet. 77 (1998) 201–218Google Scholar
  680. Sybert, V.P., Incontinentia pigmenti nomenclature. Am.J.Hum.Genet. 55 (1994) 209–210PubMedGoogle Scholar
  681. Hollander, N.S.den, H.J.van der Harten, C. VermeijKeers, M.F. Niermeijer and J.W. Wlimiroff, Firsttrimester diagnosis of BLOMSTRAND lethal osteochondrodysplasia. Am.J.Med.Genet. 73 (1997) 345–350Google Scholar
  682. Leroy, J.G., G. Keersmaeckers, M. Coppens, J.E. Dumon and H. Roels, BLOMSTRAND lethal osteochondrodysplasia. Am.J.Med.Genet. 33 (1996) 84–89Google Scholar
  683. Young, I.D., J.M. Zuccollo and N.J. Broderick, A lethal dysplasia with generalised sclerosis and advanced skeletal maturation: BLOMSTRAND chondrodysplasia ? J.Med.Genet. 30(1993) 155–157PubMedGoogle Scholar
  684. Chan, J.Y.H. and F.F. Becker, Defective DNA ligase I in BLOOM’S syndrome cells. Simultaneous analysis using immunoblotting and the ligase( 32 P)AMP adduct assay. J.BioI.Chem. 263 (1988) 18231–18235Google Scholar
  685. Ellis, N.A. and J. German, Molecular genetics of BLOOM’S syndrome. Hum.Molec.Genet. 5 (1996) 1457–1463PubMedGoogle Scholar
  686. Mori, S., N. Kondo, F. Motoyoshi et al., Diabetes mellitus in a young man with BLOOM’S syndrome. Clin.Genet. 38 (1990) 387–390PubMedGoogle Scholar
  687. Shiraishi, Y.Nature and role of high sister chromatid exchange in BLOOM syndrome cells: Some cytogenetic and immunological aspects. Cancer Genet.Cytogenet. 50 (1990) 175–187PubMedGoogle Scholar
  688. Straughen, J.E., J. Johnson, D. McLaren, M. Proytcheva, N. Ellis, J. German and J. Groden, A rapid method for detecting the predominant Ashkenazi Jewisch mutation in the BLOOM s syndrome gene. Hum.Mutat. 11 (1998) 175–178PubMedGoogle Scholar
  689. Drummond, K.N., A.F. Michael, R.A. Ulstrom and R.A. Good, The blue diaper syndrome. Familial hypercalcemia with nephrocalcinosis and indicanurie. A new familial disease, with definition of the metabolic abnormality. Am.J.Med. 37 (1964) 928PubMedGoogle Scholar
  690. Libit, S.A., R.A. Ulstrom and D. Doeden, Fecal pseudomonas aeroginosa as a cause of the blue diaper syndrome. J.Pediatr. 81 (1972) 546–547PubMedGoogle Scholar
  691. Folkman, J. and P.A.D. Amore, Blood vessel formation: What is its molecular basis? Cell 87 (1996) 1153–1155PubMedGoogle Scholar
  692. Ohishi, M., Y. Higuchi and M. Kagimoto, Multiple facial hemangioma and iron-deficiency anaemia: Blue Rubber Bleb Nevus Syndrome. Head and Neck Surg. 7 (1985) 249–254Google Scholar
  693. Satya-Murti, S., S. Navada and F. Eames, Central nervous system involvement in Blue Rubber Bleb Nevus Syndrome. Arch. Neurol. 43 (1986) 1184–1186PubMedGoogle Scholar
  694. Brouwers, H.A.A., Lvan Ertbruggen, G.P.J. Alsbach et al., What is the best predictor of the severity of ABO-haemolytic disease of the newborn ? Lancet 1988/II 641–644Google Scholar
  695. Gerencer, M., Z. Singer, S. Pfeifer et al., HLA and red blood group antigen in pregnancy disorders. Tissue Antigens 32 (1988)130–138PubMedGoogle Scholar
  696. Cusi, D., M.L. Melz, C. Bariassina et al., Genetic models of arterial hypertension - role of tubular ion transport. Pediatr.Nephol. 7 (1993) 865–870Google Scholar
  697. Kurtz, T.W. and M.A. Spence, Genetics of essential hypertension. Am.J.Med. 94 (1993) 77–84. Lifton, R.P., Genetic determinants of human hypertension. Proc.Natl.Acad.Sci. 92 (1995) 8545- 8551Google Scholar
  698. Lin, B., J. Nasir, H. McDonald, R. Graham, J.M. Rommens, Y.P. Goldberg and M.R. Hayden, Genomic organization of the human a-adducin gene and its alternatively spliced isoforms. Genomics 2 (1995) 93–99Google Scholar
  699. Williams, B.R., S.C. Hunt, S.J. Hasstedt et al., Multigenic human hypertension: Evidence for subtypes and hope for haplotypes. J.hypertens. 8 (1990) Suppl.7 (39–46Google Scholar
  700. Williams, B.R., S.C. Hunt, P.N. Hopkins et al., Tabulations and expectations regarding the genetics of human hypertension. Kidney lnt.Suppl. 44 (1994) S57-S64Google Scholar
  701. Cassal, H.B., M. Malone, A.J. Petros and R.M. Winter, Familial persistent pulmonary hypertension of the newborn resulting from misalignment of the pulmonary vessels (congenital alveolar capillary dysplasia). J.Med.Gent. 35 (1998) 58–60Google Scholar
  702. Fried, R., G. Flakovsky, J. Newburger et al., Pulmonary arterial changes in patients with ventricular septal defects and severe pulmonary hypertension. Pediat.Cardiol. 7 (1986) 147–154Google Scholar
  703. Nichols, W.E., D.L. Koller, B. Slovis, T. Foroud et al., Localization of the gene for familial primary pulmonary hypertension 15 (1997) 277–280Google Scholar
  704. Reeves, J.T., K.M. Gheen and D.B. Badesch, Variability in pulmonary hypertension: Possible importance of genetic factors. Eur.Respir.Rev. 5 (1995) 255–258Google Scholar
  705. Ardinger, H.H., J.W. Hanson, and H.U. Zellweger, BORJESON-FoRSSMAN-LEHMANN syndrome: further delineation in five cases. Am. J.Med.Genet. 19 (1984) 653–664PubMedGoogle Scholar
  706. Dereymaeker, A.-M., J.P. Fryns, M. Hoefnagels et al., The BORJESON-FoRSSMAN-LEHMANN syndrome. A family study. Clin. Genet. 29 (1986) 317–320PubMedGoogle Scholar
  707. Gecz, J., E. Baker, A. Donnelly, J.E. Ming et al. Fibroplast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the BORJESON-FoRSSMAN-LEHMANN syndrome region in Xq26 delineated by 9 duplication breakpoint in a BFLS-like patient. Hum.Genet. 104(1999) 56–63PubMedGoogle Scholar
  708. Gedeon, A.K., H.M. Kozman, H. Robinson, G. Pilia, D. Schiessinger, G. Turner and J.C. Mulley, Refinement of the background genetic map of Xq26-q27 and gene localisation for BORJESONFORSSMAN- LEHMANN syndrome. Am.J.Med.Genet. 64 (1996) 63–68PubMedGoogle Scholar
  709. Lenz, W. und F. Majewski, Fehlbildungen der GliedmaBen. In: Schinz, Radiologische Diagnostik in Klinik und Praxis. Bd.VII2. Auf!. Thieme-VerI. Stuttgart New York 1991. S. 936–948Google Scholar
  710. Raff, M.L., K.A. Leppig, J.C. Rutledge, E. Weinberger and R.A. Pagon, Brachydactyly type Al with abnormal menisci and scoliosis in three generations. Clin.Dysmorphoi. 7 (1998) 29–34Google Scholar
  711. Robin, N.H., M. Gunay-Aygun, A. Polinkovsky, M.L. Warman and S. Morrison, Clinical and locus heterogeneity in brachydactyly C. Am.J.Med.Genet. 68 (1997) 369–377PubMedGoogle Scholar
  712. Slavotinek, A. and D. Donnai, A boy with severe manifestations of type Al brachydactyly. Clin.Dysmorphoi. 7 (1998) 21–27Google Scholar
  713. Temtamy, S.A. and V.A. McKusick, The genetics of hand malformations. Alan R.Liss, Inc. New York 1978Google Scholar
  714. Chitayat, D., A. Grix, J.W. Balfe, J.S. Abramowicz, J. Garza et al., Brachydactyly-short stature-hypertension (BILGINTURAN) syndrome: report on two families. Am.J.Med.Genet. 73 (1997) 279–285PubMedGoogle Scholar
  715. Grange, D.K., I.C. Balfour, S. Chen and E.G. Wood, Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachydactyly, and learning disability. Am.J.Med.Genet. 75 (1998) 469–480PubMedGoogle Scholar
  716. Schuster, H., T.F. Wienker, S. Bahring, N. Bilginturan, H.R. Toka, H. Neitzel, E. Jeschke, O. Toka et al., Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to chromosome 12. Nature Genet. 13 (1996) 98–100PubMedGoogle Scholar
  717. Gardner, J. and P. Beighton, Brachyolmia: An autosomal dominant form. Am.J.Med.Genet. 49 (1994) 308–312PubMedGoogle Scholar
  718. Grain, L., O. Duke, G. Thompson and E.G. Davies, TOLEDO type brachyolmia. Arch.Dis.Child 71 (1995) 448–449Google Scholar
  719. Fielding, D.W. and A.E. Fryer, Recurrence of orbital cysts in the branchio-oculo-facial syndrome. J.Med.Genet. 29 (1992) 430–431PubMedGoogle Scholar
  720. Legius, E., J.P. Fryns and H. Van den Berghe, Dominant branchial cleft syndrome with characteristics of both branchio-oto-renal and branchiooculo- facial syndrome. Clin.Genet. 37 (1990) 347–350PubMedGoogle Scholar
  721. Lin, A.E., R.J. Gorlin, I.W. Lurie et al., Further delineation of the branchio-oculo-facial syndrome. Am.J.Med.Genet. 56 (1995) 42–59PubMedGoogle Scholar
  722. Vincent, c., V. Kalatzis, S. Abdelhak, H. Chaib, S. Compain, J. Helias, F.-M. Vaneecioo and C. Petit, BOR and BOF syndromes are allelic defects of EYA1.Eur.J.Hum.Genet. 5 (1997) 242–246PubMedGoogle Scholar
  723. Abdelhak, S., V. Kalatzis, R. Heilig, S. Compain, D. Samson et al., Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absenthomologous region (eyaHR) of EYAL.Hum.Molec-Genet. 6 (1997) 2247–2255PubMedGoogle Scholar
  724. Gu, J.Z., X. Lin and D.E. Wells, The human B22 subunit of the NADH-ubiquinone oxido-reductase maps to the region of chromosome 8 involved in branchio-oto-renal syndrome. Genomics 35 (1996) 6–10PubMedGoogle Scholar
  725. Gu, J.Z., M.J. Wagner, E.A. Haan and D.E. Wells, Detection of a megabase deletion in a patient with Branchio-Oto-Renal syndrome (BOR) and Tricho- Rhino-Phalangeal syndrome (TRPS): Implication for mapping and cloning the BOR gene. Genomics 31 (1996) 201–205PubMedGoogle Scholar
  726. Kumar, S., W.J. Kimberling, J.B. Kenyon, R.J.H. Smith, H. A.M. Marres and C.W.R.J. Cremers, Autosomal dominant branchio-oto-renal syndrome -localization of a disease gene to chromosome 8q by linkage in a Dutch family. Hum. Molec.Genet. 1 (1992) 491–495PubMedGoogle Scholar
  727. Lin, A.E., R. Doherty and D. Lea, Letter to the Editor: Branchio-oculo-facial and Branchio-oto-renal syndromes are distinct entities. Clin.Genet. 41 (1992) 221–222PubMedGoogle Scholar
  728. Vincent, C., V. Kalatzis, S. Compain, J. Levilliers, R. Slim, F. Graia et al., A proposed new contiguous gene syndrome on 8q consists of branchio- oto-renal (BOR) syndrome, DUANE syndrome, a dominant form of hydrocephalus and trapeze aplasia; implication for the mapping of the BOR gene. Hum.Molec.Genet. 3 (1994) 1859–1866PubMedGoogle Scholar
  729. Vincent, C., V. Kalatzis, S. Abdelhak, H. Chaib, S. Compain, J. Helias, F.-M. Vaneecioo and C. Petit, BOR and BOF syndromes are allelic defects of EYAI.Eur.J.Hum.Genet. 5 (1997) 242- 246PubMedGoogle Scholar
  730. Wang, Y., K. Treat, R.J. Schroer, J.E.O. Brien, R.E. Stevenson and C.E. Schwartz, Localization of Branchio- oto-renal (BOR) syndrome to a 3Mb region of chromosome 8q. Am.J.Med.Genet. 51 (1994) 169–175PubMedGoogle Scholar
  731. Reish, O., R.J. Gorlin, M. Hordinsky, E.B. Rest, B. Burke and S.A. Berry, Brain anomalies, redardation of mentality and growth, ectodermal dysplasia, skeletal malformations, HIRSCHSPRUNG disease, ear deformities and deafness, eye hypoplasia, cleft palate, cryptorchism, and kidney dysplasia/ hypoplasia (BRESEK/BRESHECK): New Xlinked syndrome ? Am.J.Med.Genet. 68 (1997) 389–390Google Scholar
  732. Brody, LA, Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor. New Engl.J.Med. 281 (1969) 187–192PubMedGoogle Scholar
  733. Odermatt, A., P.E.M. Taschner, V.K. Khanna, H.F.M. Busch, G. Karpati, Ch.K. Jablecki, M.H. Breuning and D.H. MacLennan, Mutations in the gene-coding SERCA1the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+ ATPase, are associated with BRODY disease. Nature Genet. 14 (1996) 191–194PubMedGoogle Scholar
  734. Davis, P.B., V.S. Hubbard, K. McCoy and L.M. Taussig, Familial bronchiectasis. J.Pediat. 102 (1983)177–185PubMedGoogle Scholar
  735. Wayne, K.S. and L.M. Taussig, Probable familial congenital bronchiectasis due to cartilage deficiency (WILLIAMS-CAMPBELL-Syndrom). Am. Rev.Resp.Dis. 114 (1976) 15–22PubMedGoogle Scholar
  736. Berry, D.A. and G. Parmigiani, Assessing the benefits of testing for breast cancer susceptibility genes: A decision analysis. Breast Dis. 10 (1998)115-l25PubMedGoogle Scholar
  737. Ford, D., D.F. Easton, D.T. Bishop, S.A. Narod, D.E. Goldgar et al., Risks of cancer in BRCAl-mutation carriers. Lancet 1994/1 692–695Google Scholar
  738. Hamann, U., M. Häner, U. Stosiek, G. Bastert and R.J. Scott, Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families. J.Med.Genet. 34 (1997) 884–888PubMedGoogle Scholar
  739. Li, L. X.Li, U. Francke and S.N. Cohen, The TSG101tumor susceptibility gene is located in chromosome II band pIS and is mutated in human breast cancer. Cell 83 (1997) 143–154Google Scholar
  740. Mérette, Ch., M.-C. King and J. Ott, Heterogeneity analysis of breast cancer families by using age at onset as a covariante. Am.J.Hum.Genet. 50(1992) 515–519PubMedGoogle Scholar
  741. Miyazaki, S., A. Imatani, L. Ballard, A. Marchetti et al., The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6and its status in human breast carcinomas. Genomics 46 (1997) 155–158PubMedGoogle Scholar
  742. Peelen, T., R.S. Cornelis, M. van Vliet, A. Petrij-Bosch et al., The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1of BRCA2.Eur.J.Hum.Genet. 4 (1996) 225–230PubMedGoogle Scholar
  743. Rimer, B.K., J. Sugarman, E. Winer et al., Informed consent for BRCA1and BRCA2testing. Breast. Dis. 10(1998) 99–114PubMedGoogle Scholar
  744. Seitz, S., K. Rohde, E. Bender, A. Nothnagel, K. Kiilble, P.M. Schlag and S. Scherneck, Strong indication for a breast cancer susceptibility gene on chromosome 8pl2-p22: linkage analysis in German breast cancer families. Oncogene 14 (1997) 741–743PubMedGoogle Scholar
  745. Srivastava, S., Z. Zou, K. Pirollo et al., Germ-line transmission of a mutated p53 gene in a cancer- prone family with LI FRAUMENI syndrome. Nature 348 (1990) 747–749PubMedGoogle Scholar
  746. Stratton, M.R., Recent advances in understanding of genetic susceptibility to breast cancer. Hum. Molec.Genet. 5 (1996) 1515–1519PubMedGoogle Scholar
  747. Zhang, H., G. Tombline and B.L. Weber, BRCA1, BRCA2, and DNA damage response: Collision or Collusion? Cell 92 (1998) 433–436PubMedGoogle Scholar
  748. Magli, A., R. Fusco, E. Chiosi, and G. DelBono, Inheritance of BROWN’S syndrome. Ophthalmologica 192 (1986) 82–87PubMedGoogle Scholar
  749. Zerres, K., KlassifIkation und Genetik spinaler Muskelatrophien. Thieme Verlag Stuttgart 1989Google Scholar
  750. Albert, T., B. Urlbauer, F. Kohlhuber et al., Ongoing mutations in the N-terminal domain of c-MYCaffect transactivation in BURKITT’S lymphoma cell lines. Oncogene 9 (1994) 759–763PubMedGoogle Scholar
  751. Salawu, I., O.A. Fatusi, F. Kemi-Ritimi et al., Familial BURKITT’S lymphoma in Nigerians. Ann.Trop. Paediatr. 17 (1997) 375–379PubMedGoogle Scholar
  752. Zur Stadt, U., A. Reiter, K. Welte und K.-W. Sykora, Nachweis der Translokation t(8;14)(q24;q32) in kindlichen BURKITT-Lymphomen mittels der ’long distance’ -Polymerase-Ketten-Reaktion: Eine neue Methode zur Diagnostik von BURKITT- Lymphomen. Klein.Pädiatr. 205 (1997)165–171Google Scholar
  753. Verb ox, J. and R. Graham, BUSCHKE-OLLENDORFF syndrome - Disseminated dermatofibrosis with osteopoikilosis. Clin.Exp.Derm 11 (1986) 17–26Google Scholar
  754. Giro, M.G., M. Duvic, L.T. Smith, R. Kennedy, R. Rapini, F.C. Arnett and J.M. Davidson, BUSCHKEOLLENDORFF syndrome associated with elevated elastin production by affected skin fibroblasts in culture. J.lmvest.Derm. 99 (1992) 129- 137Google Scholar
  755. Walpole, LR. and P.J. Manners, Clinical considerations in BUSCHKE-OLLENDORFF syndrome. Clin.Genet. 37 (1990) 59–63PubMedGoogle Scholar
  756. Cleper, R., A. Kauschansky, I. Varsano and M. Frydman, VARADY syndrome (OFD VI) or OPITZ trigonocephaly syndrome: Overlapping manifestations in two cousins. Am.J.Med.Genet. 47 (1993) 451–455PubMedGoogle Scholar
  757. Glickstein, J., J. Krasik, D. Garcia Caride and R.W. Marion, ’c’ trigonocephaly syndrome: Report of a child with agenesis of the corpus callosum and tetralogy ofFALLoT, and review. Am.J. Med.Genet. 56 (1995) 215–218PubMedGoogle Scholar
  758. Lajeune, E., M. Le Merrer, D. Marchac and D. Renier, Syndromal and nonsyndromal primary trigonocephaly: Analysis of a series of 237 patients. Am.J.Med.Genet. 75 (1998) 211–215Google Scholar
  759. Stratton, R.F., N.J. Sykes and T.W. Hassler, C syndrome with apparently normal development. Am.J.Med.Genet. 37 (1990) 460–462PubMedGoogle Scholar
  760. Zampino, G., C.Di Rocco, G. Butera, F. Balducci, C. Colosimo, M.G. Torrioli and P. Mastroiacovo, OPITZ C trigonocephaly syndrome and midline brain anomalies. Am.J.Med.Genet. 73 (1997) 484–488PubMedGoogle Scholar
  761. Brunner, H.G., T. Hulsebos, P.M. Steijlen et al., Exclusion of the neurofibromatosis 1 locus in a family with inherited café-au-lait spots. Am.J. Med.Genet. 46 (1993) 472–474PubMedGoogle Scholar
  762. Charrow, J., R. Listernick and K. Ward, Autosomal dominant multiple cafe-au-lait spots and neurofibromatosis- I: evidence of no-linkage. Am.J. Med.Genet. 45 (1993) 606–608PubMedGoogle Scholar
  763. Hall, J., Genetic aspects of PERTHES’ disease: A critical review. Clin.Orthop.Relat.Res. 209 (1986)100–114PubMedGoogle Scholar
  764. Harper, P.S., B.J. Brotherton and D. Cochlin, Genetic risks in PER THES’ disease. Clin.Genet. 10 (1976)178–182PubMedGoogle Scholar
  765. Higgs, J.M., Chronic mucocutaneous candidiasis: Iron deficiency and the effect of therapy. Proc. Roy.Soc.Med. 66 (1973) 802–804PubMedGoogle Scholar
  766. Nauseef, W.M., S. Brigham and M. Cogley, Hereditary myeloperoxidase deficiency due to a missense mutation of arginine 569 to tryptophan. J.Biol. Chern. 269 (1994) 212–216Google Scholar
  767. Zaki, S.R., G.E. Austin, W.C. Chan, A.L. Conaty, S. Trusler et al., Chromosomal localization of the human myeloperoxidase gene by in situ hybridization using oligonucleotide probes. Genes, Chromosomes Cancer 2 (1990) 266–270PubMedGoogle Scholar
  768. Aplin, H., K.L. Hirst, A.H. Crosby and M.J. Dixon, Mapping of the human dentin matrix acidic phosphoprotein gene (DMPl) to the Dentinogensis imperfecta type II critical region at chromosome 4q21. Genomics 30(1995) 347–349PubMedGoogle Scholar
  769. Bonaventura, J., R. Stanescu, V. Stanescu et al., Type II collagen defect in two sibs with the GOLDBLATT syndrome, a chondrodysplasia with dentinogenesis imperfecta, and joint laxity. Am.J. Med.Genet. 44 (1992) 738–753Google Scholar
  770. Dean, J.A., J.K. Hartsfield Jr. and T.C. Hart, Dentin dysplasia, type II linkage to chromosome 4q. J.Craniofac.Genet.Dev.Biol. 17 (1997) 172–177PubMedGoogle Scholar
  771. MacDougall, M., M. Zeichner-David, J. Murray, M. Crall, A. Davis and H. Slavkin, Dentin phosphoprotein gene locus is not associated with Dentinogenesis imperfecta types II and III. Am.J.Hum.Genet. 50(1992) 190–194PubMedGoogle Scholar
  772. Ranta, H., P.-L. Lukinmaa and J. Knif, Dentin dysplasia type II: Absence of type III collagen in dentin. J.Oral Pathol.Med. 19 (1990) 160–165PubMedGoogle Scholar
  773. Blouin, J.L., G. Duriaux Sail and S.E. Antonarakis, Mapping of the human holocarbopxylase synthetase gene (HCS) to the DOWN syndrome critical region of chromosome 21q22. Ann.Genet. 39 (1996) 185–188PubMedGoogle Scholar
  774. Holme, E., C.-E. Jacobson and B. Kristiansson, Biotin- responsive multiple carboxylase deficiency in an 8-year-old boy with normal serum biotinidase, and fibroblast holocarboxylase-synthase activities. J.Inherit.Metab.Dis. 11 (1988) 270–276PubMedGoogle Scholar
  775. Suormala, T., B. Fowler, C. Jakobs et al., Late-onset holocarboxylase synthetase-deficiency. Eur.J. Pediatr. 15 (1998) 570–575Google Scholar
  776. Wolf, B., Disorders of Biotin Metabolism. In Scriver, C.R., W.S.Beaudet, W.S.Sly and D.Valle (Eds.), The Metabolic and Molecular Bases ofInherited Disease.McGraw-Hill, New Yoek, 7thEdit. 1997, S.3151–3177Google Scholar
  777. Schimke, R.N., D.L. Collins and J.M. Hiebert, Congenital nonprogressive myopathy with MOBIUS and ROBIN sequence - The CAREy-FINEMAN-ZITER syndrome: A confirmatory report. Am.J. Med.Genet. 46 (1993) 721–723PubMedGoogle Scholar
  778. Christodoulou, J., S.H. Teo, J. Hammond, K.G. Sim et al., First prenatal diagnosis of the carnitine transporter defect. Am.J.Med.Genet. 66 (1996) 21–24PubMedGoogle Scholar
  779. Huizing, M., V. Iacobazzi, L. Lodewijk, P. Savelkoui et al., Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient. Am.J.Hum.Genet. 61 (1997) 1239–1245PubMedGoogle Scholar
  780. Nezu, J., I. Tamai, A. Oku et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nature Genet. 21 (1999) 91–93PubMedGoogle Scholar
  781. Bonnefont, J.-P., F. Taroni, P. Cavadini, C. Cepanec, M. Brivet et al., Molecular analysis of carnitinepalmitoyltransferase II deficiency with hepatocardiomuscular expression. Am.J.Hum.Genet. 58 (1996) 971–978PubMedGoogle Scholar
  782. Britton, C.H., D.W. Mackey, V. Esser, D.W. Foster et al., Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A)and (CPTlB).Genomics 40(1987) 209–21lGoogle Scholar
  783. Demaugre, F., J.-P. Bonnefont, M. Colonna et al., Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death: physiopathological approach to palmitoyltransferase II deficiencies. J.Clin.lnvest. 87 (1991) 859–864Google Scholar
  784. Nezu, J., I. Tamai, A. Oku et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitinetransporter. Nature Genet. 21 (1999) 91–93PubMedGoogle Scholar
  785. Bonnefont, J.-P., F. Taroni, P. Cavadini, C. Cepanec, M. Brivet et al., Molecular analysis of carnitinepalmitoyltransferase II deficiency with hepatocardiomuscular expression. Am.J.Hum.Genet. 58 (1996) 971–978PubMedGoogle Scholar
  786. Britton, C.H., D.W. Mackey, V. Esser, D.W. Foster et al., Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A)and (CPTlB).Genomics 40(1987) 209–21lGoogle Scholar
  787. Demaugre, F., J.-P. Bonnefont, M. Colonna et al., Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death: physiopathological approach to palmitoyltransferase II deficiencies. J.Clin.lnvest. 87 (1991) 859–864Google Scholar
  788. Kaufmann, P., M. EI-Schahawi and S. DiMauro, Carnitine palmitoyltransferase II deficiency: diagnosis by molecular analysis of blood. MoI.Cell. Biochem. 174 (1997) 237–239Google Scholar
  789. Kieval, R., A. Sotrel and M.E. Weinblatt, Chronic myopathy with a partial deficieny of the carnitine palmityl transferase deficiency. Arch.NeuroI. 46 (1989) 575–576Google Scholar
  790. Wataya, K., J. Akanuma, P. Cavadini, Y. Aoki et al., Two CPT2mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency: Functional analysis and association with polymorphic haplotypes and two clinical phenotypes. Hum.Mutat. 11 (1998) 377–386PubMedGoogle Scholar
  791. Terplan, K.L. and H.L. Cares, Histopathology of the nervous system in carnosinase enzyme deficiencywith mental retardation. Neurology 22 (1972) 644–655PubMedGoogle Scholar
  792. Dallapiccola, B., A. Pizzuti and G. Novelli, How many breaks do we need to CATCH on 22q 11 ? Am.J.Hum.Genet. 59 (1996) 7 - 11PubMedGoogle Scholar
  793. Hall, J., Catch. J.Med.Genet. 30(1993) 801–802Google Scholar
  794. Ryan, A.K., J.A. Goodship, D.I. Wilson, N. Philip, A. Levy, H. Seidel et al., Spectrum of clinical features associated with interstitial chromosome 22q 11 deletions: a European collaboratory study. J.Med.Genet. 34 (1997) 798–804PubMedGoogle Scholar
  795. Sabry, M.A., M. Zaki, S.J. Abdul Hassan, D.G. Ramadan, M.A.Abdel Rasool, S.A.Al Awadi and Q.Al Saleh, KENNy-CAFFEY syndrome is part of the CATCH22 haploinsufficiency cluster. J.Med.Genet. 35 (1998) 31–36PubMedGoogle Scholar
  796. Thompson, E.M., R.M. Winter and M.J.H. Williams, A male infant with the CATEL-MANZKE syndrome and dislocatable knees. J. Med.Genet. 23 (1986) 271–274PubMedGoogle Scholar
  797. Wilson, G.N., T.E. Kind and G.S. Brooshire, Index finger hyperphalangy and multiple anomalies: CATEL-MANZKE syndrome? Am.J.Med.Genet. 46 (1993) 176–179PubMedGoogle Scholar
  798. Pfeiffer, R.A. and M. Meisel-Stosiek, Present nosology of the CENANI-LENZ type of syndactyly. Clin.Genet. 21 (1982) 74–79PubMedGoogle Scholar
  799. Mulley, J.C., H.M. Kozman, H.A. Phillips, A.K. Gedeon, J.A. McCure, D.E. Iles. R.G. Gregg, K. Hogan, F.J. Couch, D.H. MacLennan and E.A. Haan, Refined genetic localization for central core disease. Am.J.Hum.Genet. 52(1993) 398–405Google Scholar
  800. Quane, K.A., J.M.S. Healy, K.E. Keating, B.M. Manning, F.J. Couch et al., Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nature Genet. 5(1993) 51–55PubMedGoogle Scholar
  801. Romero, N.B., Y. Nivoche, J. Lunardi et al., Malignant hyperthermia and central core disease: analysis of two families with heterogeneous clinical expression. Neuromuscular Disord. 3(1993) 547–551Google Scholar
  802. Bamezai, B.,S.A. Hussain, S. Misra and A.K. Thacker, Cerebellar ataxia and total albinism. Clin.Genet. 31 (1987) 178–181PubMedGoogle Scholar
  803. Filla, A., G. De Michele, M.A. Maggio et al., Acute double-blind trial with thyrotropin-releasing hormone (TRH) in inherited ataxias. Med.Sci. Res. 16(1988) 1177–1178Google Scholar
  804. Benomar, A., E.Le Guern, A.Durr et al., Autosomaldominant cerebellar ataxia with retinal degeneration (ADCA type II) is genetically different from ADCA type 1. Ann.Neurol. 35(1994) 439–444)PubMedGoogle Scholar
  805. Krols, L., J.-J. Martin, G. David, N. van Regenmorter, A. Benomar et al., Refinement of the locus for autosomal dominant cerebellar ataxia type II to chromosome 3p21.1–14.1. Hum.Genet. 99(1997) 225–232PubMedGoogle Scholar
  806. Young, I.D., Lethal olivopontocerebellar hypoplasia with dysmorphic features in sibs. J.Med.Genet. 29(1992) 733–735PubMedGoogle Scholar
  807. Al-Gazali, L.I., D. Bakalinova, E. Varady, J. Scorer and M. Nork, Further delineation of NEVO syndrome. J.Med.Genet. 34(1997) 366–370PubMedGoogle Scholar
  808. Blackett, P.R., M.A. Coffman, G.B. Schaefer and O.M. Rennert, Case report: Dominantly inherited childhood gigantism resembling SOTOS syndrome. Am.J.Med.Sci. 297(1989) 181–185PubMedGoogle Scholar
  809. Cole, T.R.P. and H.E. Hughes, Sotos syndrome: A study of the diagnostic criteria and natural history. J.Med.Genet. 31(1994) 20–32PubMedGoogle Scholar
  810. Durnic, M., D. Vukelic, V. Plavsic, A. Cviko, L. Sokolic and B. Filipovic-Grcic, NEVO syndrome. Am.J. Med.Genet. 76(1998) 67–70Google Scholar
  811. Eiss-Informationsblatt der Eltern-initiative Sotossyndrom, Das SOTos-Syndrom. Mainz 1996,4 SGoogle Scholar
  812. Fryns, J.P., The Prader-Wiili syndrome and the Sotos syndrome: Syndromes or sequences ? Clin.Genet. 33(1988) 457–458PubMedGoogle Scholar
  813. Hilderink, B.G.M. and H.G. Brunner, Nevo syndrome. Clin.Dysmorphol. 4(1995) 319–323PubMedGoogle Scholar
  814. Scarpa, P., R. Faggiolo and A. Voghenzi, Familial Sotos syndrome: Longitudinal study of two additional cases. Genet.Counsel. 5(1994) 155–159PubMedGoogle Scholar
  815. Wajntal, A. and C.P.Koiffmann, Chromosome aberrations in SOTOS syndrome. Clin.Genet. 40(1991) 472PubMedGoogle Scholar
  816. Drossou-Agakidou, V., A. Andreou, V. SoubassiGriva and M. Pandouraki, Cerebromandibular syndrome in four sibs, two pairs of twins. J.Med. Genet. 28(1991) 704–707PubMedGoogle Scholar
  817. Hennekam, R.C.M., F.A. Beemer, W.A.R. Hulibers, P.A. Hustinx and F.J. van Sprang, The cerebrocosto- mandibular syndrome: third report of familial occurrence. Clin.Genet. 28(1985) 118–12lPubMedGoogle Scholar
  818. Hennekam, R.C.M. and R. Goldschmeding, Complete absence of rib ossification, micrognathia and ear anomalies: extreme expressions of cerebro- costo-mandibular syndrome ? Europ.J. Hum.Genet. 6(1998) 71–74Google Scholar
  819. Leroy, J.G., E.A. Deros, L.J. van den Bulcke, and N.S. Robbe, Cerebro-costo-mandibular syndrome with autosomal dominant inheritance. J.Pediat. 99(1981) 441–443PubMedGoogle Scholar
  820. van der Ende, J.J., C. Schrander-Stumpel, E. Rupprecht, P. Meinecke, P. Maroteaux, C. de DieSchmulders and B.C.J. Hamel, The cerebro-costo- mandibular syndrome: seven patients and review of the literature. Clin.Dysmorphol. 7(1998) 87–95PubMedGoogle Scholar
  821. Baumgart, E., J.C.T. Vanhooren, M. Fransen et al., Molecular characterization of the human peroxisomal branched-chain acyl-CoA oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence for the absense of the protein in ZELLWEGER syndrome. Proc.NatI.Sci. USA 93(1996) 13748–13753Google Scholar
  822. Clayton, P.T., B.D. Lake, M. Hjelm et al., Bile acid analysis in ’pseudo-Zellweger’ syndrome: clues to the defect in peroxisomal B-oxidation. J.lnherit.Metab.Dis. 11Suppl.2 (1988) 165–168Google Scholar
  823. Distel, B., R. Erdmann, S.J. Gould, G. Blobel, D.I. Crane et al., A unified nomenclature for peroxisome biogenesis factors. J.Cell Biol. 135(1996) 1–3PubMedGoogle Scholar
  824. Fitzpatrick, D.R., Zellweger syndrome and associated phenotypes. J.Med.Genet. 33(1996) 863–868PubMedGoogle Scholar
  825. Gärtner, J., W. Kearns, C. Rosenberg, P. Pearson, N.G. Copeland, D.J. Gilbert, N.A. Jenkins and D. Valle, Localization of the 70-kDa peroxisomal membrane protein to human 1p21-p22 and mouse 3. Genomics 15(1993) 412–414PubMedGoogle Scholar
  826. Singh, I., R.G. Voigt, F.G. Sheikh et al., Biochemical features of a patient with Zellweger-like syndrome with normal PTS-l and PTS-2 peroxisomal protein import srstem: A new peroxisomal disease. Biochem.Mo.Med. 61(1997) 198–207Google Scholar
  827. Stanczak, H., K. Kremser, A.K. Singh at al., Complementation in Zellweger syndrome: Biochemical analysis of newly generated peroxisomes. Hum.Hered. 42(1992) 172–178PubMedGoogle Scholar
  828. Suzuki, Y., N.Shimozawa, T.Orii et al., Zellwegerlike syndrome with detectable hepatic peroxisomes: A variant of peroxisomal disorder. J.Pediat. 113(1988) 841–845PubMedGoogle Scholar
  829. Waterham, H.R. and J.M. Cregg, Peroxisome biogenesis. BioEssays 19(1997) 57–66Google Scholar
  830. Casteels, I, A. Wijnants, P. Casaer, E. Eggermont, L. Misotten and J.P. Fryns, Cerebra-oculo-facial- skeletal (COFS) syndrome. The variability of presenting symptoms as a manifestation of two subtypes? Genet. Counsel. 2(1991) 43–46Google Scholar
  831. Temtamy, S.A., M.A. Megiud, A. Mahmoud, H.H. Afifi, A. Gerzaqwy and M.S. Zaki, Cofs syndrome with familial 1;16 translocation. Clin. Genet. 50(1996) 240–243PubMedGoogle Scholar
  832. Gardiner, M., A. Sandford, M. Deadman et al., Batten disease (Spielmeyer-Vogt disease, juvenile onset neural ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16. Genomics 8(1990) 387–390PubMedGoogle Scholar
  833. Järvelä, I., J. Schleutker, L. Haataja et al., Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics 9(1991) l70–173Google Scholar
  834. Järvelä, I., H.M. Mitchinson, P.B. Munroe, A.M. O’Rawe, S.E. Mole and A.-C. Syvanen, Rapid diagnostic test for the major mutation underlying Batten disease. J.Med.Genet. 33(1996) 1041–1042PubMedGoogle Scholar
  835. Järvelä, I., M. Sainio, T. Rantamaki, V.M. Olkkonen, O. Carpen, L. Peltonen and A. Jalanko, Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten- disease. Hum.Molec.Genet. 7(1998) 85–90PubMedGoogle Scholar
  836. Liu, c.-G., D.E. Sleat, R.J. Donnelly and P. Lobel, Structural organization and sequence ·of CLN2the defective gene in classical late infantile neuronal ceroid lipofuscinosis. Genomics 50 (1998)206–212PubMedGoogle Scholar
  837. Mitchinson, H.M., S.L. Hofmann, C.B.P. Becerra, P.B. Munroe et al., Mutations in the palmitoylprotein thioesterase gene (PPT; CLN1)causing juvenile neuronal ceroid lipofuszinosis with granular osmophilic deposits. Hum.Molec.Genet. 7(1998) 291–297Google Scholar
  838. Munroe, P.B., J. Rapola, H.M. Mitchison et al., Prenatal diagnosis in Batten’s disease. Lancet 347(1996) 1014–1015PubMedGoogle Scholar
  839. Rapola, J., R. Salonen, P. Ammala and P. Santavuori, Prenatal diagnosis of the infantile type of neuronal ceroid lipofuscinosis by electron microscopic investigation of human chorionic villi. Prenatal Diagn. 10(1990) 553–559Google Scholar
  840. Savukoski, M., T.Klckars, V. Holmberg, P. Santavuori, E.S. Lander and L. Peltonen, CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nature Genet. 19(1998) 286–289PubMedGoogle Scholar
  841. Sharp, J.D., R.B. Wheeler, B.D. Lake, M. Savukoski, I.E. Jarvela et al., Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes llp15 and 15q21–23. Hum.Molec. Genet. 6(1997) 591–595PubMedGoogle Scholar
  842. Tachner, P.E.M., N. Devos and M.H. Breuning, Rapid determination of the major deletion in the Batten disease gene CLN3by allel specific PCR. J.Med.Genet. 34(1997) 955–956Google Scholar
  843. Vesa, J., E. Hellsten, L.A. Verkruyse et al., Mutation in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuszinosis. Nature 376(1995) 586–587Google Scholar
  844. Char, F., Peculiar facies with short philtrum, duckbill lips, ptosis and low-set ears - a new syndrome? BD/OAS XIVl6B(1978) 303–305Google Scholar
  845. Slavotinek, A.J. Clayton-Smith and M. Super, Familial patent ductus arteriosus: A further case of CHAR syndrome. Am.J.Med.Genet. 71(1997) 229–232PubMedGoogle Scholar
  846. Devriendt, K., A. Swillen and J.-P. Fryns, Deletion in chromosome region 22q11 in a child with CHARGE association. Clin.Genet. 52(1998) 408–410Google Scholar
  847. Edwards, B.M., L.A. Van Riper and P.R. Kileny, Clinical manifestations of CHARGE association. Int.J.Pediatr.Otorhinolaryngol. 33(1995) 23–42PubMedGoogle Scholar
  848. Ghalili, K., H.J. Issenberg, N.J. Freeman and R.F. Brodman, Isolated left carotid artery in Charge association: Diagnosis and repair. Ann.Thorac.Surg. 50(1990) 130–132PubMedGoogle Scholar
  849. Harris, J., E. Robert and B. Kalian, Epidemiology of choanal atresia with special reference to the Charge association. Pediatrics 99(1997) 393–396Google Scholar
  850. Murofushi, T., R.A. Ouvrier, G.D. Parker et al., Vestibular abnormalities in Charge association. Ann.Otol.Rhinol.Laryngol. 106(1997) 129–134PubMedGoogle Scholar
  851. North, K.N., B.L. Wu, B.N. Cao, D.A.H. Whiteman and B.R. Korf, Charge association in a child with de novo inverted duplication (14)(q22- 24.3). Am.J.Med.Genet. 57(1995) 610–614PubMedGoogle Scholar
  852. Tellier, A.L., V. Cormier-Daire, V. Abadie, J. Amiel, S. Sigaudy et al., Charge syndrome: Report of 47 cases and review. Am.J.Med.Genet. 76(1998) 402–409PubMedGoogle Scholar
  853. Diukman, R., S. Tanigawara, M.J. Cowan and M.S. Golbus, Prenatal diagnosis OfChediak-Higashi syndrome. Prenatal Diagn. 12(1992) 877- 885Google Scholar
  854. Nagle, D.L., M.A. Karim, E.A. Wolf, L. Holmgren, P. Bork et al., Identification and mutation analysis of the complete gene for Chediakhigashi syndrome. Nature Genet. 14(1996) 307–31lPubMedGoogle Scholar
  855. Pastural, E., F.J. Barrat, R. Dufourcq-Lagelouse, S. Certain et al., Griscelli disease maps to chromosome 15q21 and is associated with mutations in the Myosin-Va gene. Nature Genet. 16(1997) 289–292PubMedGoogle Scholar
  856. Virelizier, J.L., A. Lagrue, A. Durandy, F. Arenzana, C. Oury, C. Griscelli and P. Reinert, Reversal of natural killer defect in a patient with Chediak-Higashi syndrome after bone-marrow transplantation. New Engl.J.Med. 306(1982) 1055–1056PubMedGoogle Scholar
  857. Khalifa, M.C. and R.A. Ibrahim, Cherubism. J.Laryngol. Otol. 102(1988) 568–570PubMedGoogle Scholar
  858. Pina-Neto, J.M., A.F.C. Moreno, R.L. Silva, M.A.S.L. Velludo et al., Cherub ism, gingival fibromatosis, epilepsy and mental retardation (RAMON syndrome) with rheumatoid arthitis. Am.J.Med.Genet. 25(1986) 433–441PubMedGoogle Scholar
  859. Pina-Neto, J.M., N. Vieira de Souza, M.A.S.L. Velludo, G.B.D. Perosa et al., Retinal changes and tumorigenesis in Ramon syndrome: Follow-up of a Brazilian family. Am.J.Med.Genet. 77(1998) 43–46PubMedGoogle Scholar
  860. Burn, J., C. McKeon, J. Wagget, R. Bray and J. Goodship, New dysmorphic syndrome with choanal atresia in siblings. Clin.Dysmorph. 1(1992) 137–144PubMedGoogle Scholar
  861. Ferguson, J.L. and H.B. Neel III, Choanal atresia: Treatment trends in 47 patients over 33 years. Ann.Otol.Rhinol. Laryngol. 98(1989) 110–112Google Scholar
  862. Harris, J., E. Robert and B. Kallan, Epidemiology of choanal atresia with special reference to the Charge association. Pediatrics 99(1997) 393–396Google Scholar
  863. Wilson, L.c., B.A. Kerr, R. Wilkinson, c. Fossard and D. Donnal, Choanal atresia and hypothelia following methimazole exposure in utero. A second case. Am.J.Med.Genet. 75(1998) 220–222Google Scholar
  864. Andrew, L.J., V. Brancolini, L. Serrano de la Pena et al., Refinement of the chromosome 5p locus for familial calcium pyrophosphate dehydrate deposition disease. Am.J.Hum.Genet. 64(1999) 136–144PubMedGoogle Scholar
  865. Balsa, A., W. Martin-Mola, T. Gonzalez et al., Familial articular chondrocalcinosis in Spain. Ann. Rheum. Dis. 49(1990) 531–535PubMedGoogle Scholar
  866. Eshel, G., A. Gulik, N. Halperin et al., Hereditary chondrocalcinosis in an Ashkenazi Jewish family. Ann Rheum.Dis. 49(1990) 528–530PubMedGoogle Scholar
  867. Marcos,J.e., M.A. de Benyacar, a. Garcio-Monteo et al., Idiopathic familial chondrocalcinosis due to apatite crystal deposition. Am.J.Med. 71(1981) 557–564Google Scholar
  868. Buheitel, G. und R.A. Pfeiffer, Child-Syndrom. Monatsschr. Kinderheilk. 143(1995) 572–575Google Scholar
  869. Fryburg, J.S. and T.E. Kelly, Chondrodysplasia punctata, humero-metacarpal type: A. Second case. AmJ.Med.Genet. 64(1996) 493–496Google Scholar
  870. Happle, R., X-gekoppelte dominante Chondrodysplasia punctata. Mschr.Kinderhk. 128(1980) 203–207Google Scholar
  871. Heikoop, J.e., R.J.A. Wanders, A. Strijkland, R. Purvis, R.B.H. Schutgens and J.M. Tager, Genetic and biochemical heterogeneity in patients with the rhizomelic form of chondrodysplasia punctata - a complementation study. Hum.Genet. 89(1992) 439–444PubMedGoogle Scholar
  872. Hosenfeld, D. and H.-R. Wiedemann, Chondrodysplasia punctata in an adult recognized as vitamin K antagonist embryopathy. Clin.Genet. 35(1989) 376–381PubMedGoogle Scholar
  873. Ofman, R., E.H. Hettema, E.M. Hogenhout et al., Acyl-CoA:Dihydroxyacetonephosphat acyltransferase: Cloning of the cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum.Molec.Genet. 7(1998) 847–853PubMedGoogle Scholar
  874. Motley, A.M., E.H. Hettema, E.M. Hogenhout, P. Brites, A.L.M.A. ten Asbroek et al., Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nature Genet. 15(1997) 377–380PubMedGoogle Scholar
  875. Parenti, G., P. Buttitta, G. Meroni, B. Franco et al., Xlinked recessive chondrodysplasia punctata due to a new point mutation of the ARSEgene. Am.J. Med.Genet. 73(1997) 139–143PubMedGoogle Scholar
  876. Rittler, M., H. Menger and J. Spranger, Chondrodysplasia punctata, tibia-metacarpal (MT) type. Am.J.Med.Genet. 37 (1990) 200–208PubMedGoogle Scholar
  877. Sutphen, R., M.J. Amar, B.G. Kousseff and K.E. Toomey, XXY male with X-linked dominant chondrodysplasia punctata (Happle syndrome). Am.J.Med.Genet. 57(1995) 489–492PubMedGoogle Scholar
  878. Van Maldergem, L., M. Espeel, F. Roels, C. Petit, G. Dacremont, R.J.A. Wanders, A. Verloes and Y. Gillerot, X-linked recessive chondrodysplasia punctata with XY translocation. Hum.Genet. 87(1991) 661–664PubMedGoogle Scholar
  879. Wilson, c.J. and S. Aftimos, X-linked dominant chondrodysplasia punctata: A peroxisomal disorder? Am.J.Med.Genet. 78(1998) 300–302PubMedGoogle Scholar
  880. Zizka, J., J. Charvat, A. Baxova, P. Balicek and K. Kozlowski, Brachytelephalangic chondrodysplasia punctata with distinctive phenotype and normal karyotype. Am.J.Med.Genet. 76(1998) 213–216PubMedGoogle Scholar
  881. Auburger, G., T. Ratzlaff, A. Lunkes, H.W. Nelles, B. Leube et al., A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1 p, probably within 2 cM between D15443 and D1S197. Genomics 31(1996) 90–94PubMedGoogle Scholar
  882. Fouad, G.T., S. Servidei, S. Durcan, E. Bertini and J.J. Ptacek, A gene for familial paroxysmal dyskinesia (FPDl) maps to chromosome 2q. Am.J. Hum.Genet. 58(1996) 135–145Google Scholar
  883. Hofele, R. and G. Auburger, Gene locus FDP1 of the dystonic Mount-Reback type of autosomal-dominant paroxysmal choreoathetosis. Neurology 49(1997) 1252–1256PubMedGoogle Scholar
  884. Klein, C und P. Vieregge, Nichtepileptische paroxysmale BewegungsstOrungen. Nervenarzt 69(1998) 647–659PubMedGoogle Scholar
  885. Muller, U., D. Steinberger and A.H. Nemeth, Clinical and molecular genetics of primary dystonias. Neurogenetics 1(1998) 165–177PubMedGoogle Scholar
  886. Raskind, W.H., T. Bolin, J. Wolff, J. Fink, M. Matsushita, M. Litt, H. Lipe and T.D. Bird, Further localization of a gene for paroxysmal dystonic choreoathetosis to a 5-cM region on chromosome 2q34. Hum.Genet. 102(1998) 93–97PubMedGoogle Scholar
  887. Krill, A.E. and D.B. Archer, Krill’s Hereditary Retinal and Choroidal Diseases. Harper and Row, New York, San Francisco, London 1977Google Scholar
  888. Verraz, R. Heredofamilial central choroidal sclerosis. Arch.Sci.Med. 126(1969) 875–880Google Scholar
  889. Cremers, F.P.M., D.J.R. Van De Pol, L.P.M. Van Kerkhoff et al., Cloning of a gene that is rearranged in patients with choroideremia. Nature 347(1990) 674–677PubMedGoogle Scholar
  890. Cremers, F.P.M, C.M. Molloy, D.J.R. Van De Pol, J.A.J.M. van den Hurk, I. Bach, A.H.M. Gerts von Kessel and H.H. Ropers, An autosomal homologue of the choroideremia gene colocalizes with the Usher syndrome type II locus on the distal part of chromosome 1q. Hum.Molec.Genet. 1(1992) 71–75PubMedGoogle Scholar
  891. Mashima, Y., A. Murakami, R.G. Weleber, N.G. Kennaway, L. Clarke, T. Shiono and G. lnana, Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am.J.Hum.Genet. 51(1992) 81–91PubMedGoogle Scholar
  892. Mashima, Y.T. Shiono and G. lnana, Rapid and efficient molecular analysis of gyrate atrophy using denaturing gradient gel electrophoresis. Invest.Ophthalmol.Vis.Sci. 35(1994) 1065–1070PubMedGoogle Scholar
  893. Wirtz, M.K., N.G. Kennaway and R.G. Weleber, Heterogeneity and complementation analysis of fibroblasts from vitamin B 6 responsive and nonresponsive patients with gyrate atrophy of the choroid and retina. J.Inherit.Metab.Dis. 8(1985) 71–74PubMedGoogle Scholar
  894. Jaspers, N.G.J., R.D.F. Taalman and C. Baan, Patients with an inherited syndrome characterized by immunodeficiency, microcephaly and chromosomal instability: genetic relationship to ataxia teleangiectasia. Am.J.Hum.Genet. 43(1988) 66–73Google Scholar
  895. Seemanová, E., E. Passarge, D. Benesková, J. Houstek, P. Kasal and M. Sevciková, Familial microcephaly with normal intelligence, immunodeficiency, and risk for Iymphoreticular malignancies: a new autosomal recessive disorder. Am.J.Med. Genet. 20(1985) 639–648Google Scholar
  896. Sperling, K., Analisi dell’ eterogeneita nell’uomo. Prospettive in Pediatria 49(1983) 53–66Google Scholar
  897. Borgaonkar, D.S., Chromosomal Variation in Man. A Catalog of Chromosomal Variants and Anomalies. 8th Edit. Wiley-Liss, New York, Chichester, Brisbane, Toronto, Singapore 1997Google Scholar
  898. Mitelman, P., Catalog of Chromosome Aberrations in Cancer’98. Wiley-Liss, New York, Chichester, Brisbane, Toronto, Singapore 1998Google Scholar
  899. Schinzel, A., Catalogue of Unbalanced Chromosome Aberrations in Man. Walter de Gruyter, Berlin, New York 1984Google Scholar
  900. Issa, A.R.A., G. Yadav, and A.S. Teebi, Intrafamilial phenotypic variability in citrullinaemia: Report of a family. J.lnherit.Metab.Dis. 11(1988) 306–307Google Scholar
  901. Kakinoki, H., K.Kobayashi, H.Terazono, Y.Nagata and T.Saheki, Mutations and DNA diagnoses of classical citrullinemia. Hum.Mutat. 9 (1997) 250–259PubMedGoogle Scholar
  902. Northrup, H., A.L. Beaudet and W.E. O’Brien, Prenatal diagnosis of citrullinaemia: Review of a 10-year experience including recent use of DNA analysis. Prenatal Diagn. 10 (1990)771–779Google Scholar
  903. Kumar, S. and R. Rankin, Renal insufficiency is a component of COACH syndrome. Am.J.Med. Genet. 61 (1996) 122–126PubMedGoogle Scholar
  904. Verloes, A. and C. Lambotte, Further delineation of a syndrome of cerebellar vermis hypo/aplasia, oligophrenia, congenital ataxia, coloboma, and hepatic fibrosis. Am.J.Med.Genet. 32 (1989) 227–232PubMedGoogle Scholar
  905. Dianov, G.L., J.-F. Houle, N. lyer et al., Reduced RNA polymerase II transcription in extracts of Cockayne syndrome and Xeroderma pigmentosum/ Cockayne syndrome cells. Nucleic Acid Res. 25 (1997) 3636–3642PubMedGoogle Scholar
  906. Ellis, N.A., DNA helicases in inherited human disorders. Genet.Develop. 7 (1997) 354–363Google Scholar
  907. Hamel, B.C.J., A. Raams, A.R. Schuitema-Dijkstra, P. Simons, I. van der Burgt, N.G.J. Jaspers and W.J. Kleijer, Xeroderma pigmentosum-Cockayne syndrome complex: a further case. J.Med.Genet. 33(1996) 607–610PubMedGoogle Scholar
  908. Itoh, T.J.E. Cleaver and M. Yamaizumi, Cockayne syndrome complementation group B associated with xeroderma pigmentosum phenotype. Hum.Genet. 57 (1996) 176–179Google Scholar
  909. Lehmann, A.R., A.F. Thompson, S.A. Harcourt, M. Stefanini and P.G. Norris, Cockayne’s syndrome: correlation of clinical features with cellular sensitivity of RNA synthesis to UV irradiation. J.Med.Genet. 30(1993) 679–682PubMedGoogle Scholar
  910. Mallery, D.L., B. Tanganelli, S. Colella, H. Steingrimsdottir, A.J. van Gool, C. Troestra, M. Stefanini and A.R. Lehmann, Molecular analysis of mutations in the CSB (ERCC6)gene in patients with Cockayne syndrome. Am.J.Hum.Genet. 62(1998) 77–85PubMedGoogle Scholar
  911. Stefanini, M., H. Fawcett, E. Botta, T. Tiziana and A.R. Lehmann, Genetic analysis of twenty-two patients with Cockayne syndrome. Hum.Genet. 97 (1996) 418–423PubMedGoogle Scholar
  912. Troelstra, C., R.M. Landsvater, J. Wiegand, M. van der Ploeg, G. Viel, C.H.C.M. Buys and J.H.J. Hoeijmakers, Localization of the nucleotide excision repair gene ERCC6 to human chromosome 10qll-q21. Genomics 12 (1992) 745–749PubMedGoogle Scholar
  913. Venema, J., L.H.F. Mulienders, A.T. Natarajan et al., The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc.Acad.Sci.USA 87(1990) 4707–4711Google Scholar
  914. Vermeulen, W., J. Jaeken, N.G.J. Jaspers, D. Bootsma and J.H.J. Hoeijmakers, Xeroderma pigmentosum complementation group G associated with Cockayne syndrome. Am.J.Hum.Genet. 53(1993) 185–192PubMedGoogle Scholar
  915. Gilgenkrantz, S., P. Mujica et al., Coffin-Lowry syndrome: a multicenter study. Clin.Genet. 34(1988) 230–245PubMedGoogle Scholar
  916. Jacquot, S., K. Merienne, D. De Cesare et al., Mutation analysis of the RSK2gene in Coffin-Lowry patients: Extensive allelic heterogeneity and a high rate of de novo mutations. Am.J.Hum.Genet. 63(1998) 1631–1640PubMedGoogle Scholar
  917. Plomp, A.S., C.E.M. De Die-Smulders, P. Meinecke, J.M. Ypma-Verhulst, D.A. Lissone and J.P. Fryns, Coffin-Lowry syndrome: Clinical aspects at different ages and symptoms in female carriers. Genet.Counsel. 6(1995) 259–268PubMedGoogle Scholar
  918. Trivier, E., D. DeCesare, S. Jacquot, S. Pannetier, E. Zackai et al., Mutations in the kinase Rsk-2 associated with COFFIN-LOWRY syndrome. Nature 384(1996) 567–570PubMedGoogle Scholar
  919. Fryns, J.P., On the nosology of the Cornelia de Lange and Coffin-Siris syndrome. Clin.Genet. 29(1986) 262–267Google Scholar
  920. Levy, P. and M. Baraitser, Coffin-Siris syndrome. J.Med.Genet. 28(1991) 338–341PubMedGoogle Scholar
  921. Podder, S. and R.C. Shepherd, Cogan’s syndrome: A rare systemic vasculitits. Arch.Dis.Chiid. 71(1994) 163–164Google Scholar
  922. Fryns, J.P., E. Legius, K. Devriendt, F. Meire, L. Standaert et al., Cohen syndrome: the clinical symptoms and stigmata at a young age. Clin.Genet. 49(1996) 237–241PubMedGoogle Scholar
  923. Kolehmainen, J., R. Norio, S. Kivitie-Kallio, E. Tahvanainen, A. de la Chapelle and A.-E. Lehesjoki, Refined mapping of the COHEN syndrome gene by linkage disequilibrium. Eur.J.Hum.Genet. 5(1997) 206–2l3PubMedGoogle Scholar
  924. Kondo, I., S. Nagataki and N. Miyagi, The Cohen syndrome: Does mottled retina separate a Finnish and a Jewish type? Am.J.Med.Genet. 37(1990) 109–1l3PubMedGoogle Scholar
  925. Massa, G., L. Dooms and M. Vanderschueren-Lodeweyckx, Growth hormone deficiency in a girl with the Cohen syndrome. J.Med.Genet. 28(1991) 48–50PubMedGoogle Scholar
  926. Tahvanainen, E., R. Norio, E. Karila, S. Ranta, J. Weissenbach, P. Sistonen and A. de la Chapelle, Cohen syndrome gene assigned to the long arm of chromosome 8 by linkage analysis. Nature Genet. 7(1994) 201–204PubMedGoogle Scholar
  927. Cahill, R.J., C.J.Foltz, J.G.Fox, C.A.Dangler, F.Powrie and D.B.Schauer, Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infections and Immunity (1997) 3126–3131Google Scholar
  928. Cho, J.H., D.L. Nicolae, L.H. Gold et al., Identification of novel susceptibility loci for inflammatory bowel disease on chromosome 1 p, 3q, and 4q: Evidence for epistasis between 1 p and IBD 1. Proc.Natl.Acad.Sci.USA 95(1998) 7502–7507PubMedGoogle Scholar
  929. Lashner, B.A., A.A. Evans, J.B. Kirsner and S.B. Hanauer, Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology 91(1986) l346–1400Google Scholar
  930. Orholm, M., L. Iselius, r.I.A. Sorensen et al., Investigation of inheritance of chronic inflammatory bowel disease by complex segregation analysis. BLMed.J. 306(1993) 20–24Google Scholar
  931. Orholm, M., P. Munkholm, E. Langholz et al., Familial occurrence of inflammatory bowel disease. New.Engi.J.Mcd. 324(1991) 84–88Google Scholar
  932. Stokkers, P.C.F., B.E. Van Aken, N. Basoski et al., Five markes in the interleukin 1 family in relation to inflammatory bowel disease. Gut 43(1998) 33–39PubMedGoogle Scholar
  933. Fijen, C.A.P., R. Van den Bogaard, M.R. Daha et al., Carrier detection by microsatellite haplotyping in 10 properdin type 1-deficient families. Eur.J. Clin.Invest. 26(1996) 902–906PubMedGoogle Scholar
  934. Schneider, P.M. and R. Würzner, Complement genetics: Biological implications of polymorphisms and deficiencies. Immunology today 20(1999) 2–6PubMedGoogle Scholar
  935. Eriksson, A.W., W. Lehmann and H. Forsius, Congenital cornea plana in Finland. Clin.Genet. 4(1973) 301–310PubMedGoogle Scholar
  936. Sigier-Villanueva, A., E. Tahvanainen, S. Lindh et al., Autosomal dominant cornea plana: Clinical findings in a Cuban family and a review of the literature. Ophthalmic Genet. 18(1997) 55–62Google Scholar
  937. Tahvanainen, E., H. Forsius, E. Karila, S. Ranta, M. Eerola, J. Weissenbach, P. Sistonen and A. de la Chapelle, Cornea plana congenita gene assigned to the long arm of chromosome 12 by linkage analysis. Genomics 26(1995) 290–293PubMedGoogle Scholar
  938. Allen, M.I.van, G. FiliPPi, J. Siegel-Bartelt, S.-L. Yong, B. McGillivray et al, Clinical variability within BRACH Mann-de Lange syndrome: a proposed classification system. Am.J.Med.Genet. 47(1993) 947–958PubMedGoogle Scholar
  939. Blaschke, R.J., A.P. Monaghan, S. Schiller, B. Schechinger et al., Shota Shox-related homeobox gene, is implicated in craniofacial, brain, heart, and limb development. Proc.Nat.Acad.Sci. 95(1998) 2406–2411PubMedGoogle Scholar
  940. Holder, S.E., L.M. Grimsley, R.W. Palmer, L.J. Butler and M. Baraitser, Partial trisomy 3q causing mild Cornelia-de-Lange phenotype. J.Med.Genet. 31(1994) 150–152PubMedGoogle Scholar
  941. McKenney, R.R., F.F.B. Elder, J. Garcia and H. Northrup, Brachmann-de-Lange syndrome: Autosomal dominant inheritance and male-tomale transmission. Am.J.Med.Genet. 66(1996) 44–49Google Scholar
  942. Andermann, E., F. Andermann, S. Carpenter, G. Karpati, A. Eisen, O. Melancon and J. Bergeron, Agenesis of the corpus callosum with sensorimotor neuropathy: a new autosomal recessive malformation syndrome with high frequency in Charlevoix County. Birth Oef., Orig.Art.Ser. 13/3 B (1977) 232–233Google Scholar
  943. Blum, A., M. Andre, P. Oroulle et al., Prenatal echographic diagnosis of corpus callosum agenesis. The Nancy experience 1982–1989. Genet.Counsel. 1(1990) 115–126PubMedGoogle Scholar
  944. Naritomi, K., Y. Chinen and Y. Asato, Agenesis of corpus callosum in three sibs. Jpn.J.Hum.Genet. 42(1997) 539–541PubMedGoogle Scholar
  945. Costello, J.M., Costello syndrome: Update on the original cases and commentary. Am.J.Med.Genet. 62(1996) 199–201PubMedGoogle Scholar
  946. Mori, M., T. Yamagata, Y. Mori, M. Nokubi, K. Saito, Y. Fukushiam and M.Y. Momoi, Elastic fiber degeneration in Costello syndrome. Am.J.Med.Genet. 61(1996) 304–309PubMedGoogle Scholar
  947. Okamoto, N., H. Chiyo, K. Imai, K. Otani and Y. Futagi, A Japanese patient with the Costello syndrome. Hum.Genet. 93(1994) 605–606PubMedGoogle Scholar
  948. Pratesi, R., M. Santos and Lferrari, Costello syndrome in two Brazilian children. J.Med.Genet. 35(1998) 54–57PubMedGoogle Scholar
  949. Zampino, G., P. Mastroiacov, R. Ricci et al., Costello syndrome: Further clinical delineation, natural history, genetic definition, and nosology. Am.J.Med.Genet. 47(1993) 176–183PubMedGoogle Scholar
  950. Eng, Ch., V. Murday, S. Saei, S. Mohammed, S.V. Hodgson, M.A. Chaudary, LS. Fentiman, B.A.J. Ponder, R.A. Eeles, Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy ? J.Med.Genet. 31(1994) 458–46lPubMedGoogle Scholar
  951. Eng, c., Genetics of Cowden syndrome: Through the lokingglass of oncology. (Review). Int.J.Onc- ol. 12(1998) 701–710Google Scholar
  952. Hansen, A.M.N., W.H. Suys and J.P. Fryns, Cowden syndrome: report of a large family with macrocephaly and increased severity of signs in subsequent generations. Clin.Genet. 44(1993) 281- 286Google Scholar
  953. Liaw, D., D.J.Marsh, J.Li, P.L.M.Dahia, S.Lwang et al., Germline mutations of the Ptengene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16(1997) 64–67PubMedGoogle Scholar
  954. Nelen, M-R., G.W. Padberg, E.A.J. Peeters et al., Localization of the gene for Cowden disease to chromosome 10q22–23. Nature Genet. 13(1996) 114–116PubMedGoogle Scholar
  955. Tsou, H.C., D.H.-F. Teng, X.L. Ping, V. Bransolini, T. Davis et al., The role of Mmac1mutation in early-onset breast cancer: causative in association with Cowden syndrome and excluded in Brcal-negative cases. Am.J.Hum.Genet. 61(1997) 1036–1043PubMedGoogle Scholar
  956. Tsuchiya, K.D., G. Wiesner, S.B. Cassidy, C. Lingwongse, J.T. Boyle and S. Schwartz, Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden- like syndrome. Genes Chromosomes Cancer 21(1998) 113–118PubMedGoogle Scholar
  957. Yamasaki, M., P. Thompson and V. Lemon, Crash syndrome: Mutations in L1camcorrelate with severity of the disease. Neuropediatrics 28(1997) 175–178PubMedGoogle Scholar
  958. Bertoni, J.M., P. Brown, L.G. Goldfarb et al., Familial Creutzfeldt-Jakob disease (codon 200 mutation) with supranuclear palsy. J.Am.Med.Assoc. 268(1992) 2413–2415Google Scholar
  959. Bosque, P.J., C.L. Vnencak-Jones, M.D. Johnson et al., A PrP gene codon 178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt-Jakob disease. Neurology 42(1992) 1864–1870PubMedGoogle Scholar
  960. Kitamoto, T., N. Amano, Y. Terao et al., A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann.Neurol. 34(1993) 808–813PubMedGoogle Scholar
  961. Kitamoto, T., M. Ohta, K. Dohura et al., Novel missense variants of prion protein in Creutzfeldt- Jakob disease of Gerstmann-Straussler syndrome. Biochem.Biophys.Res.Commun. 191(1993) 709–714PubMedGoogle Scholar
  962. Kretschmar, H.A., P. Kufer, G. Riethmuller et al., Prion protein mutation at codon 102 in an Italian family with Gerstmann-Straussler-Scheinker syndrome. Neurology 42(1992) 809–810Google Scholar
  963. Kretzschmar, H.A. and O. Windl, Spongiforme Enzephalopathien. In: Rieß, O. und L. Schöls (Hrsg.) Neurogenetik. Molekulargenetische Diagnostik neurologischer Erkrankungen. Springer-Veri. Berlin, Heidelberg. 1998, S. 95–107Google Scholar
  964. Palmer, M.S., S.P. Mahal, T.A. Campbell, A.F. Hill, K.C.L. Sidle, J.L. Laplanche and J. Collinge, Deletions in the prion protein gene are not associated with CJD. Hum.Molec.Genet. 2(1993) 541–544PubMedGoogle Scholar
  965. Palmer, M.S. and J. Collinge, Mutations and polymorphisms in the prion protein gene. Hum.Mut. 2(1993) 168–173PubMedGoogle Scholar
  966. Petersen, R.B., M. Tabaton, L. Berg et al., Analysis of the prion protein gene in thalamic dementia. Neurology 42(1992) 1859–1863PubMedGoogle Scholar
  967. Prusiner, S.B. and M.R. Scott, Genetics of prions. Annu.Rev.Genet. 31(1997) 139–157PubMedGoogle Scholar
  968. Speer, M.e., D. Goldgaber, L.G. Goldfarb et al., Support of linkage of Gerstmann-Straussler-Scheinker syndrome to prion protein gene on chromosome 20p12-pter. Genomics 9(1991) 366–368PubMedGoogle Scholar
  969. Borgaonkar, D.S., Chromosomal Variation in Man. A Catalog of Chromosomal Variants and Anomalies, 8th Edit. Wiley-Liss, New York, Chichester, Brisbane, Toronto, Singapore 1997Google Scholar
  970. Overhauser, J., X. Huang, M. Gersh et al., Molecular and phenotypic mapping of the short arm of chromosome 5: sublocalization of the critical region for the cri-du-chat syndrome. Hum.Molec.Genet. 3(1994) 247–252PubMedGoogle Scholar
  971. Adachi, Y., T. Kamisako, O. Koiwai et al., Genetic background of constitutional unconjugated hyperbilirubinemia. Int.Hepatoi. Commun. 5(1996) 297–307Google Scholar
  972. Moghrabi, N., D.J. Clarke, B. Burchell and M. Boxer, Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: Implication in carrier detection and prenatal diagnosis. Am.J.Hum.Genet. 53(1993) 722–729PubMedGoogle Scholar
  973. Nowicki, M.J. and J.R. Poley, The hereditary hyperbilirubinaemias. Baillierés Clin.Gatroenteroi. 12(1998) 355–367Google Scholar
  974. Ritter, J.K., M.T. Yeatman, P. Ferreira and I.S. owens, Identification of a genetic alteration in the code for bilirubin UDP-glucuronyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J.Clin.Invest. 90(1992) 150–155PubMedGoogle Scholar
  975. Akolkar, P.N., B. Gulwani-Akolkar, D. Heresbach et al., Differences in risk of Crohn’s disease in offspring of mothers and fathers with inflammatory bowel disease. Am.J.Gastroenterol. 92(1997) 2241–2244PubMedGoogle Scholar
  976. Balas, A., J.L. Vicario, A. Zambrano et al., Absolute linkage of celiac disease and dermatitis herpetiformis to Hla-dq. Tissue Antigens 50 (1997)52–56PubMedGoogle Scholar
  977. Binder, V. and M. Orholm, Familial occurrence and inheritance studies in inflammatory bowel disease. Neth.J.Med. 48(1996) 53–56PubMedGoogle Scholar
  978. Cahill, R.J., C.J. Foltz, J.G. Fox, C.A. Dangler, F. Powrie and D.B. Schauer, Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infections and immunity (1997) 3126–313lGoogle Scholar
  979. Cho, J.H., D.L. Nicolae, L.H. Gold et al., Identification of novel susceptibility loci for inflammatory bowel disease on chromosome Ip, 3q, and 4q: Evidence for epistasis between 1p and IBD1. Proc.Natl.Acad.Sci.USA 95(1998) 7502–7507PubMedGoogle Scholar
  980. Hugot, J.-P., P. Laurent-Puig, C. Gower-Rousseau et al., Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379(1996) 821–823PubMedGoogle Scholar
  981. Küster, W., L. Pascone, J. Purrmann, S. Funk and F. Majewski, The genetics of Crohn disease: Complex segregation analysis of a family study with 265 patients with CROHN disease and 5,387 relatives. Am.J.Med.Genet. 32(1989) 105–108PubMedGoogle Scholar
  982. Orholm, M., L. lselius, T.I.A. Sorensen et al., Investigation of inheritance of chronic inflammatory bowel disease by complex segregation analysis. Br.Med.J. 306(1993) 20–24Google Scholar
  983. Polito, II J.M., R.C. Rees, B. Child et al., Preliminary evidence for genetic anticipation in Crohn’s disease. Lancet 347(1996) 798–800PubMedGoogle Scholar
  984. Navarrete, C., R. Pena, R. Penaloza and F. Salamenca, Germinal mosaicism in Crouzon syndrome. A family with three affected siblings of normal parents. Clin.Genet. 40(1991) 29–34PubMedGoogle Scholar
  985. Preston, R.A., J.C. Post, B.J.B. Keats, C.E. Aston, R.E. Ferrell, J. Priest, N. Nouri, H.W. Losken, C.A. Morris, M.R. Hurt, J.J. Mulvihill and G.D. Ehrlich, A gene for Crouzon craniofacial dysostosis maps to the long arm of chromosome 10. Nature Genet. 7(1994) 149–152PubMedGoogle Scholar
  986. Rollnick, B.R., Germinal mosaicism in Crouzon syndrome. Clin. Genet. 33(1988) 145–150PubMedGoogle Scholar
  987. Steinberger, D., F. Vriend, J.B. Mulliken and U. Müller, The mutations in FGFR2-associated craniosynostoses are clustered in five structural elements of immunoglobulin-like domain III of the receptor. Hum.Genet. 102(1998) 145–150PubMedGoogle Scholar
  988. Crameri, J.A., W.D.A. Ford and L.I. Morris, Familial triad of anorectal, sacrococcygeal and presacral anomalies that includes sacrococcygeal teratomas. Pediat.Surg.Int. 10(1995) 350–353Google Scholar
  989. Holthusen, W., T. Birtel, J. Brinkmann, J. Gunkel, C. Jannek und E. Richter, Die Currarino-Triade. Fortschr.Rontgenstr. 143(1985) 83–89Google Scholar
  990. Nagai, T., R. Katoh, T. Hasegawa, H. Ohashi and Y. Fukushima, Currarino triad (anorectal malformation, sacral bony abnormality and presacral mass) with partial trisomy of chromosomes 13q and 20p. Clin.Genet. 45(1994) 272–273PubMedGoogle Scholar
  991. Howard, T.D., A.E. Guttmacher, W. McKinnon, M. Sharma, V.A. McKusick and E.W. Jabs, Autosomal dominant postaxial polydactyly, nail dystrophy, and dental abnormalities map to chromosome 4p16, in the region containing the ELLIs-van Creveld syndrome locus. Am.J. Hum.Genet. 61(1997) 1405–1412PubMedGoogle Scholar
  992. Roubicek, M. and J. Spranger, Weyers akrodental dysostosis in a family. Clin.Genet. 26(1984) 287–290Google Scholar
  993. Shapiro, S.D., R.J. Jorgenson and e.F. Salinas, Curry- Hall syndrome. Am.J.Med.Genet. 17(1984) 579–583PubMedGoogle Scholar
  994. Temple, I.K., D.M. Eccles, R.M. Winter, M. Baraitser, S.B. Carr et al., Craniofacial abnormalities, agenesis of the corpus callosum, polysyndactyly and abnormal skin and gut development – the Curry-Jones syndrome. Clin.Dysmorphol. 4(1995) 116–129PubMedGoogle Scholar
  995. Findley, J.e., L.R. Sheeler, W.C. Engeland and D.e. Aron, Familial adrenocorticotropin-independent Cushing’s syndrome with bilateral macronodular adrenal hyperplasia. J.Clin.Endocrin. Metab. 76(1993) 189–191Google Scholar
  996. Minami, S., H. Sugihara, J. Sato et al., ACTH independent Cushing’s syndrome occurring in siblings. Clin.Endocrinol. 44(1996) 483–488Google Scholar
  997. Damkier, A., F. Bandrup and H. Starklint, Cutis laxa: autosomal dominant inheritance in five generations. Clin.Genet. 39(1991) 321–329PubMedGoogle Scholar
  998. Davies, S.J. and H.E. Hughes, Costello syndrome: natural history and differential diagnosis of cutis laxa. J.Med.Genet. 31(1994) 486–489PubMedGoogle Scholar
  999. Khakoo, A., R. Thomas, R. Trompeter, P. Duffy, R. Price and F.M. Pope, Congenital cutis laxa and lysyl oxidase deficiency. Clin.Genet. 51(1997) 109–114PubMedGoogle Scholar
  1000. Ogur, G., M. Yuksel-Apak and M. Demiryont, Syndrome of congenital cutis laxa with ligamentous laxity and delayed development: Report of a brother and sister from Turkey. Am.J.Med.Genet. 37(1990) 6–9PubMedGoogle Scholar
  1001. Tassabehji, M., K. Metcalfe, J. Hurst et al., An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fibres in a patient with autosomal dominant cutis laxa. Hum.Mol.Genet. 7(1998) 1021–1028PubMed